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ABSTRACT 
ABSTRACT 
The production of p-lactamase was found as the single most prevalent mechanism 
which was responsible for resistance to P-lactams among clinical isolates of the 
family Enterobacteriaceae (Sanders et al. 1992) and extended spectrum p-lactamases 
(ESBLs) which mediate resistance to oxyimino-cephalosporins but not to 
cephamycins were observed worldwide in majority of species of Enterobacteriaceae 
(Bradford 2001). Extended Spectrum P-lactamases (ESBLs) are widespread all over 
the world, but the prevalence and phenotypic characteristic among clinical isolates 
may vary between geographical areas (Winokur et al. 2001; Navon-Venezia et al. 
2003). This geographical difference may be due to the differences in the use of 
antibiotics and selection of organisms. TEM and SHV were found as the most 
prevalent type of ESBLs followed by CTX-M enzymes in various countries (Xiong et 
al. 2002; Mulvey et al. 2004). CTX-M is the most common type of ESBL and has 
been reported in Enterobacteriaceae isolates from various countries including Poland, 
Canada, France, UK, Russia, Cameroon, Japan and Bulgaria (Bonnet 2004; Novais et 
al. 2007; Coque et al. 2008, Shahid et al. 2011). and also in India (Ensor et al 2006). 
There are reports from various countries describing the concurrent occurrence of 
blacTx-M, blasHv and blajEM in Enterobacteriaceae (Al-Agamy et al. 2009; Kalantar & 
Mansouri 2010; Bali et al. 2010) however, similar reports are fragmentary from India. 
There are onl}' few recent reports describing the co-occurrence of these genes 
especially in Klebsiella. Enterohacter and Citrohacter spp. (Grover et al. 2006; 
Muzaheed et al. 2009; Goyal et al. 2009; Kingsley et al 2008; Shahid et al. 2011). 
Co-existence of class A and class C type p-lactamases in Enterobacteriaceae is 
frcquentK- reported from many countries (Saladin ei al. 2002; Song et al. 2006: 
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Moland et al 2007), however fragmentary reports are provided from India regarding 
co-occuiTence of class A and class C type P-lactamases (Shahid et al. 2009). Hence, 
this study was designed to investigate in greater details for the presence of bla genes 
of Class A type ESBLs and Class C type P-lactamases in Indian Enterobacteriaceae. 
Moreover due to paucity of Indian literature on mobile genetic elements {ISEcp], 
IS26, 0RFJ7i, CS, SuI-1) and their association with ESBLs, especially CTX-M, this 
fact prompted us to investigate systematically the presence of the said mobile genetic 
elements and their association with ESBLs in our collection of Indian 
Enterobacteriaceae. 
In the present study maximum numbers of isolates were obtained from pus samples 
(53.8%), followed by urine (31.5%), and then drain (5.3%). We obtained the major 
numbers of isolates from clinical samples of Surgery (57), followed by Gynaecology 
(29), Orthopaedic (25), Medicine (12) and Paediatric (7). Furthermore, to study the 
ESBL production in of our collection we subdivided this part in the phenotypic and 
genotypic experiments for determination of CTX-M type P-lactamase. We found most 
of the isolates, resistant to any of the third generation cephalosporins which included 
100% resistance to cefotaxime, followed by the forth-generation cephalosporins, 
78.4% resistance to cefpirome and 63% to cefepime. Resistance to cefotaxime was the 
main marker of our bacterial isolates indicating the presence ofhlacjx-M genes. Along 
with rising resistance to cephalosporins, the second highest rates of resistance was 
noticed for fluoroquinolone (88.4% to ofloxacin and 83.8% to gatifloxacin) but the 
genes responsible for this resistance were not studied in this study. However, 
resistance rates to aminoglycosides in our collection were not comparatively so high 
(56.1% to gentamycin and 41.5% to amikacin) as compared to cephalosporins and 
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fluoroquinolones. Resistance rates to third- as well as fourth- generation 
cephalosporins in our collection indicate the presence of class A and class C type P-
lactamases. On confirming ESBL-production by full for (DDST), (CDT) and 
(MTDET), higher numbers of ESBL producers were observed by CDT (89.2%) as 
compared to DDST (78.4%) and MTDET (80%). All isolates were found as ESBL-
producers by any of the three phenotypic confirmatory tests. Genotypically by 
monoplex PCR, 86.1% (112) were found to harbour blacrx-u genes. Most probably, 
any other enzyme mimics the property of CTX-M type P-lactamases so we observed 
resistance to cefotaxime in higher number of isolates while blacix-u was noticed in 
lesser number of isolates. On reviewing the Indian literature for the presence of 
different CTX-M type genogroups we found CTX-M genogroup-1 as the predominant 
genogroup (Ensor et al. 2006; Shahid et al. 2009). Similar to previous reports we also 
observed CTX-M-genogroup-1 as dominant genogroup, while in this collection we 
have also found five E. coli isolates harbouring one more genogroup in association 
with genogroup-1. Of which one isolate was found positive for genogroup-8 and four 
were found positive for genogroup-9. Of the four isolates that harboured CTX-M-
genogroup-9 only one isolate provided the amolicon that corresponded with 
correspond the exact amplicon size (205 bp) of genogroup-9 while other three isolates 
did not provided the amplicon that corresponding to the exact position for genogroup-
9. On sequencing of the representative isolates, the amplicons of CTX-M-genogroup-
1 were confirmed as CTX-M-15 type. The sequencing results of amplicon of 
genogroup-9 (that corresponded to the exact amplicon size) confirmed it to be CTX-
M-9 like. Thus, we for the first time have observed the presence of CTX-M 
genogroup-9 in Indian Enterobacterial isolates. Moreover, it shows that the different 
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genogroups of CTX-M type of ESBLs are also rapidly emerging in Indian 
Enterobacteriaceae. 
In the second part of this study all isolates were determined for co-occurrence of TEM 
and SHV type ESBLs by PCR. blacrx-M, blasuv and blai^u alone were noticed in 
29.7%, 2.4% and 3.3% of cefotaxime resistant isolates. Maximum number of isolates 
showed the combination of ^/OCTX-M+^/OSHV+^/^TEM (30.3%), followed by blacjx-
M+hlasHv (23.2%). The resistance pattern of the isolates for fourth generation 
cephalosporins showed the presence of class C type P-lactamases in the present 
collection. So in this part of study we also determined all /^OESBL positive isolates for 
co-existence of bkhmpc- We noticed that 71.9% isolates showed co-existence of 
blai-sBis and bla^mpc- We noticed higher co-existence (81.2%) of these class C type P-
lactamases in those isolates that harbours blacjx-M+hlajEM and then in 76.9% and 
76.4% isolates harbouring ^/ACTX-M+^/^SHV and blacix-'w&bla^YU+bla^wy genes, 
respectively. Least co-existence for bla^mpc was noticed in isolates harbouring blacjx-
M genes only. This is showing that the probability for co-existence of class C type P-
lactamases increases if any other type of ESBL gene also exists with hhcrx-M type. 
On comparative evaluation of occurrence of Class A and Class C type P-lactamases in 
Enterohaderiaceae during 2009 and 2010. we noticed nearly similar occurrence of 
bla\:sBis ill 92.1% and 94.4% isolates in the respective years, 2009 and 2010. Various 
combinations of /'/AHSBIS like blacix-M, blacjx-M~^blasHV-, blacYx-M+blamM, and 
blac\x-h&blasuv+hlaj\:M were observed in 31.4%, 18.5%, 20%, and 25.7% isolates 
harbouring these genes, respectively, in 2009, while in 2010 these combinations were 
noticed in, 27.4%, 25.4%, 3.9%, and 31.3% isolates, respectively. We also observed 
that in 2010 the combination of hianx-M+bICIWM genes were observed in only 3.9% 
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isolates while in 2009, 20% isolates were found to harbour the same combination. In 
2010, we have noticed 3.9% isolates harbouring combination of 6/asHv+6/flTEM while 
this combination was absent in 2009 collection. By PCR, in isolates which harboured 
bla£SBLs, bloampc type ^-lactamases were observed in 81.4% and 58.8% isolates in the 
collections of year 2009 and 2010, respectively. In 2009, co-existence of bla^mpc was 
noticed in 86.3%, 92.3%, 85.7%, 72.2% isolates which harboured different 
combinations of blacjx-M, blacTx-M+blosHv, blacTx-M^blajEu, blacjx-
M+blas\jv+blajEM, respectively, while in 2010 the co-existence of/j/^ ampc with these 
combinations was observed in 42.8%), 61.5%, 50%), and 81.2% isolates, respectively. 
In 2010 we observed that the isolates harbouring combination of bla^\\\+bla-xEM were 
found positive for co-existence of bhampc- While in 2009, we also noticed that of the 
two isolates that harboured /J/OSHV only, one was found positive for co-existence with 
bloampL- while in 2010 none of the isolate harbouring blas^v or blajzM only showed 
this co-existence. This study reflects that the occurrence of various bla genes has 
reduced from 2009 to 2010. This is showing that the implementation of antibiotic 
prescription policies in our institution is moving on a right track. 
In the third part we have studied all isolates for the presence of mobile genetic 
elements to understand the mobilization pattern of various bla genes among Indian 
Enterobacteriaceae. These mobile genetic elements included integrons {sul-I type 
class 1 integrons and CS regions of integrons) and insertion sequences [ISEccpL 
IS26. \SCR1). We have noticed 89.2% isolates harbouring these mobile genetic 
elements. Of the total 112 isolates harbouring bbcTx-M genes. 92.8% isolates were 
found associated with these mobile genetic elements. In all CTX-M positive isolates. 
62.5%. 54.4%. 32.1%. 61.6%, and 60.7% isolates were found associated with ISEcpl. 
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\SCR1 {ORF513), IS26, sul-1 type class 1 integron and CS regions, respectively. This 
showed nearly equal number of CTX-M harbouring isolates was associated with 
ISEcp], sul-1 and CS regions, followed by ORF513, but least number of the isolates 
were observed associated with IS2(5. 76.1% isolates showed the presence of Integrons 
which included sul-1 type class 1 integrons and CS variable regions of integrons. 
59.2% isolates were noticed positive for the presence of sul-1 type class 1 integrons. 
We also observed that higher number of isolates harbouring blacjx-M, ^^^TEM and 
blasHv, were observed associated with sul-1 gene and suggests their mobilization by 
sul-1 type class 1 integrons. While least association with sul-\ type integron was 
noticed in isolates harbouring combination of blacjx-M+blaTZM- 3.8% isolates were 
also found to possess sul-I type class 1 integrons but not associated with any bla gene 
noticed in this study: probably these integrons were mobilizing some other resistance 
genes such as aminoglycosides and flouroquinoolones resistance genes. 55.3% 
isolates (harbouring ail three types of bla genes i.e. CTX-M, TEM and SHV) were 
noticed positive for the presence of variable regions of CS integrons. We have also 
noticed isolates harbouring variable amplicon sizes of CS regions at ~1.6kb, ~900bp, 
~800bp, ~500bp. ~-450bp. ~350bp, and ~180bp, while some of the isolates were also 
harbouring multiple amplicons. The occurrence of CS regions (specific regions for 
integrons) was noticed in 55.3% (72/130) whereas the sul-1 type class-1 integrons 
was observed in 59.2% (77/130). This showed higher occurrence of classic class 1 
integrons due to the presence of sul-1 gene in 3'CS region as previously reported by 
Partridge et al (2009). We obserxed 17 isolates to harbour CS regions but not found 
positive for sul-l genes, this is showing the presence of non-classic class 1 integrons 
as previously reported by Vinue et al. (2010), that the qacEAl-sull fragment of 
normal 3'CS region replaced by qacH-lS440-sul3. 
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On detection of insertion sequences like ISEcpl, ORP513 and IS26 we have noticed 
83% isolates containing any of these insertion sequences to mobilize bla genes. 
Resistance genes of 56.9% isolates were mobilized by ISEcpl type insertion 
sequences, while 53.07% and 32% isolates were mobilized by ORF513 and IS26, 
respectively. On analysing ISEcpl type genetic element in the isolates harbouring 
various combinations of bla^sBis, maximum number (29.7%) of isolates harboured 
combination of /^acrx-M+ /^'^ TEM+ /^flSHv- Those isolates that harbour blaj^M and 
combination of blaxEM+blasHv were not found to be associated with ISEcpl, while 
association ofblosuw was noticed with ISEcpl. 53.07% isolates were detected for the 
presence of ORF513 (also known as ISCRl) associated with blaESBis- It was found 
associated with all types of A/OESBLS v.i.z. blacrx-wi, blaj^M, and blasnv, and also in the 
isolates which harbour hlajiM or hlasnv alone. This is showing that ORF513 type 
insertion sequence can mobilize an\' type of bla^sBi- In this study we have noticed 
only 33%o isolates positive for IS26 type insertion sequences to mobilize associated 
bla genes. These isolates harboured variable size of ampiicons i.e. 1.8kb, ~850bp, 
~800bp, ~700bp, ~650bp, ~600bp, ~590bp, ~550bp, ~350bp, and ~180bp, some 
isolates also showed multiple amplicons of \S26 elements. In the present study we 
found that majority of the isolates showed amolicon of ~850bp. In our study, in 
isolates that harboured ISEcpl like insertion sequences, 31.5% isolates were found 
flanking by the \S26 elements. In this study we found four isolates that harboured 
blac\x-M alone, and were associated with only IS26 elements. It represents that this 
gene can be mobilized only with the help of this mobile element. 79.3% isolates 
harbouring sul-1 type class 1 integrons were found associated with ORF513. This is 
showing higher occurrence of complex class 1 integrons in studied collection of 
Indian Enterohacteriaceae. On determination of various combinations of mobile 
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genetic elements in present collection, sul-]+CS+ORF5\3+lSEcpl is the most 
common combination of mobile genetic elements followed by sul-I+CS+ 
IS£'c/?/+ORF513+IS26. None of the studied isolates represents the 
IS£c/?7+ORP513+IS2<5 combination of mobilizing elements. In this study, all isolates 
have shown a single plasmid of c.a.~23 kb. On analysis of randomly selected 
plasmids for CTX-M genogroups by multiplex PCR, most of the isolates have shown 
occurrence of CTX-M-genogroup-1 on plasmids while the isolate found positive for 
genogroup-1 and genogroup-9 also showed the presence of these genogroups on 
plasmids. The isolate that harboured CTX-M genogroup-1 and genogroup-9 also 
showed the presence of sul-l+CS+ lSEcpI+lS26 but was not found positive for 
ORF513. 
On RAPD typing of our collection, we observed that out of 130 isolates, 51 isolates 
could be clustered into 18 clusters which included 15 clusters of £. coli and 3 clusters 
of Klebsiella spp. Most of the isolates that were clustered in different groups were 
from Surgery, and have also been found clonally related with the isolates collected 
from various other wards such as Orthopaedic, Medicine, Gynaecology and 
Paediatric. Only one isolate from Paediatric ward was found clonally related with 
isolates of Surgery and Gynaecology. Based on this study we reached to following 
conclusions: 
Conclusions 
*l* In the present study higher resistance rates were observed in our collection of 
Enterobacterial isolates. Among third-generation cephalosporins, 100% 
isolates were resistant to cefotaxime, followed by resistance to fourth-
generation cephalosporins. In our collection flouroquinolones also showed 
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higher resistance rates such as 88.4% to ofloxacin but comparatively lower 
resistance rates to aminoglycosides was noticed. Resistance rates and patterns 
to third- as well as fourth-generation cephalosporins denotes the presence of 
class A and class C type P-lactamases in this collection of North Indian 
Enterobacteriaceae. 
<• All cefotaxime resistant isolates were found as ESBL producers on the basis of 
any of the three detection methods such as double disk synergy test (DDST), 
combination disk test (CDT) and modified three-dimensional extract test 
(MTDET). In the present study we found CDT as the best detection method 
for identification of ESBL producers. 
• In our Enterobacterial collection, on molecular basis we found 93% (121/130) 
occurrence for WansBLs which included hlacjx-M 92.5% (112/121) as the 
predominant type of ESBL gene followed by blajEM 54.5% (66/121) and 
blasm 45.4% (55/121). 62.8% isolates of this collection of Indian 
Emterobacteria showed co-occurrence of blacjx-M with blaj^M or hla^i^y or 
with both of these genes. Out of total hlaEssis harbouring isolates, 29.7% 
(36/121) were harbouring single gene ofblacjx-M while only 3.3% (4/121) and 
2.4% (3/121) isolates harboured single gene of each hlaj^M and blasuv. 
respectively. This shows that in our collection higher occurrence of multiple 
genes has occurred due to the selection pressure developed by increasing 
usage of cephalosporins. 
•:• In the present study, by multiplex PCR. we found CTX-M-genogroup-1 as the 
predominant genogroup. but for the iu-st time we also observed C'TX-M-
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genogroup-9 in one E. coli isolate that was confirmed by sequencing. This is 
showing that other CTX-M types are also emerging in Indian Enterobacteria. 
<• Due to the presence of resistance to third- as well as fourth- generation 
cephalosporins in our isolates, of the ESBL positive isolates, 71.9% (87) also 
showed co-existence of 6/aampc with 6/aESBLs- Moreover, in 112 isolates that 
harboured blacix-u genes, 75% showed co-existence of bluampc- This shows 
that in our collection of Indian Enterobacteriaceae class C type beta-
lactamases is concurrently present with class A type beta-lactamases on the 
same plasmid. 
"> On comparative studies of class A and class C type ^-lactamases in the 
Enterobacterial collections during 2009 and 2010, we found nearly similar 
occurrence of 6/aESBLs in 92.1% and 94.4% isolates in the respective years, 
2009 and 2010. On characterization of co-existence of class A and class C 
type P-lactamases, we found that co-existence of these classes decreased from 
81.4% to 58.8% in the respective years, 2009 and 2010. This is showing 
improvement of the prescription policies of antibiotics as well as the 
implementation of straight infection control policies in our Institution. 
I* On determination of various mobile genetic elements {sul-1, CS region, 
ISEcpL \S26 and ORF513), we found 89.2% (116/130) isolates carrying these 
mobile genetic elements with various hla genes and passively help in their 
mobilization. 92.8% isolates that harboured blacjx-M genes were found to be 
associated with these mobile genetic elements. We noticed higher number of 
isolates harbouring combination of CTX-M+TEM+SHV that were associated 
v/ith these mobile genetic elements for mobilization. 
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<• We also found 4.6% isolates which harboured only gene of blacix-u but not 
associated with any mobile genetic elements, and passively in these cases bla 
genes were mobilized through plasmids. 
<• 76.1% (99/130) isolates were found to harbour integrons {sul-1 and CS 
regions) and showed higher association of bla genes with sul-1 type class-1 
integrons than CS region. This denotes higher occurrence of classic class-1 
integrons in our collection as previously reported by Partridge et al. (2009) 
where it is being reported that presence of sul-1 gene in 3'CS region of class 1 
integron is the characteristic of classic class 1 integron and absence of this 
normal 3'CS region denotes the presence of non-classic class 1 integron. We 
also found that 17 isolates that harboured CS regions but not associated with 
sul-1 gene which is showing the presence of non-classic class 1 integrons for 
mobilization of various /^<3HSBLS in this Enterobacterial collection. We also 
found higher number of isolates harbouring combination of blacxx. 
M+blajEM+blasHV associated with class 1 integrons. 
•> We observed that all isolates that harboured SHV/TEM or combination of 
these genes were associated with sul-1 type integrons while none of the isolate 
v/as found associated with the CS region of integrons, only one isolate that 
harboured SHV gene was found associated with CS region and ]S26 like 
insertion sequence. So we can hypothesized that in our Enterobacterial 
collection those isolates that harboured only SHV or TEM genes are mobilized 
more frequently by sul-1 type class 1 integrons. 
<• On detemiination of various insertion sequences (ISEcpl. ORF513 and IS26) 
we found 83.8% (109/130) Enterohacteriaceae isolates that harboured 
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insertion sequences such as ISEcpJ, ORF513 (ISCRI) and IS26. Like 
integrons we also found these insertion sequences in most of the isolates that 
harboured combination of blacn-v&blajEu+blasm- High frequency (56.9%) 
of isolates harbouring /^OESBLS was found associated with ISEcpl, while least 
(33%) were found with \S26. 
*l* We also found that in the present collection the isolates that harboured TEM 
or TEM+SHV genes were not associated with ISEcpi, while the isolates 
harbouring only SHV-gene were associated with ISEcpl. This shows probably 
blajEM and combination of blaj^M+bla^iw is not mobilized by these mobile 
elements, while blasuv gene is mobilized by this insertion sequence. 
• In the present study we observed that IS26 is most commonly found in those 
isolates that harboured blasnv genes (with other ESBLs) and this shows that 
the mobilization of SHV type of ESBLs is by \S26 elements. We also found 
various molecular sizes of IS26 elements inserted with Wa^ SBLs, but amplicon 
size of ~850bp was the most frequently observed. We found four isolates that 
harboured only i/acTX-M genes associated with only IS26 elements, and thus 
suggests that this gene can even be mobilized only by the help of this insertion 
sequence. 
•> We also found CTX-M genogroup-9 like gene associated with ISEcpl and 
IS26. while this gene was not associated with ORF513 (also known as \SCR1). 
<* Of the 69 isolates that harboured sul-l type class-1 integrons, 73.9% (51) were 
found to harbour ORFJ/i which shows the higher occurrence of complex 
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class-1 type integrons with ^/^ESBLS including hlacjx-M in our North Indian 
collection of Enterobacteriaceae. 
»> We found all isolates to harbour -23 kb plasmid, and on analysis for the 
presence of various CTX-M genogroups on plasmids, we found presence of 
CTX-M-genogroup-1 and -9 on the plasmid. 
•> By RAPD t '^ping to determine the clonal relationship of our bacterial isolates, 
it can be concluded that probably the very same clone is circulating in the 
gynaecology, surgery and orthopaedics wards as these wards are sharing the 
same building block in our hospital and hence the chances of cross 
contamination are high. As some isolate from different wards were also found 
matching, so it can be concluded that still stringent sterilization conditions are 
not maintained in our hospital wards/operation theatres; however, variability 
among isolates is still maintained. Therefore, we suggest further work-out 
steps to minimize the spread of bla genes in our hospital envirormient. 
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u+blajEM+blasHV (Lane 6-13) of different wards, lanes M are showing 
Fermentas DNA ladder. 
Figure 38b: Clusters of the Klebsiella isolates harbouring various combinations of 
ESBLs (K1-K3). 
Figure 39: 2% Agarose gel is showing RAPD pattern of the all isolates that 
harbouring blajEu or 6/asHv or combination of these genes. 
XI 

INTRODUCTION 
CHAPTER 1 
INTRODUCTION 
Antibacterial tiierapy tias emerged over the last few decades as a practical 
proposition and has become one of the bases of modem medicine. However, the 
treatment of infectious disease is compromised by the development of antibiotic-
resistant strains of microbial pathogens, thus making it necessary for microbiologist to 
understand the waj's by 'v\'hich microbes have become resistant. There is no doubt that 
many variations have taken place in the microbial population whenever antibiotics 
were used. Emergence of resistance to P-lactam antibiotics was understood as soon as 
the first P-lactam, penicillin, was developed. The first description of the clinical use of 
penicillin was simultaneous vsdth the report of an enzyme penicillinase, a member of 
p-lactamase family, which destroyed benzylpenicillin and conferred resistance to 
penicillin (Chain & Abraham, 1940). The mechanisms by which antibiotic resistance 
spread among medically important bacteria are now better understood. Now it is clear 
that the horizontal gene pool, which consists of different genes present on a plethora 
of diverse mobile genetic elements, results in the lateral gene transfer among strains 
of an mdividual species and also among different species of both Gram-negative and 
Gram-positive bacteria, which generates multiresistant bacteria. This process occurs 
due to the selecti\e pressure of antimicrobial use, in the hospital environment where 
the clear relationships between antimicrobial use and the emergence of multiresistant 
strains can be seen (Graffunder et al. 2005; Lautenbach et al. 2006; Martinez et al 
2006). 
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Maiiy genera of Gram-negative bacteria possess a naturally occurring, 
chromosomally mediated P-Iactamases, tiiought to iiave evolved from penicillin 
binding proteins (PBP), with which these enzymes show some sequence homology. 
This production of p-lactamases in Gram-negative bacteria is a serious problem 
worldwide to protect bacteria against the lethal effect of P-lactam antibiotics, p-lactam 
antibiotics are a broad class of antibiotics that contain a P-lactam nucleus in its 
molecular structure and include penicillin derivatives, cephalosporins, monobactams, 
and P-lactamase inhibitors and carbepenems. P-lactam antibiotics inhibit the synthesis 
of the peptidoglycan layer of bacterial cell walls but P-lactamases open the p-lactam 
ring of p-lacatms and thus abolish their antimicrobial activity (Shahid et al. 2009a). 
Antibacterial agents have been used for the treatment of infectious diseases 
smce the 17* centur>'. The third generation cephalosporins have been introduced into 
clinical practice in the early 1980s and were heralded as a major breakthrough in the 
fight against p-lactamase-mediated bacterial resistance to antibiotics. The production 
of P-lactamase was found as the single most prevalent mechanism which was 
responsible for resistance to p-lactams among clinical isolates of the family 
Enterobacteriaceae (Sanders et al. 1992) and extended spectrum P-lactamases 
(ESBLs) which mediate resistance to oxyimino-cephalosporins but not to 
cephamycins were observed worldwide in majority of species of Enterobacteriaceae 
(Bradford 2001). AmpC type P-lactamases mediate resistance to both oxyimino- and 
7-a-methoxy-cephalosporins and monobactams (Shahid et al. 2009b). A commonly 
used definition for ESBLs is that the ESBLs are B-lactamases capable of conferring 
bacterial resistance to the penicillins, first-, second-, and third-generation 
cephalosporins, and aztreonam but not to cephamycin or carbapenems, by hydrolysis 
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of these antibiotics, and are inhibited by B-lactamase inhibitors such as clavulanate 
(Paterson & Bonomo 2005). Most ESBLs are variants of the classical TEM-1 and 
SHV-1 P-lactamases, with one or more amino acid substitutions that confer resistance 
to broad-spectrum cephalosporins and aztreonam (Bush et al. 1995). In recent years, 
an emerging family of ESBLs, the CTX-M type ESBLs that are derived from point 
mutation from TEM and SHV type beta-lactamases have emerged as a well-known 
cause of antibiotic resistance (Gniadkowski 2001; Ensor et al. 2006; Shahid 2010). 
CTX-M type ESBLs confer resistant to cefotaxime and ceftriaxone but usually are 
susceptible to ceftazidime. The first plasmid-encoded 6-laciamase, able to destroy 
extended-spectrum B-lactam antibiotics, was described in Germany in 1983 (Bush & 
Sykes 1983). Although ESBLs have been described in a range of Enterobacteriaceae 
and Pseudomonadaceae from different parts of the \s'orld. the>' are most often 
identified in Klebsiella pneumoniae and Escherichia coli. 
1.1 Classification of P-Iactamases 
Of the different fimctional classification schemes one is that of Richmond 
and Sykes (1973) scheme which included all of the P-lactamases classified into five 
major groups on the basis of substrate profile. However most common 6-lactamases 
were classified on the basis of two general systems, the Ambler molecular 
classification system and the Bush-Jacoby-Medeiros fianctional classification system 
(Ambler eM/. 1980; Bush era/. 1995). 
According to the Ambler classification, 6-lactamases are classified into four 
classes, A, B, C, and D, on the basis of their amino acid homology and not phenotypic 
characteristics (Ambler et al. 1980). In this classification system, ESBLs of classes A, 
C, and D are serine B-lactamases, and the class B enzymes are metallo-B-lactamases 
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that utilize at least one active-site zinc ion to facilitate p-lactam hydrolysis; class A 
and class C being the most frequently occurring among bacteria. The activity of Class 
A enzymes is inhibited in vitro by 6-lactamase inhibitors such as clavulanic acid, 
sulbactam and tazobactam but enzymes belonging to class D are not inhibited by these 
inhibitors. According to Bush-Jacoby-Medeiros, 6-lactamases are classified based on 
functional similarities such as on the basis of substrate and inhibitor profile. In this 
classification, class A ESBLs are clustered in group 2be; a designation which shows 
that these enzymes have been deri\ed from group 2b 6-lactamases such as TEM-1, -2 
and SHV-1 which hydrolyze penicillin, ampicillin. and to lesser degree carbenicillin 
or cephalothin, and 'e' denotes that the 6-lactamases ha\"e an extended spectrum 
activity (Ambler et al. 1980; Bush et al 1995). The majorit} of ESBLs identified in 
clinical isolates have been SHV or TEM i}pes. which have evolved from narrow-
spectrum 6-lactamases such as TEM-1, -2 and SH\'-1 (Bradford 2001), and can be 
subdivided on the basis of their activities towards ceftazidime and cefotaxime as 
ceftazidimases (higher levels of hydrol>tic activit}' towards ceftazidime than against 
cefotaxime) and cefotaximases (higher levels of hydrohtic activity towards 
cefotaxime than towards ceftazidime), respectively (Jacoby 1994). However, class A 
ESBLs form a heterogeneous molecular cluster comprising 6-lactamases sharing 20%-
>99% identity. The earliest class A ESBLs. which were reponed from 1985 to 1987, 
differed from widespread plasmid-mediated TEM-1'2 and SH\'-1 penicillinases by 
one to four point mutations, which extend their hydroKtic spectra (Kiiebe et al. 1985; 
Sirot et al. 1987; Sougakoff /^ al. 1988). TEM and SHV t>pe ESBLs now comprise 
over 130 members (http://www.lahey.org.studies) and have a worldwide distribution. 
Most of them are ceftazidimases, and a small number are cefotaximases. TEM family 
is the most diverse family of P-lactamases. 
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Class A ESBLs hydrolyze oxyimino-cephalosporins and aztreonam but not 7-
d-substituted 6-lactams. They are generally susceptible to fi-lactamase inhibitors 
(clavulanate, sulbactam, tazobactam). They were initially reported in the second half 
of the 1980s, and their rate of dissemination among bacteria and in most parts of the 
world has increased dramatically since 1995. More recently, many groups of p-
lactamases have hydrolytic profiles similar to those of the TEM and SHV mutants but 
have quite different evolutionary histories, although they also belong to molecular 
class A. These non-TEM and non-SHV plasmid-mediated class A ESBLs have been 
reported as cefotaximases of the CTX-M, SFO-1, andBES-1 types and ceftazidimases 
en2}-mes of the PER, VEB, TLA-1, and GES,aBC tjpes (Livermore 2008; Bonnet 
2004). 
1.2 CTX-M-t>pe ESBLs 
The first report on Extended-spectrum p-lactamase (ESBL) in 1983 (Knothe 
et al. 1983) was followed with the emergence of several transferable ESBLs among 
nosocomial isolates oi Klebsiella pneumoniae (Baurenfeind et al. 1993; Jacoby & 
Medeiros 1991). CTX-M type ESBLs constitutes a distinct lineage of molecular class 
A p-lactjmiases, and are a rapidly growing group. The main characteristic of all CTX-
M producing isolates is the higher level of resistance to cefotaxime than to 
ceftazidime (Bonnet 2004; Chen et al. 2005). Recently this group of ESBLs have 
emerged as the predominant type in many parts of the world, including south 
America, Europe, Canada, parts of the United states and India (Lewis et al. 2007; 
Livermore et al 2007; Pitout et al. 2007; Rossolini et al. 2008; Shahid et al. 2011). 
The sources of CTX-M determinants are chromosomal genes resident in members of 
the genus Kluyvera, which includes a number of environmental species with little or 
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non-pathogenic activity against humans. From first detection in 1986 (Matsumoto et 
al. 1988), CTX-M enzymes comprise more than 100 variants belonging to the six 
groups: CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9, CTX-M-25 and CTX-M-45, on 
the basis of their amino acid sequence similarities (Boimet 2004; Rossolini et al. 
2008). 
1.3 Mobile genetic elements and Insertion sequences responsible for antibiotic 
resistance in bacteria 
The phenomenon of gene acquisition implies gene transfer from some 
outside source such as other bacteria. Bacteria can transfer DNA from one cell to 
another by three methods: transformation, transduction and conjugation (Bennett et al. 
2004) and more specifically with the elements that promote it named as bacterial 
plasmids. Rapid and widespread emergence of multidrug resistance patterns observed 
in closely ias well as distantly related bacterial species are due to the presence and 
activity of mobile genetic elements. In gram negative bacteria many of the antibiotic 
resistant genes are found to be associated with some mobile genetic elements such as 
plasmids, transposons and other elements capable to inter-generic and interspecific 
mobility (integrons). Integrons were characterized even later, in the late 1980s, but it 
was the time when they were found to be as the genetic system responsible for the 
gathering of resistance determinants in these mobile elements (Martinez & de la Cruz 
1988) and termed integrons (Stokes & Hall 1989). h is now well known that these 
mobile elements are named as integrons because of their intimate association to 
transposons, they constitute the major vectors of antibiotic multiresistance in Gram-
negative and to a lesser extent in Gram-positive bacteria (Partridge et al. 2009). The 
molecular mechanisms of the acquisition and dissemination of resistance genes 
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among bacterial isolates have been studied thoroughly (Hall & Collis 1995; Yum et 
al. 2002), but the most common mechanism by which Gram-negative bacteria capture 
gene cassettes is the incorporation of resistance genes into resistance integrons. 
Mobile genetic elements such as plasmids or transposons may harbor these integrons. 
Integrons v/ere defmed as elements which contain the genetic determinants of the 
components of a site-specific recombination system that recognises and captures 
mobile gene cassettes and provides an efficient means for determining the cumulating 
resistance (Hall & Collis 1995: Ploy et al. 2000). An integron is composed of a gene 
encoding an integrase (int) and an integration site for the gene cassettes also iaiov,Ti as 
recombination site (an). Gene cassettes are not necessarily part of the integron but 
they become part of the integron when integrated. As previously described by Fluit & 
Schmitz (2004). integrons can be de\ided into two major groups: resistance integrons 
(RI) and super-integrons (SI). Nearly most of the gene cassettes from resistance 
integrons that encode resistance to antibiotics or disinfectants, can be found either on 
transposons, plasmids and the bacterial chromosome, but the large chromosomally-
located integrons, which contain gene cassettes to encode a variety of functions 
belong to the super-integron group. Many species harbour super-integrons, which are 
species-sp(?cific. whereas particular resistance integrons can be present in a variety of 
species. The gene cassettes in resistance integrons possibly originated from super-
integrons. Man>- resistance genes, like dfr genes, aad genes, and ^-lactamase genes 
are reported to be present as gene cassettes in an integron (Hall & Collis 1995). These 
resistance genes can move to other genetic sites or tt-ansfer horizontally to other 
bacteria (Hall & Collis 1995). Such Xy^t of genetic transfer is significant if the new 
host is a pathogenic organism and the inserted gene confer resistance to a widely used 
antimicrobial agent (Maguire et al. 2001). Three classes of resistant integrons are 
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known as: class 1, class 2 and class 3 (Hall & Collis 1995; Collis & Hall 1995; 
Radstrom et al. 1994; Arakawa et al 1995; Senda et al. 1996). While according to 
Mazel et al. 1998, the presence of chromosomal integrons (CIs) in the bacterial 
genomes, which are not found to take part in resistant phenotype, was known in late 
1990s with the discovery of the Vibrio cholerae super-integron. These CIs are the 
source of the mobile integrons (Mis) backbones and of their antibiotic resistance gene 
cassettes (Mazel 2006). Five different classes of Mis have been defined, on the basis 
of the sequence which encoded integrases (40°'o-58°'o identit}'), while only first three 
classes; Classl, class2 and class 3 have been found to involve in the spread of 
multiresistance phenotj^ pes (Mazel 2006). 
Class 1 integrons are most prevalent in clinical isolates and usually 
associated with multidrug resistance phenot\"pes. This t}pe of integrons usually 
consists of 5' conserved segment (5'CS). 3' conser\ed segment (3'CS) and gene 
cassette(s) in between. The 5'CS region is composed of three key elements: intl gene 
encoding the integrase; primary' recombination site atti; and outward oriented 
promoter Pc that directs transcription of captured gene cassettes (Hall et al. 1994; Hall 
& Vockler 1987; Recchia et al 1994; Stokes & Hall 1989). The 3'CS region defined 
by Stokes and Hall (1989) included the sull sulfonamide resistance determinant 
(Stokes & Hall 1989; Sundstrom et al 1988) and a further t\\o open reading frames 
(ORFs), one of which has been identified as a defecti\e \ersion of the quaternary-
ammonium compound resistance determinant qacE and designated qacEM (Paulsen 
et al. 1993); this region can be variable in length and even be absent (Hall et al. 
1994). 
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Rapid dissemination of P-lactamases involves plasmid or strain epidemics, 
but these also involve mobile elements like insertion sequences. Bacterial insertion 
sequences were initially recognized during the studies of model genetic systems; 
which showed the capabilities of insertion sequences to generate mutations due to 
their translocation. Interest in antibiotic resistance and transmissible plasmids 
subsequently revealed an important role for these mobile elements in dissemination of 
resistance genes and in promotion of gene acquisition (Mahillon & Chandler 1998). 
These insertion sequences includes ISEcplAike insertion sequences and the ISCRI 
element (previously called ORF513) (Toleman et al. 2006; Rossolini ei al 2008). 
while IS2(5 is an 820 bp long insertion sequence that t>pically generates 8bp target 
duplication upon transposition (MoUet et al. 1983). IS£cp7-like insertion sequences 
have been found responsible for the capture and mobilization of a number of 
unrelated antibiotic resistance genes including blacjx-M groups (Rossolini et al. 2008). 
This insertion sequence is bounded by 14-bp inverted repeats, IRL at the left-hand side 
with respect to the direction of transcription of the transposes gene and IRR at the 
right-hand side. While, ISEcpl mostly found to use IRL in conjunction with 
alternative sequences resembling these IR to mobilize adjacent regions, generating 5-
bp duplications of flanking sequence on transposition (Pohel et al. 2003; Poirel et al. 
2005; Lartigue et al. 2006; Wachino et al. 2006; Zong et al. 2010). Recently a new 
element, 'ORF513' has been increasingly associated with class 1 integrons, this 
element demonstrate IS97-like characteristics and can mobilize adjacent DNA 
sequences via rolling circle replication process. So this element was named as 
'insertion sequence CRs' (ISCi?5), which reflects their appropriate structure-function 
properties (Toleman et al. 2006). If we analyze the existing literature for the presence 
of mobile genetic element such as insertion sequences we noticed that most blacrx-M 
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genes belonging to 6/acTX-M-2,-3,-5,-io,-i5,-i7,-i8,-i9,-25,-26,-27 were reported associated with 
ISEcpl (Bonnet 2004; Saladin et al. 2002; Lartigue et al. 2004; Canton & Coque 
2006), while ISCRl was found upstream of bhcjx-u-i and blacTx-M-9 genes (Sabate et 
al. 2002; Eckert et al. 2006). Few studies have reported that insertion sequences 
connected to blacix-u as well as other genes were located between two \S26 elements 
(Literacka et al. 2009; CuUik et al. 2010). From India, very few reports are available 
on for the presence of different mobile genetic elements and insertion sequences (such 
as ISEcpL ORF513 and 1S2<5) and their association with blacrx-u and also with other 
ESBLs in Indian Enierobaieriaceae (Shahid 2010; Bhattacharjee et al. 2010). 
CTX-M is the most common t>pe of ESBL and has been reported in 
Enterobacteriaceae isolates jfrom various countries including Poland, Canada, France, 
UK, Russia, Cameroon, Japan and Bulgaria (Bonnet 2004; Novais et al. 2007; Coque 
et al. 2008, Shahid et al. 2011), and also in hidia (Ensor et al. 2006). There are 
reports from various countries describing the concurrent occurrence ofblacrx-M, 
blasHX and blajzM in Enterobacteriaceae (Al-Agamy et al. 2009; Nasehi et al. 2010; 
Feizabadi et ai 2010; Kalantar & Mansouri 2010; Bali et al 2010) however, 
similar reports are fragmentarj' from India. There are only few recent reports 
describuag the co-occurrence of these genes especially in Klebsiella, Enterobacter 
and Citrobacter spp. (Grover et aL 2006; Muzaheed et at 2009; Goyai et al. 2009; 
Kingsley et aL 2008; Shahid et aL 2011). Co-existence of class A and class C t>pe 
P-lactamases in Enterobacteriaceae is frequently reported from many countries 
(Hanson et aL 1999; Saladin et aL 2002; Alvarez et aL 2004; Yan et aL 2004; Song 
et aL 2006; Moland et aL 2007), however fragmentary reports are provided from 
India regarding co-occurrence of class A and class C t} pe ^-lactamases (Shahid 
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et al. 2009). Hence, this study was designed to investigate in greater details for 
the presence oibla genes of Class A type ESBLs and Class C type p-lactamases in 
Indian Enterobacteriaceae. Moreover due io paucity of Indian literature on 
mobile genetic elements and their association with ESBLs, especially CTX-M, 
this fact prompted us to investigate systematically the presence of the said mobile 
genetic elements and their association with ESBLs in our collection of Indian 
Enterobacteriaceae. 
Therefore, the present study was designed with the following aims and objectives: 
1.4 Aim and Objectives 
• To determine the antibiotic resistance rates and patterns in Escherichia coli 
imd Klebsiella pneumoniae obtained from the department of Microbiology of 
J. N. Medical College and Hospital, Aligarh Muslim University, Aligarh. 
• To determine the prevalence of extended-spectrum p-lactamases by 
phenotypic methods. 
• To determine the prevalence of /J/OESBL genes {blacix-M, blajEu, blasw) in 
third generation cephalosporins resistant bacterial isolates. 
• To characterize the presence of CTX-M-genogroups and genotypes by 
molecular methods. 
• To analyse co-carriage ofbla^mpc genes in CTX-M producers. 
• To screen the CTX-M producing isolates for plasmids and genetic elements 
responsible for mobilization of bla genes. 
• And, evaluate the clonal relationship (if any) of our bacterial collection by 
genotyping. 
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2.1 Historical Perspective 
The initial discovery of antibiotics is generally attributed to Alexander Fleming in 
1929, who observed a diffusible bacteriolytic substance produced by a mould strain, 
contaminant of an agar plate inoculated with Staphylococcus aureus. Because the contaminant 
mould was identified as a Penicillium sp.. he named this bacteriol}tic substance penicillin 
(Fleming 1929). Using the filtrate of liquid cultures of Penicillin notatum, he determined the 
antibacterial activity of this antibiotic in vitro, as well as its non-toxicity when injected into 
mice and rabbits. Nevertheless, since no studies with bacterial infected animals were 
performed, Fleming failed to demonstrate the penicillin's ability to overcome these types of 
infections (Rolinson 1998). 
With yet weak techniques, attempts to obtain purified penicillin in the 1930s were 
mostly unsuccessful, and interest in penicillin had almost disappeared. However, a study in 
1940 by Florey and his associates at Oxford Universit}' isolated the active ingredients and used 
the crude material clinically. A decade later, penicillin was developed as a semisynthetic 
therapeutic agent and found as effecti%e antibacterial agents against a streptococcal infection 
in mice (Abraham & Chain et al. 1940). 
Penicillins are a class of P-lactam antibiotics of related structure with slightly 
different properties and activities. The subsequent introduction of penicillin into clinical use in 
humans motivated the discover)' of other antibiotics (Shahid et al. 2009a). Cephalosporin 
compounds v/ere first isolated from cultures of marine fungus, Cephalosporium acrenwnium 
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from a sewer in Sardinia in 1948 by Italian scientist Giuseppe Brotzu (Pdplsky & Lawrence 
1998). He noticed that these cultures produced substances that were effective against 
Salmonella enterica serovar Typhi, the cause of typhoid fever that produced a P-lactamase. 
The culture in which the fungus was grown contained three dintinct antibiotics named as 
Cephalosporin P, N, and C. These antibiotics were effective against Gram-positive and Gram-
negative bacteria and had similar properties as semisynthetic penicillins. P-lactams expansion 
began only in the early 1960s, with the development of the semisynthetic penicillins, followed 
by semisynthetic cephalosporins, as well as other p-lactam antibiotics (Rolinson 1998). The 
first synthetic P-lactam was prepared by Hermann Staudinger in 1907 by reaction of the Schiff 
base of aniline and benzaldehyde with diphenylketene (Tidwall & Thomas, 2008; Staudinger 
1907) in a [2+2] cycloaddition as shown below in Figure 1. 
Ph 
Ph 
+ 
Ph. 
c=c--o 
Ph' 
Ph 
^ Ph 1 
Ph 
0 
- N 
Ph 
Figure 1: Schiff base reaction of aniline and benzaldehyde with diphenylketene to form 
synthetic p-lactam (Tidwall & Thomas, 2008; Staudinger 1907) 
2.2 p-Iactams antibiotics 
2.2.1 Structure of p-Iactams 
P-lactam antibiotics are composed of an isolated ring, as in monobactams, or associated 
in bicyclic ring structures in other classes. While penicillins are a group of natural or 
semisynthetic antibiotics, in which the P-lactam ring is fused with a thiazolidine ring, in 
cephalosporins the P-lactam ring are merged with a dihydrothiazine ring (Figure 2). In the 
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carbapenems, the p-lactam ring is combined with a hydroxyethyl side chain, lacking an 
oxygen or sulphur atom in the bicycUc nucleus. 
Overall, modifications of the R and R' groups (Figure 3), alter the pharmacokinetic 
and antibacterial properties in different p-lactam antibiotics. For example, modifications at 
position 7 of cephalosporins increase the penetration into the periplasmatic space and the 
stability against p-lactamases, but may reduce antibiotic activity (Donowitz & Mandell 1988). 
In contrast to the antibiotic, the clavulanic acid, a P-lactamase inhibitor, is composed of a P-
lactam ring fused with an oxazolidine ring and does not possess an amide function. 
2.2.2 Nomenclature of p-lactams 
P-Lactams are classified according to their core ring structures. 
> P-Lactams fused to saturated five-membered rings: 
• P-Lactams containing thiazolidine rings are named penams i.e. penicillin. 
• P-Lactams containing pvrrolidine rings are named carbapenams i.e. 
imipenem. 
• P-Lactams fused to oxazolidine rings are named oxapenams or clavams i.e. 
clavulanic acid. 
> P-Lactams fused to unsaturated five-membered rings: 
• P-Lactams containing 2,3-dihydrothiazole rings are named penems i.e. 
faropenem. 
• P-Lactams containing 2,3-dihydro-lH-pyrrole rings are named 
carbapenems i.e. meropenem. 
> P-Lactams fused to unsaturated six-membered rings: 
• p-Lactams containing 3,6-dihydro-2H-l,3-thiazine rings are named 
cephems i.e. cephalosporins and cephamycins. 
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• P-Lactams containing 1,2,3,4-tetrahvdropvridine rings are named 
carbacephems i.e. lobacarbef. 
• p-Lactams containing 3,6-dihydro-2H-l,3-oxazine rings are named 
oxacephems i.e. moxalactam and flomoxef. 
> P-Lactams not fused to any other ring are named monobactams i.e. aztreonam. 
R, y c; ® K 1 ® R, y © 
o-^-? 0^-^ 0^-? 
COOH CXXX COOH 
R y 5 ® RvL^ © \ © 
COOH COOH 
© R. ?^® R. 9/.© 
Figure 2: The beta-lactam core structures: A. Penam, B. Carbapenam, C. Oxapenam, D. 
Penem, E. Carbapenem, F. Monobactam, G. Cephem, H. Carbacephem, I. Oxacepham 
(adapted from Wikipedia) 
2.2.3 Chemistry of cephalosporins 
Cephalosporin C contains a side chain derived from D-a-aminoadipic acid, which is 
condensed \\i\h a dihydrothiazine P-lactam ring system (7-aminocephalosporanic acid). 
Cephalosporin C can be hydrolyzed by acid to 7-aminocephalosporanic acid (Figure 3). The 
discover)' of the nucleus, 7-aminocephalosporanic acid, made it possible to introduce 
semisynthetic compounds, with antibacterial activity greater than that of the parent substance, 
by addition of side chains (Abraham 1962; Flynn 1972). Subsequent modifications were 
achieved by addition of different side chains to create a whole family of cephalosporin 
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antibiotics (Mandell et al. 1996). The cephamycins are similar to the cephalosporins, but have 
a methoxy group at position 7 of the P-lactam ring of the 7-aminocephalosporanic acid nucleus 
(Shahide/a/. 2009a). 
R: 
o 
H H 
^ / - N W ^ R I 
O^^OH 
Figure 3; Structure of Chephalosporins 
2.3 Mechanism of action of p-lactam antibiotics on Bacteria 
P-lactfim antibiotics act on bacteria by inactivating the enzyme located in the 
cytoplasmic membrane which catalyses synthesis of the cross-linked peptidoglycan, 
which is an essential component of the bacterial cell wall. 
',i 35 r-,; 
nmmKmiim 
Granvpotitive 
Cf.opi2srr,ic 
Gram-negadve 
Figure 4: Stmcture of cell wall of Gram-positive and Gram-negative bacteria 
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The cell walls of bacteria are essential for their normal growth and development. 
Peptidoglycan is a heteropolymeric component to form the cell wall which provides rigid 
mechanical stability due to its highly cross-linked lattice work structure. The wall 
structure of Gram-positive and Gram-negative bacteria is different; the peptidogycan in 
Gram-positive bacteria it is 50 to 100 molecules thick, while in Gram-negative bacteria it 
is only 1 or 2 molecules thick (Figure 4). 
The peptidoglycan is composed 
of glycan chains, which are linear 
strands of two alternating amino sugars: 
N-acetyleglucosamine (NAG) and N-
acetylmuramic acid (NAM) linked by p-
(l,4)-glycoside units (Figure 5). The 
biosynthesis of the peptidoglycan 
involves about 30 bacterial enzvmes and 
Peptidoglycan Monomer 
NAM NAG 
CHjOH 
CH3 
H NH-C=0 
- O 
/ H NH-C=0 cHjOH 
O -
HjC-CH-CsO 
L-Aianine 
i 
D-Gtutamic acid 
I 
meto Oiaminopimelic acid 
I 
D-Alanine 
- tetrapeptide 
Figure 5: Structure of peptidoglycan monomer 
is completed in three stages. The first stage, takes place in cytoplasm, the product uridine 
diphosphate (UDP)-acet)'muramyl-pentapeptide, accumulates in cells when subsequent 
synthetic stages are mhibited. 
The last reaction in the s\"nthesis of this compound is the addition of a 
dipeptide,D-alanyl-D-alanine synthetase. D-Cycloserine is a structural analog of D-
alanine and acts as a competiti\ e inhibitor of both the racemase and the sjTithetase. In the 
reactions of the second stage, UDP-acetylmuramyl-pentapeptide and UDP-
acetylglucosamine are linked to form a long polymer with the release of uridine 
nucleotides. In the final stage for the completion of cross-link, a transpeptidation reaction 
occurs outside the cell membrane, with the help of membrane bound transpeptidase. The 
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terminal glysine; residue of the pentaglycine bridge is linked to the fourth residue of the 
pentapeptide (D-alanine), releasing the fifth residue (also D-alanine). D,D-
carboxypeptidases are responsible for the removal of the terminal D-alanine from the 
peptide chain, which could become a donor in the transpeptidation reaction. This is the 
last step of peptidoglycan synthesis that is inhibited by the P-lactam antibiotics. The 
penicillin-binding proteins (PBPs), transpeptidase and carboxypeptidase, are involved in 
the final stages of the synthesis of peptidoglycan. These PBPs are subject to inhibhion by 
P-lactam antibiotics, because penicillins act as an analog of D-alanyl-D-alanine (Tipper & 
Strominger 1965). These transpeptidase and carbox\peptidases react with acyl-D-alanyl-
D-alanine. p-lactam-enzyme complex, formed after interaction between the enz>'me and 
the P-lactam-enzyme complex, would act as participant to the formation of the normal 
acylated enzyme. The P-lactam-enzyme complex is \er}" stable, and terminates with the 
inactivation of the PBP's fiinctions (Ghuysen 1988), which results in cellular lysis by 
interference in normal cross-linking of cell wall s>nthesis. In addition of transpeptidase 
and carboxypeptidase functions, PBPs also have transglycosylase function, which is 
responsible for the polymerization of glycan chain in peptidoglycan, which is not 
sensitive to P-lactams (Waxman & Strominger 1983). Various bacterial strains have 
diverse PBPs, which are polypeptides with 40 to 120 kDa. hi Enterobacteriaceae, the 
number of PBPs varies from six to eight, Escherichia coli shows seven enzymes while 
Klebsiella pneumoniae shows six (Georgopapadakou & Lin 1980; Spratt 1983). In E. 
coli, the inactivation of PBPs with higher molecular weight normally \sith transpeptidase 
or transglycosylase functions, leads in bacterial death. The inhibition of PBPl results to 
cellular lysis (Spratt 1983), inhibition of PBP2 effects the formation of spherical cells 
while PBP3 effects the formation of filaments (Spencer et al. 1987). The inactivation of 
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low moleculai- weight PBPs with lower molecular weight, normally with 
carboxypeptidase functions, does not found lethal to the cell (Spratt 1983). 
PBPs have different affinities towards P-lactams, on the bases of substitutions 
present in the P-lactam ring. In E. coli, penicillin derived P-lactams show higher affinities 
to PBPl (amoxicillin), PBP2 (mecillinam and piperacillin), PBP3 (mezlocillin and 
piperacillin) and to PBP4, all chephalosporins show higher affinities to PBPl, while some 
of them like cefotaxime shows affinity to PBP2 and PBP3 and ceftazidime to PBP3 
(Bryan & Godfrey 1991). 
2.4 Mechanism of resistance against ^-lactam antibiotics 
After several decades of successful use of antibiotics as therapeutic agents 
against bacterial infections, now we are facing a troubling condiuon, the accelerated 
evolution of anitibiotic resistance in important human pathogens and the scarcity of new 
anti-infective drug families under development. With the begirming of semisynthetic 
penicillins in 1950-1960, followed by cephalosporins and by the other P-lactam 
antibiotics in 1970-1980, bacterial cells continuously evolved due to some mechanisms of 
mutations, genetic transference and natural selection (Frere et al. 1991; Jacoby & Archer 
1991). There are usually four mechanisms are responsible for bacterial resistance to 
antibiotics (Babic et al. 2006) (Figure 7): 
2.4.1 Modification of Beta-lactam antibiotics 
The most common and important mechanism by which clinical isolates becomes 
resistant to antibacterial drugs is through the acquisition of genes that code for enzymes 
that modif>' or destroy the target antibiotic. These genes are frequently located on mobile 
genetic elements, including plasmids and transposons, these genes may also be located on 
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the bacterial chromosome. In the case of resistance genes that form part of a transposable 
element, these may move between the chromosome and other replicons in the bacterial 
cell, including plasmids. Resistance genes on certain plasmids may also become 
integrated within the bacterial chromosome. Bacteria become resistance to antibiotics due 
to the production of |3-lactamase, an enzyme that hydrolyses the P-lactam bond in P-
lactam antibiotics such as penicillin. This bond is essential in the activity of P-lactam 
antibiotics, acting as an analogue of the peptide bond that joins the terminal D-alanine to 
the peptidoglycan monomer. The P-lactamases are now a large family of enzymes, all of 
which cleave P-lactam bond to make various P-lactam antibiotics inactive (Figure 6). 
Initially p-lactamases only had a narrow spectrum of activity to hydrolyze the p-lactam 
bond of either penicillins or of cephalosporins. But recently broad-spectrum P-lactamases 
have evolved to facilitate activity against both penicillins and cephalosporins. Various 
families of such enz}'mes have arisen due to the point mutations accumulating in the 
genes that code for penicillinases. Many of these new enzymes are encoded by self-
transmissible plasmids and these new resistance determinants can spread very easily. 
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2.4.2 Modincation of target site 
Changes in the active site of penicillin binding proteins (PBPs) can lower the 
affinity of cell wall to P-lactam antibiotics and thus cause resistance to these agents, like 
those as seen in PBP2x of Streptococcus pneumoniae (Laible et al. 1991). Through 
natural transfomiation and recombination with DNA from other organisms, Nisseria spp. 
and Streptococcus spp. have acquired highly resistant, low affinity PBPs (Bowler et al. 
1994; Page 2007; Zapun et al. 2008). In Streptococcus sanguis, Streptococcus oralis, and 
Streptococcus mitis penicillin resistance developed due to horizontal transfer of a PBP2b 
gene from Streptococcus pneumoniae (Dowson et al. 1990; Potgieter & Chalkley 1995). 
Methicillin resistance in Staphylococcus spp. is also a significant clinical challenge. 
WTiile there are many reasons for this resistance, the P-lactam resistance phenotype is also 
conferred by acquisition of the mecA gene which produces PBP2a (also denoted PBP2') 
(Chambers 1999). PBP2a can assemble new cell wall in the presence of high 
concentration of penicillins and cephalosporins. 
2.4.3 Permeability based resistance 
Decreiised expression of outer membrane proteins (OMPs) is another mechanism 
of resistance. In order to access PBPs on the inner plasma membrane, (3-lactams must 
either diffuse through or directly cross porin channels in the outer membrane of Gram-
negative bacterial cell walls. Some Enterobacteriaceae (e.g., Enterobacter spp., 
Klebsiella pneumoniae, and Escherichia coli) exhibit resistance to carbapenems based on 
loss of these OMPs; the loss of OprD is associated with imipenem resistance and reduceti 
susceptibility to meropenem in the non-fermenter Pseudomonas aeruginosa (Hopkin et 
al. 1990; Jacoby et al. 2004; Livermore 2001; Nikaido 1994; Oteo et al. 2008; 
Studemeister & Quinn 1988). Resistance to imipenem and meropenem has also been 
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associated with the loss of the CarO OMP in clinical isolates of muUidrug-resistant 
Acinetohacter baumannii (Mussi et al. 2005; Poirel & Nordman 2006). The penetration of 
P-lactams is usually through porins, OMPF and OMPC, which are proteins inserted into 
the outer membranes that act as water filled, non-specific, transmembrane diffusion 
channels for hydrophilic molecules (Sawai et al. 1982). OMPF is larger than OMPC, 
which is a major porin responsible for penetration of P-lactam antibiotics. Overall, 
hydrophobicity, size and charge of the molecules are responsible to control the rate of 
penetration; such as cephalosporins are less hydrophobic than penicillins so they have a 
better penetration rate (Nikaido 1989). Point mutations or insertion sequences in porin-
encoding genes can produce proteins with reduced function and lead to lower 
permeabilit)' to P-lactams (Doumith et al. 2009). 
2.4.4 Efflux Pump 
Among the various mechanisms involved in bacterial resistance, the balance of 
membrane permeabilit)' which controls the traffic (in or out) of various molecules plays a 
key role in the influx and efflux of antibiotics, and limiting their intracellular 
concentration. The complex cell wall of Gram-negative bacteria contains a variety of 
protein channels involved in influx or efflux of a large variety of nutrients and also 
noxious compounds like metabolites, drugs, biocides, detergents etc. Among these 
transporters one is the efflux pimip that recognize toxic agents like antibiotics and pump 
out the agent from the periplasm to the siurounding environment of the cell (Poole, 2004), 
to reduce the intracellular accumulation of the agent. A characteristic of efflux pumps is 
the variety of molecules they may transport, due to poor substrate specificity. This 
multidrug efflux system plays an important role in providing resistance to a very wide 
range of compounds in Gram-negative bacteria (Nikaido, 1996), particularly in P. 
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aeruginosa, and Acinetohacter spp. Phylogenetically, batterial antibiotics belongs to five 
families: (i) ABC (ATP-binding cassette); (ii) SMR (small multidrug resistance) 
subfamily of the DMT (drug/metabolite transporters) superfamily; (iii) MATE (multi-
antimicrobial extrusion) subfamily of the MOP (multidrug/oligosaccharidyl-
lipid/polysaccharide flippases) superfamily; (iv) MFS (major facilitator superfamily); and 
(v) RND (resistance/nodulation/division superfamily), which all are secondary active 
transporters driven by ion gradients (Mahamoud et ali 2007). One of these multidrug 
efflux pumps, RND pumps are found exclusively in Gram-negative bacteria and exhibit 
an extremely wide spectrum of substrates, including antibiotics, antiseptic compounds, 
dyes, or detergents ( Levy, 2002; Li & Nikaido 2004; Lomovskaya & Totrov 2005; Poole, 
2005; Van Bambeke et al. 2003; Koronakis, 2003; Piddock, 2006). Genome of E.coli has 
the AcrAB-Tol C System; P. aeruginosa has the Mex AB-OprM, Mex CD-Opr J, Mex 
EF-OprN, Mex XY, Mex JK, Mex GHI-Opm D and Mex VW Systems. While other 
Gram-negative bacteria, such as B. cepacia complex with emerging resistance in cystic 
fibrosis patients, S. maltophilia and Niesseria gonorrhoe may have Ceo AB-Opc M, Amr 
AB-Opr A, Sme ABC, Sme DBF or Mtr CDE Systems respectively (Shahid et al. 2009a). 
Efflux pump ^ * ^ 
Antibiotic deg^fng 
en/yme 
Antibiotic 
Figure 7: Antibiotic resistance mechanism in bacteria (Courtesy by Kenneth Todar, 
University of Wisconsin-Madison, Department of Bacteriology) 
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2.5 Genetic mechanisms of resistance 
Bacteria can also develop resistance tlirough the acquisition of new genetic 
material from other resistant organisms. This is known as horizontal evolution, and may 
occur between the same species or between different species or genera. Bacterial genetic 
inheritance can occur due to changes in two ways (1) by mutations that alter the pre-
existing DNA of the cell- these alterations may be ba^e changes, DNA deletions and 
i 
inversions (Avinson & Bennett, 2005), and by (2) acquisition of new genetic material 
such as capture of new genes in the cell that expands the genome. In this phenomenon of 
acquisition gene transfer occurs from any outside source; like other bacteria. The 
mechanisms responsible for genetic exchange between same or different bacterial species 
include transduction, transformation and conjugation (Figure 8 Courtesy by Kenneth 
Todar, University of Wisconsin-Madison, Department of Bacteriology) (McManus et al. 
1997). 
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Figure 8: Mechanisms of genetic exchange: Horizontal gene transfer (Courtesy by 
Kenneth Todar, University of Wisconsin-Madison, Department of 
Bacteriology). 
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2.5.1 Transformation: This process involves the passage of DNA to a recipient through 
a specific medium. This process to transfer genetic material is mostly observed in vitro by 
using molecular techniques in the molecular biology laboratory. 
2.5.2 Transduction: Transduction is a process in which DNA is transferred from a donor 
to a recipient with the help of a host, a phage. Still it is unknown that whether this process 
causes clinically observed resistance to antibiotics. Because this process is highly 
dependent on bacterial phages, so it may occur only in certain bacterial species. Limited 
amount of DNA can be packed into the head of the phage to transfer. Therefore, 
transduction is usually not responsible for multiple drug resistance. 
2.5.3 Conjugation: In this process DNA transfers from a donor to a recipient by direct 
cell to cell contact. This process allows the passage of more than one functional gene at a 
time so that multiple resistances occur within a single step. Many different organisms can 
act as recipients, allowing DNA (resistant genes) to be donated freely from different 
sources. Resistance can be transferred from commensals in the gut to a pathogens existing 
in the same environment. Conjugation is an important and highly efficient process for 
transferring and acquisition of resistant genes by the most of the pathogens. 
2.6 Mobile genetic elements 
Acquisition of bacterial genes needed to elaborate various mechanisms is greatly 
aided by a variety of immoral gene transfer systems, such as bacterial conjugative 
plasmids, transposable elements and integron systems, that move genes from one DNA 
system to another and from one bacterial cell to another, not necessarily one related to the 
gene donor. Mobile genetic elements include bacterial plasmids, transposons, integrons 
including gene cassettes, and insertion sequences like ISCR-promoted gene mobilization. 
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Plasmids and conjugative transposons transfer from one cell to another by replication, 
while transposons, gene cassettes and ISCR-mediated gene transfer require some form of 
recombination which may or may not include replication (Bonnett, 2005). 
2.6.1 Bacterial Plasmids 
The elements that move many bacterial genes from one bacterial cell to another 
by horizontal gene transfer are known as bacterial plasmids or conjugative plasmids. 
These plasmids are able to promote their own transfer and transfer of other plasmids from 
one bacterial cell to another. Most plasmids are circular, double stranded DNA molecule 
capable of autonomous replication. Plasmids belong to a special biological category of 
extra-chromosomal, accessory DNA elements (Reanney et al. 1976; Campbell et al. 
1981). Plasmids are defined as the genetic elements which do not carry genes essential for 
growth of their host under non-stressed conditions. Plasmids play an important part in the 
field of scientific research as an excellent model of DNA replication. The plasmids may 
range from 2-3 kb (with just 2 or 3 genes) to those elements that are corresponding to 
10% or more to the host chromosome to accommodate 400 or more genes. Plasmid which 
carries one or more resistance genes is known as resistance plasmid. Plasmid-encoded 
antibiotic resistance encompases many classes of antibiotics like, cephalosporins, 
flouroquinolones and aminoglycosides. Mostly, resistance plasmids are conjugative as 
they can encode the functions necessary to promote cell-to-cell DNA transfer, mainly 
their own transfer. Plasmids are usually classified in incompatibility (Inc) groups, with 
incompatibility defined as the inability of two plasmids to be propagated stably in the 
same cell line. Inc is manifestation of relatedness, sharing common replication controls or 
equipartitioning elements (Couturier et al. 1988). Antimicrobial resistance on plasmids 
arises from a complex multi-factorial process supported by panoply of mobile genetic 
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elements that can transfer resistance determinants by assemblage of modular components, 
by transposition, homologous recombination and improper recombination events 
(Bennett, 2004). The presence of multiple genes on plasmids that confer resistance to 
different classes of antibiotics may provide a selective advantage to the bacterial host 
when several antimicrobials are simultaneously administered. Once these determinants 
have been selected by the bacterial host, they can evolve further and then transferred to 
other bacterial populations, enabling them to penetrate into niches (Carattoli 2008). 
Several insertion sequences (IS) are involved in the assembly of the resistance island. 
Such as IS26 can mobilize sulII-strA-atrB resistance determinants from the IncQ RFIOIO 
broad-host range plasmid and acquired on the pHCMl scaffold. Transposition-
recombination events have been found to mobilize other resistance determinants, like 
chloramphenicol (catl) and p-lactams {blajEM-i) genes, and the mer operon (mercuric 
ions) inserted into the resistance island of the pHCMl plasmid (Miriagou et al. 2006; 
Wain et al. 2003). Bacteria can possess plasmids that can code for more than one (3-
lactamase in addition to their expression of chromosomal enzyme. Due to the presence of 
plasmids in bacteria and promiscuous exchange of such material between bacteria, these 
antibiotic resistance genes have spread widely (Lee et al. 2001). In early 1960s, first 
plasmid mediated P-lactamases were recognised in Gram-negative bacteria (Livermore 
1993). Recently it has been reported that CTX-M encoding genes are commonly located 
on plasmids which vary in size from 7-200 kb (Kariuki et al. 2001; Saladin et al 2002; 
Bonnet 2004; Novais et al. 2007; Coque et al 2008). 
2.6.2 Transposons 
Resistance transposons are also known as jumping gene systems which 
incorporate a resistance gene within the element. These elements have the ability to move 
27 
REVIEW OF LITERATURE 
both intra- and inter-molecularly. They can jump from one site to another within a DNA 
molecule or from one DNA molecule to another such as from one plasmid to another or 
from a bacterial plasmid to a chromosome and vice versa. Transposons belongs to the set 
of mobile elements known as transposable elements which covers small cryptic elements 
like insertion sequences (IS elements), transposons and transposing bacteriophages 
(Bennett, 2004). A transposon differs from an IS element by encoding at Jeast one 
function that changes phenotype of the cell, for example a resistance transposon confers 
resistance to a particular antibiotic. Transposons are found to be constructed from a pair 
of IS elements and a central DNA sequence that is not inherently able to transpose, the 
expression of which alters the cell phenotype (Bennett 2008). Some well known 
transposons are TnJ, TnlO, Tni, and Tn27. Tn5 is found to encode resistance to 
aminoglycosides (Kanamycin and neomycin). TnlO is found to encode resistance to 
tetracycline while Tn5, encoding resistance to some |3-lactams including ampicillin, and 
Tn27 encoding resistance to streptomycin, spectinomycin and sulphonamides as well as 
mercuric ions are examples of complex transposons and found on the plasmids in the 
members of Enter obacteriaceae. 
2.6.3 Gene Cassettes and their mobility 
Gene cassettes, mostly encoded antibiotic resistance, consist of one coding 
sequence; a 59-base element is located at the 3'end of this sequence. Gene cassettes may 
also contain a variable number of non-translated nucleotides. Recently a number of gene 
cassettes have been reported (Fluit & Schmitz 1999; Partridge et al. 2009). Most of these 
gene cassettes have been found to encode proteins which are involved in the resistance to 
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antibiotics. Gene cassettes encoding resistance against antibiotics cover a wide range of 
antibiotics and antibiotic classes (Partridge et al 2009). Gene cassettes mobilization is 
mediated by the intll gene encoded Intll, which belongs to the family of integrases. The 
integrase excises the gene cassettes as covalently closed supercoiled circular molecules 
(Collis & Hall 1992a), these circular molecules can also be integrated. Deletions, 
duplications and rearrangements of gene cassettes in integrons have been observed (Collis 
& Hall 1992b). The formation of cointegrates between plasmids have been also found to 
contribute gene cassette exchange (Martinez et al. 1990). Besides the integrase. the atti 
and 59-base elements are involved in gene cassette mobilit)'. Gene cassettes are promoter-
less genes containing an attC recombination site. The 59-base elements, also known as 
attC, are considerably variable in length (Fluit & Schmitz 1999). As reviewed by 
Partridge et al. (2009), compilation of the attC sites have inverted repeats with two 7bp 
core regions, the consensus GTTRRRY/RYYYAAC for right-hand'left-hand ends (Hall 
et al. 1991). jAjialysis of right hand consensus sequences which were obser\ed initially 
indicated GTTAGGC, GTTAGCC and GTTAGAC as dominant sequences. In which A is 
the most common nucleotide present at fourth position but recently G, C has also been 
seen at this position in one example {gculS, GTTCTGT), so the final nucleotide of right 
hand was A or G, rather than T or C in a number of attC sites but few were found 
mismatched between IR and IL. GTTA and GTTG sequences were found to play an 
important role in the binding of the four integrase molecules to the anil site, but it is not 
clear whether all four are necessary for recombination (Fluit & Schmitz 1999). 
2.6.4 Integrons 
Antibiotic resistance genes have frequently been found to be encoded by the 
determinants carried on mobile genetic elements, such as plasmids, transposons and 
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integrons which are then responsible for the horizontal transfer of antibiotic resistance 
genes (Ploy et al). Integrons are mobile elements that participate in a powerful site-
specific recombination system to capture, accumulate, excise and organize gene cassettes, 
and convert them to functional genes by ensuring their correct expression and thus 
become natural expression vectors of these genes (Bennet 1999; Hall & CoUis 1995; 
Carattoli 2001; Mazel 2006). Integrons play a major role in spreading antibiotic resistance 
genes found in Gram-negative bacteria as part of a gene cassette inserted into an integron 
(Fluit & Schmitz 1999; Yu et al. 2004). Five different classes of mobile integrons have 
been defined, on the basis of the sequence which encoded integrases (40%-58% identity), 
uhile only first three classes; classl, class2 and class 3 have been found to involve in the 
spread of multiresistance phenotypes (Mazel 2006), whereas class 4 is a distinctive class 
found in Vibrio cholerae and not associated with antibiotic resistance (Mazel 1988). Class 
I integrons are the most widespread and clinically important, as they were detected in 
22%-59% of Gram-negative isolates (Labbate et al. 2009), and also reported in 
environmental isolates of Gram-nagative bacilli (Fluit & Schmitz 1999; Jones et al. 
1997). Class 1 type integrons comprise two conser\'ed segments flanking another, of 
variable length, within which antibiotic resistance gene cassettes are found. (Rechia & 
Hall 1995; Fluit & Schmitz 1999). The 5'conser\ed segment (5'CS) of class 1 integrons 
is conser\ed and encodes a DNA integrase (Intll) which mobilizes and inserts gene 
cassenes through a site specific recombination mechanism at a specific site {attl) adjacent 
to the Intl gene (Hall & Stokes 1993). This 5" CS region of integron behaves as a 
receptor for gene cassettes, this region also contains promoters Pim and Pc (Pi) responsible 
for transcription of both the integrase and gene cassettes, and to express most of the genes 
carried on cassettes (Carattoli, 2001; Mazel 2006). Three versions of PI are known to 
exist, with different combinations of 235 and 210 sequences in comparison to consensus 
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sequences. These are TTGACAN17TAAACT (a strong promoter), 
TGGACAN177^AAGCT (a weak promoter), and TGGACAN17TAAACT (a hybrid 
promoter) (Levesque et al. 1994; Stokes & Hall 1989). Such sequence changes may be a 
crude mechanism of control of gene expression. In addition the insertion of three 
guanosine molecules 119 bases downstream of the promoter PI creates a downstream 
secondary weak promoter, P2, resulting in a second initiation point of transcription, thus 
increasing the expression of inserted gene cassettes (CoUis & Hall 1995; Levesque et al. 
1994). The 3"conser\ed segment (3'CS) of class 1 integrons includes a truncated 
antiseptic resistance gene {qacEAl), a sulphonamide resistance gene (sulJ) and an open 
reading frame (orp) of unkno\ra fiinction (Rechia & Hall 1995). 
2.6.5 Insertion Sequences 
Rapid dissemination of P-lactamases involves plasmid or strain epidemics, but 
these also involve mobile elements like insertion sequences. Bacterial insertion sequences 
were initiall}' recognized during the studies of model genetic systems; which showed the 
capabilities of insertion sequences to generate mutations due to their translocation. 
Interest in antibiotic resistance and transmissible plasmids subsequently revealed an 
important role for these mobile elements in dissemination of resistance genes and in 
promotion of gene acquisition (Mahillon & Chandler 1998). These insertion sequences 
includes IS£cp7-like insertion sequences and the ISC^7 element (previously called 
ORF513) (Rossolini et al. 2008, Toleman et al. 2006), while IS26 is an 820 bp long 
insertion sequence that t>'pically generates 8bp target duplication upon transposition 
(MoUet et al. 1983). IS£c/?7-like insertion sequences have been found responsible for the 
capture and mobilization of a number of unrelated antibiotic resistance genes including 
blaax-M groups (Rossolini et al. 2008; Shahid et al. 2011). This insertion sequence is 
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bounded by 14-bp inverted repeats, IRL at the left-hand side with respect to the direction 
of transcription of the transposes gene and IRR at the right-hand side. While, ISEcpl is 
mostly found to use IRL in conjunction with alternative sequences resembling these IR to 
mobilize adjacent regions, generating 5-bp duplications of flanking sequence on 
transposition (Lartigue et al. 2006, Poirel et al 2003, Poirel et al. 2005, Wachino et al. 
2006). ISEcpl can mobilize the same adjacent gene as part of different-size "transposition 
units," as illustrated by transposition of "hybrid" units that include adjacent vector 
sequence from cloned ISEcpZ-resistance gene combinations (Poirel et al. 2005; Wachino 
e{ al. 2006). Recently a new element, ORF513, has been increasingly associated with 
class 1 integrons, this element demonstrate IS91-like characteristics and can mobilize 
adjacent DNA sequences via rolling circle replication process. So this element was named 
as 'insertion sequence CRs' (ISCRs), which reflects their appropriate structure-function 
properties (Toleman et al. 2006). The first CR element (ISCRl) was discovered in the 
early 1990s as reported as a sequence of DNA of 2154 bp, incorporating orfSB inserted 
beside the sull genes of class 1 integrons, In(5 and In7 (Stokes et al. 1993). This sequence 
was termed as CR to distinguish it from the 5' and 3' conserved sequences (CS) of class 1 
integrons. 
2.6.6 Association of ISCRl elements with aDtibiotic resistance genes 
ORF513 (also known as ISCRl) has recently been found associated with a 
number of different antibiotic resistance genes, most of which are closely associated 
with class 1 integrons and known as complex class 1 integron (Toleman et al. 2006). 
The sequence is an example of a CR (common region) element, a group of putative 
'mobile' genetic elements that are found in 'Salmonella genomic islands (SGIs) and on 
the integrative conjugative element SXT from Vibrio cholarae (Beaber et al. 2002). 
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ISCRl, which belongs to a family of unusual insertion sequences, typified by ISP/ 
(Garcillan-Bracia et al. 2002) is closely associated with many antibiotic resistance 
genes. ISCi?7 is associated with genes encoding resistance to chloramphenicol (catAII), 
trimethoprim (dfrAlO, dfrA23, dfrASb, dfrA19) and aminoglycosides (armA), and also 
with class A {blacix-u-i, blacTx-M-9, blacrx-M-io, ^/«PER-3, /^AVEB-S) and class C (blamA-u 
blacMY-i, blacMY-&, blacwi-9, blacuY-io, blauox-i) P-Iactamases. The recently discovered 
gene, qnr, which confers resistance to quinolones and reduced susceptibility to 
fluoroquinolones, is also closely linked to ISCRl (Mammeri etal. 2005). 
2.7 Extended-spectrum 0-lactamases (ESBLs) and their classification 
The first plasmid-encoded 6-lactamase, able to destroy extended-spectrum B-
lactam antibiotics, was described in Germany in 1983 (Bush & Sykes 1983). ESBLs have 
the ability to hydrolyse oxyimino-cephalosporins such as cefotaxime, aztreonam and 
ceftazidime, and monobactams, but not cephamycins or carbapenems (Bradford 2001). 
Although ESBLs have been described in a range of Enterobacteriaceae and 
Pseudomonadaceae from different parts of the world, they are most often identified in 
Klebsiella pneumoniae and Escherichia coli. A commonly used definition for ESBLs is 
that the ESBLs are B-lactamases capable of conferring bacterial resistance to the 
penicillins, first-, second-, and third-generation cephalosporins, and aztreonam but not the 
cephamycin or carbepenems, by hydrolysis of these antibiotics, and which are inhibited 
by 6-lactamase inhibitors such as cla\'ulanate (Paterson & Bonomo 2005). Out of 
different functional classification schemes one is the Richmond & Sykes (1973) scheme 
which included all of the P-lactamases classifying into five major groups on the basis of 
substrate profile, other commonly used classifications are Ambler molecular classification 
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system and the Bush-Jacoby-Medeiros functional classification system (Ambler 1980; 
Bush e/a/. 1995) (Table 1). 
According to Ambler classification, 6-lactamases are classified into four classes 
such as A, B, C, and D, on the basis of their amino acid homology and not phenotypic 
characteristics (y-Vmbler 1980). In this classification system, ESBLs of classes A, C, and D 
are serine 6-Iactamases, and the class B enzymes are metallo-6-lactamases; class A and 
class C being the most frequently occurring among bacteria. The activity of Class A 
enz>Tnes is inhibited in vitro by 6-lactamase inhibitors such as clavulanic acid, sulbactam 
and lazobactam but enzymes belonging to class D are not inhibited by these inhibitors. 
According to Bush-Jacoby-Medeiros, 6-lactamases are classified based on functional 
similarities such as on the basis of substrate and inhibitor profile. In this classification, 
class A ESBLs are clustered in group 2be; a designation which shows that these enzymes 
have been derived from group 2b B-lactamases such as TEM-1, -2 and SHV-1 and which 
hydrolyze penicillin, ampicillin, and to lesser degree carbenicillin or cephalothin, and 'e' 
denotes that the J3-lactamases have an extended spectrum activity (Ambler 1980; Bush et 
al. 1995). Recently an updated system by Bush et al. (2010) includes group 1 (class C) 
cephalosporinaises; group 2 (classes A and D) broad-spectrum, inhibitor-resistant, and 
extended-speclTum P-lactamases and serine carbapenemases; and group 3 metallo-p-
lactamases (class B) (Table 1). Several new subgroups of each of these major groups 
have been described based on specific attributes of individual enzymes. A list of 
characteristics has been also suggested for the description of a new p-lactamase, including 
the requisite microbiological properties, substrate and inhibitor profiles, and molecular 
sequence data that provide an adequate characterization for a new p-lactam-hydrolyzing 
enzyme (Bush et al 2010). 
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The majority of ESBLs identified in clinical isolates have been SHV or TEM 
types, which have evolved from narrow-spectrum B-lactamases such as TEM-1, -2 and 
SHV-1 (Bradford 2001), and can be subdivided on the basis of their activities against 
ceftazidime and cefotaxime as ceftazidimases (higher levels of hydrolytic activity against 
ceftazidime than against cefotaxime) and cefotaximases (higher levels of hydrolytic 
activity against cefotaxime than against ceftazidime), respectively (Jacoby 1994). 
However, class A ESBLs form a heterogeneous molecular cluster comprising 6-
lactamases sharing 20 to >99% identit)'. The earliest class A ESBLs, which were reported 
from 1985 to 1987, differed from widespread plasmid-mediated TEM-1/2 and SHV-1 
penicillinases b}' one to four point mutations, which extend their hydrolytic spectra 
(Kliebe et ai 1985; Sirot el al. 1987; Sougakoff e/ al. 1988). TEM and SHV type ESBLs 
now comprise over 130 members (http://www.lahey.org.studies) and have a worldwide 
distribution. Most of them are ceftazidimases, and a small number are cefotaximases. 
2.7.1 Various classes of ESBLs and their properties 
2.7.LI Class A: Ambler Class A enzymes (Bush Group 2) are penicillinases that 
are susceptible to beta-lactamase inhibitors (Table 1). Examples are the PCI beta-
lactamase oi Staphylococcus aureus, a Group 2a beta-lactamase. The TEM-1 and SHV-1 
beta-lactamases. Group 2b, are the beta-lactamases usually found in E. coli and K. 
pneumoniae tliat confer resistance to penicillins (ampicillin and piperacillin) (Bush et al. 
1995). 
2.7.L2 Class B: Ambler class B (Bush Group 3) enzymes are MBLs that use one 
of two zinc (Zn2+) atoms for inactivating penicillins and cephalosporins (Table 1). In 
bacteria, MBLs confer resistance to carbapenems, cephalosporins and penicillins. 
Bacteria possessing MBLs are among the most resistant phenotypes encountered by the 
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clinicians. MBLs are iniiibited by chelating agents (EDTA), but not by clavulanic acid or 
sulfones. The bla genes encoding MBLs are found on a variety of genetic elements 
(chromosome, plasmid, integrons, etc.) (Walsh et al. 2005). Clinically important MBLs 
that are widespread are the IMP-type and VIM-type of P. aeruginosa. Nearly 20% of 
imipenem-resistant P. aeruginosa strains possess an MBL. 
2.7.1.3 Class C: Ambler class C enzymes (Bush Group 1) include the 
chromosomally encoded AmpC type beta-lactamses found in Citrohacter freundii, 
Enterobacter aerogenes and Enterobacter cloacae. Morganella morganii, P. aeruginosa 
and Serratia marcescens. Bacteria possessing AmpC beta-lactamases are resistant to 
penicillins, beta-lactamase inhibitors, cefoxitin, cefotetan, ceftazidime, ceftriaxone, and 
cefotaxime. Aztreonam and cefepime are usually more active against bacteria possessing 
class C beta-lactamases (Table 1). 
2.7.L4 Class D: Ambler class D enz>Tnes (Bush group 2f) are serine beta-
lactamases that are able to hydrol>'ze oxacillin (hence oxacillinases or OXA beta-
lactamases) (Table 1). The OXA enzymes of Acinetobacter baumannii and P. aeruginosa 
represent the most structurally diverse and rapidly growing group of beta-lactamases 
(Brown & Amyes 2006; W'alther-Rasmussen & Hoiby 2006). Depending on the OXA 
enzyme, these beta-lactamases confer resistance to penicillins, cephalosporins, extended-
spectrum cephalosporins (OXA-type ESBLs) or carbapenems (0XA-t}T3e 
carbapenemases). OX,A enz>TOes are relatively resistant to clavulanic acid inactivation, 
but are inhibited by sodium chloride (Naas et al. 1998; Poirel «& Nordmann, 2002). 
Recently a new classification has been proposed by Giske et al. (2009) to 
redefine the ESBLs which expand to other clinically important acquired beta-lactamases 
with activity against extended-spectrum cephalosporins and/or carbapenems. According 
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to this classification scheme functional class 2be beta-lactamases were designated as 
'class A ESBLs' (ESBLA), whereas plasmid mediated AmpC and OXA-ESBLs were 
labelled as 'miscellaneous ESBLs' (ESBLM). This ESBLM category has been divided into 
two categories, ESBLM-C (plasmid mediated AmpC; class C) and ESBLM-D ( O X A -
ESBLS; class D). Regarding carbapenemases, a completely novel concept has been 
described to all currently known acquired beta-lactamases with hydrolytic activity against 
carbapenems. ESBLCARBA has been suggested as a usefiil term to describe the 
carbapenemases and this group \\as also subdi\'ided into A. B and D subgroups which 
represents an attractive refinement of this classification. 
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2.8 Nomenclature of Class A type p-Iactamases 
The |3-lactamases were previously designated by the name of strain or 
plasmid that produced them. The P-lactamase nomenclature has been done on the 
basis of substrates, biochemical properties, peculiarities of sequence, location of their 
discovery, location of the gene on the chromosome, strains of bacteria, patient 
providing a sample and least modestly the investigators who described them (Table 
2). Recently letters have been used instead of strain numbers of these families 
differing by only one to seven amino acids but CTX-M and IMP families differ 
among themselves by as much as 20% in amino acid composition. The first plasmid-
mediated P-lactamase in gram-negative bacteria, TEM-1, was described in the early 
1960s (Datta & Koatomichalou 1965). This enz>'me was originally detected in a 
single strain of E. coli isolated from a blood culture from a patient named Temoniera 
m Athens, Greece, so named as TEM (Medeiros 1984). The spread of TEM-1 to other 
species of bacteria has mediated by plasmid and transposon. After few years of its 
isolation TEM-1 spread worldwide and now it found in many different species of 
members of the family Enterobacteriaceae, Pseudomonas aeruginosa, Haemophilus 
influenza, and Neisseria gonorrhoeae. Another common plasmid mediated P-
lactamase found in Klebsiella pneumoniae and E. coli is named as SHV-1, for 
sulphydryl variable. This enzyme is chromosomally mediated in majority of K. 
pneumoniae isolates but is usually plasmid mediated in E. coli. Resistance lo 
expanded-spectrum P-lactam antibiotics due to P-lactamases emerged quickly. SHV-2 
was first of these enzymes capable of hydrolyzing the newer P-lactams, isolated from 
a single strain of Klebsiella ozaenae in Germany (Kliebe et al. 1985). Due to their 
increased activity against oxyimino-cephalosporins these enzymes were called 
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extended-spectrum P-lactamases (ESBLs). CTX-M (Bauemfeind et al. 1990), rather 
than MEN (Bernard et al. 1992) or TLB, Toho-1-like p-Iactamase (Yagi et al. 1997), 
came to designate that family of enzymes and the Toho enzymes have recently been 
assigned CTX-M numbers (http://www.lahey.org/studies). These p-lactamases 
designated were designated as CTX because they were active on cefotaxime and 
CTX-M because of their activity on cefotaxime and their first isolation from Munich 
(Jacoby 2006). Some enzymes have been known with more than one name such as P-
lactamase CTX-1 and CTX-2 preferred with the alternate name TEM-3 and TEM-25 
respectively (Bonnet 2004, Shahid et al. 2011). MEN-1, Toho-1 and Toho-2 were 
preferred £is CTX-M-1, CTX-M-44 and CTX-M-45 respectively. 
Table 2: I^ SBLs and their nomenclature 
P-lactamase name 
Old ESBL 
New ESBL 
MinorESBL 
OXA 
ESBLs 
SHV type 
TEMtype 
CTX-M-1 group 
CTX-M-2 group 
CTX-M-8 group 
CTX-M-9 group 
CTX-M-25 group 
SFO-1 
TLA-1 
PER 
VEB 
BES-1 
GES 
BEL-l 
TLA-2 
OXA 
Countrj' of 
emergence 
Germany(1983) 
France(1985) 
Germany(1989) 
Japan(1986)/ 
Argentina(1989) 
Brazil (1996-1997) 
Spain (1994) 
Canada(2000) 
Japan (1988) 
Mexico(1991) 
France(1991) 
France(1996) 
Brazil(1996) 
France(1998) 
Belgium(2005) 
Mexico(1991) 
Turkey(1991) 
No. Of 
variants* 
-104 
-185 
-113 
1 
1 
7 
7 
1 
17 
9 
1 
209 
Origin of the name 
Sulphhydryl variable 
Patient's name:Temoneira 
Cefotaximase—Munich 
Serratia fonticola 
Tlahuicas (Indian tribe) 
Pseudomonas extended 
resistance 
Vietnam extended-spectrum P-
lactamase (ESBLs) 
Brazilian ESBLs 
Guyana ESBLs 
Belgium ESBLs 
amino-acid identity with TLA-1 
Hydrolysis of oxacillin > 
penicillin 
* Last accessed on 28 April 2011 as Lahey clinic website 
(http://www.lahev.org/studies) 
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2.9 Brief Description of representative Class A type ESBLs 
2.9.1 TEM p-lactamases 
The TEM family is the most diverse family of P-lactamases, having 185 
different enzymes (http://lahev.org/studies/temtable.asp) as last accessed on 28 April 
2011. TEM-1 is the first member of the TEM family. This enzyme was first reported 
in 1965 from an Escherichia coli isolate, which has substrate and inhibition profiles 
similar to those of SHV-1 (Datta & Kontomichalou 1965). Upto 90% of ampicillin 
resistance in E. coli is due to the production of TEM-1 (Livermore 1995). TEM-1 is 
able to hydrolyze ampicillin at a greater rate than carbenicillin, oxacillin, or 
cephalothin is slightly active against extended-spectrum cephalosporins, and is 
inhibited by clavoilanic acid. Plasmid mediated TEM-1 is considered as one of the 
parental enzymes of TEM type ESBLs and is the most prevalent P-lactam inactivating 
enz}Tne found in enteric bacilli (Liu et al 1992). TEM-2 is the second parental 
enzyme of this family, which differs fi-om TEM-1 in an amino acid substitution at 
position 39 (Gln39Lys), while confers a similar type of resistance (Ambler & Scott 
1979; Jacoby & Sutton 1985; Jacoby & Carreras 1990). This substitution changes the 
isoelectric point from 5.4 in TEM-1 to 5.6 in TEM-2 (Bradford 2001). Another 
difference between TEM-1 and TEM-2 is the strength of the promoters present 
upstream of /^ATEM genes, which encode these P-lactamases. bla-Y^u-i gene have a 
stronger promoter then the promoter of the blaj^u-x gene. TEM-2 enzyme also 
presents a higher enzymatic activity when compared to TEM-1 producing strains 
(Chaibi et al. 1996; Jacoby & Carreras 1990). TEM-3, originally reported in 1989, 
was the first enzyme of TEM family which displayed the ESBL phenotype 
(Sougakoff ef al 1988). Another feature related to genetic environment of the /J/OTEM 
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genes is found in the blajEM-6 gene, which shows a 116 bp ISi-Iike element upstream 
of coding region (Goussard et al. 1991). This element is found responsible for the 
high level synthesis of this enzyme. TEM variants are derived from parental enzymes 
TEM-la to TEM-lh and TEM-2, and from these TEM-la, TEM-lb and TEM-2 are 
encoded in three transposons, Tn3, Tn2 and Tnl, respectively (ArchambauU et al. 
2006; Pajrtridge & Hall 2005). In 1987, K. pneumoniae isolates exhibiting resistance 
to multiple antibiotics including oxyimino-cephalosporins were detected and were 
found to produce P-lactamase named as CTX-1 which refers its activity against 
cefotaxittie (Sirot et al. 1987). Sequencing of the gene encoding by this enzyme was 
related to TEM-2 and differed by two amino acids from its parent enzyme: Lys for 
Glu at position 102 and Ser for Gly at position of 236 (Sougakoff e/ al. 1988). Most 
of the en:?ymes of TEM family have ESBL activity, while some variants reveal the 
characteristic of inhibitor resistance P-lactamases (Canton et al. 2008). Mutations at 
se\eral key amino acid residues like Glul04Lys, Argl64Ser, Gly238Ser, and 
Glu240Lys are important for ESBL activity, similar to those observed in SHV ESBLs. 
In the early 1990s, P-lactamases resistant to inhibition of clavulanic acid were 
discovered. Sequencing revealed that these enzymes were variants of the TEM-1 or 
TEM-2 P-lactamase. These enzymes were initially named as IRT (inhibitor-resistant 
TEM P-lactamase), still all have subsequently been renamed with numerical TEM 
designations. Inhibitor-resistant TEM P-lactamases have been found mainly in clinical 
isolates of E. coli, but also in some strains of K. pneumoniae, Klebsiella oxytoca, P. 
mirabilis, and Citrobacter freundii (Bret et al. 1996; Lemozy et al. 1995). hihibitor 
resistant TEM-variants are resistant to inhibition by clavulanic acid and sulbactam, 
thus showing clinical resistance to the p-lactam-P-lactamase inhibitor combinations of 
amoxicillin-clavulanate, ticarcillin-clavulanate, and ampicillin-sulbactam, they remain 
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susceptible to inhibition by tazobactam and subsequently the combination of 
piperacillin/tazobactam (Bonomo et al. 1997; Chaibi et al. 1999). The combination of 
substitutions associated with ESBL phenotypes and substitutions related with IRT 
phenotypes form a group known as complex mutant of TEM enzymes (CMT). In 
France, the first description of CMT-1 appeared in 1997, which was also known as 
TEM-50, iand presented the ESBL substitutions of TEM-15 and the IRT-substitutions 
of IRT-4, respectively (Sirot et al. 1997). Other enzymes presenting amino acid 
substitutions of ESBL and IRT enz\Tnes were also described in Poland and other 
regions of France (Fiett et al 2000; Poire! et al. 2004; Robin et al. 2007). 
2.9.2 SHV p-lactamases 
As in 28 April 2011, 140 different enz^ines of SH\'' family have now been 
identified according to the Lahey Clinic database (http://lahey.org/studies). SHV 
enzymes are classified in groups 2b and 2be of the Bush-Jacoby-Medeiros 
classification scheme, and in Ambler classification it is classified as class A ESBL. 
These en2:ymes are constitutive of the majorit)' of K. pneumoniae strains which 
possess cliromosomal-mediated ^-lactamases (Babini & Livermore 2000). SHV-1 
(sulphydryl variable) is a (3-lactamase with activit}' against penicillins and narrow-
spectrum cephalosporins such as cephalothin and cephaloridine (Livermore 1995). 
This enzyme was first called as PIT-2 (from the author's name Pitton), and was also 
detected in other Enterobacteriaceae as a plasmid-mediated ^-lactamases (Matthew 
1979; Pitton 1972). The first plasmid-mediated resistance mechanism for oxyimino-
cephalosporins was revealed in 1983 in clinical isolates of A^. pneumoniae, Klebsiella 
ozaenae, and S. marcescens (Knothe et al. 1983). A large number of A:. pneumoniae 
strains possesses a chromosomal copy of either 6/asHv-i or 6/asHv-ii or close relatives, 
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encoding non-extended-spectrum enzymes (Chaves et al. 2001; Lee et al. 2006). It 
was suggested that 6/asHv genes originated from the chromosome of K. pneumoniae 
and descendent from genome to plasmid by mobilization events mediated by IS2(5 
(Ford & Avison 2004). Some studies reported the presence of blasHws between two 
IS26 elements together with the sequence identical to part of the K. pneumoniae 
chromosome (Miriagou et al. 2005; Preston et al. 2004). Another event resulted in 
IS26 insertion into the blasuw promoter as can be identified in plasmid-mediated 
SHV-2a, SHV-11 and SHV-12 (Nuesch-Inderbinen et al. 1997; Podbielski et al. 
1991). Some studies have shown that this IS26 insertion increases promoter strength 
through the introduction of a different -35 regions (Podbielsid et al. 1991). SH\' t}-pe 
enzymes probably evolved in the antibiotic era from a common ancestor, these 
descendants include both penicillinases and extended-spectrum ^-lactamases (Hall & 
Barlow 2004). Sharing 67% sequence identity of SHV with JEM en2}Tnes, substraie 
binding cavity of SHV-1 is 0.7-1.2 A larger than in TEM-1 (Kuzin et al. 1999; 
Reynolds et al. 2006). SHV type P-lactamases can have amino acid substitutions 
which can be responsible for increasing the resistance levels to narrow and extended-
spectrum cephalosporins and also to monobactams and |3-lactamase inhibitors. In 
clinical strains resistance to third generation cephalosporins have been found due the 
amino acid substitutions in residues Aspl79, Gly238 and Glu240. Residue Aspl79, 
associated to the ESBL phenotype is found to be located in the Q loop of the SHV 
active site. Amino acid substitution of Aspl79 by Ala (SHV-6), Asn (SHV-8) and Gly 
(SHV-24) probably increase the movement of the Q. loop (Knox 1995), which have 
been found to confer high-level resistance to ceftazidime but not to cefotaxime in 
enzymes isolated in France (SHV-6), Japan (SHV-24) and United States (SHV-8) 
(Arlet et al. 1997; Kurokawa et al. 2000; Rasheed et al. 1997). SHV p-lactamase 
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substitutions in the residue Gly238 have greater importance in conferring high-level 
resistance against extended-spectrum cephalosporins. The substitution Gly238Ser 
pushes the P-strand out and away from the reactive Ser70, which expands the active 
site to peimit greater substrate versatility against penicillins and cephalosporins 
(Hujer et al 2001). Enzymes like SHV-2, SHV-2A and SHV-3 confer high level 
resistance to cefotaxime than to ceftazidime (Barthelemy et al. 1988; Nicolas et al. 
1989; Podbielski et al. 1991). Substitution of residue Glu240 increases the 
hydrolysing activity against ceftazidime. Resistance to ceftazidime is increased in 
enzymes such as SH\'-5 and SH\'-12 holding at least both Gly238Ser and Glu240Lys 
substitutions (Gutmann et al. 1995; Nuesch-Inderbinen et al. 1997). An amino acid 
substitution, Alal87Thr, was also found xsith low level resistance to P-lactamase 
inhibitors in SHV-26 (Chang et al. 2001). Enzvines like SHV-2, SHV-2 A, SHV-5 and 
SHV-12 have been detected in strains of Enterobacteriaceae, Pseudomonadaceae and 
Moraxelleceae isolated in hospitals, in the community, animals and food samples 
from Europe, Afiica, Asia and Oceania (Chiaretto et al. 2008; Damjanova et al. 2007; 
Jouini et al. 2007; Paterson & Bonomo 2005). 
2.9.3 CTX-M type ^-lactamases: Brief description 
In recent years a new family of plasmid mediated ESBLs, CTX-M type 
ESBLs, has been noticed to emerge. CTX-M t>pe ESBLs constitutes a distinct lineage 
of molecular class A p-lactamases, and are a rapidly growing group. In 1989, a 
clinical isolate of £. coli has been found to produce a non-TEM, non-SHV ESBL and 
was designated as CTX-M-1 because of its hydrolytic activity against cefotaxime 
(Bauemfeind et al. 1990). The main characteristic of all CTX-M producing isolates is 
the higher level of resistance to cefotaxime than to ceftazidime (Bonnet 2004; Chen et 
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al. 2005). The sources of CTX-M determinants are chromosomal genes resident in 
members of the genus Kluyvera, which includes a number of environmental species 
with little or non-pathogenic activity against humans. CTX-M type enzymes have 
mainly been found in strains of Salmonella enter ica serovar Typhimurium and E. coli, 
but this group has also been found in other species of Enterobacteriaceae (Bradford 
2001). Recently this group of ESBLs have emerged as the predominant type in many 
parts of the world, including south America, Europe, Canada, parts of the United 
states and India (Lewis et al. 2007; Livermore et al. 2007; Pitout et al. 2007; 
Rossolini et al. 2008; Shahid et al. 2011). 
2.9.3.1 Classification and origins of CTX-M B-lactamases 
The CTX-M C-lactamases, now exceeding over 113 different variants (Table 
3, Figure 9) have been identified (http://w\\'w.lahey.org/studies), and can be divided 
into five clusters based on their amino acid identities (Bonnet 2004): the CTX-M-1 
group includes CTX-M-1, -3, -10, -11, -12, -15 (UOE-1), -22,-23 -28, -30, -28, -29, -
30, -32, -33, -36, -54, (Matsumoto et al. 1988; Barthelemy et al. 1992; Gniadkowski 
et al. 1998; Karim et al. 2001; Kariuki et al. 2001; Oliver et al. 2001); the CTX-M-2 
group mcludes CTX-M-2, -4, -5, -6, -7, -20, -31, -44 (previously Toho-1) and FEC-
l(Ishii et al. 1995; Bauemfeind et al. 1996; Bradford et al. 1998; Gazouli et al. 1998a; 
Gazouli et al. 1998b; Tassios et al 1999; Saladin et al. 2002); the CTX-M-8 group 
includes CTX-M-8, -40 (Bonnet et al 2000); the CTX-M-9 group includes CTX-M-9, 
-13,-14 (UOE-2 and Toho-3), -16,-17,-18,-19,-21, -24, -27, -45 (previously Toho-
2), -46, -47, -48, -49, -50 (Ma et al. 1998; Labia 1999; Sabate et al 2000; Bonnet et 
al 2001; Pai et al 2001; Poirel et al 2001; Cao et al 2002; Saladin et al 2002; 
Chanawong et al 2002; Bonnet et al 2003); and the CTX-M-25 group with CTX-M-
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25, -26, -25, -39, -41 (Chanawong et al. 2002; Dutour et al. 2002; Karim et al 2001; 
Oliver et al. 2001; Poirel et al. 2001; Sambrook et al. 1989; Tzouvelekis et al. 2000). 
CTX-M-14 was later found identical to CTX-M-18. But recently CTX-M-45 is 
considered as a distinct group of CTX-M type p-lactamases (Rossolini et al 2008). 
Studies have suggested that P-lactamases of CTX-M groups are structurally related to 
the naturally produced p-lactamases of various kluyvera species (Decousser et al. 
2001; Humeniuk et al. 2002; Poirel et al. 2002; Olson et al. 2005; Pitout et al. 2005). 
i3-Lactamases of CTX-M-1 group are related to the 6-lactamases of Kluyvera 
cryocrescens (Decousser et al. 2001) and CTX-M-2 group en2>-mes are structurally 
related to the naturally produced B-lactamase of Kluyvera ascorbata (Humeniuk et al. 
2002), precursors of CTX-M-8 and CTX-M-9 groups are related to 6-lactamase of 
Kluyvera Georgiana (Poirel et al. 2002; Olson et al. 2005), an enz>-me identical to 
CTX-M-3 was isolated from a strain of K. ascorbata (Rodriguez et al. 2004). The 
CTX-M-9 group is related to enzymes from Kluyrera spp. isolated in Guyana, which 
is identical with CTX-M-14 (Boyd et al. 2004). 
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Table 3: Various CTX-M types of p-lactamases reported in Gram-negative 
organisms, their year and country of origin and accession numbers 
CTX-M 
type 
CTX-M-1 
CTX-M-2 
CTX-M-3 
CTX-M-4 
CTX-M-5 
CTX-M-6 
CTX-M-7 
CTX-M-8 
CTX-M-9 
CTX-M-10 
CTX-M-11 
CTX-M-12 
CTX-M-13 
CTX-M-14 
CTX-M-15 
CTX-M-16 
CTX-M-17 
CTX-M-18 
CTX-M-19 
CTX-M-20 
CTX-M-21 
CTX-M-22 
CTX-M-23 
CTX-M-24 
CTX-M-25 
CTX-M-26 
CTX-M-27 
CTX-M-28 
CTX-M-29 
CTX-M-30 
CTX-M-31 
CTX-M-32 
CTX-M-3 3 
CTX-M-34 
CTX-M-35 
CTX-M-36 
CTX-M-3 7 
CTX-M-3 8 
CTX-M-39 
CTX-M-40 
CTX-M-41 
CTX-M-42 
CTX-M-43 
Accession 
Number 
X92506 
X92507 
Y10278 
Y14156 
U95364 
AJ005044 
AJ005045 
AF189721 
AF174129 
.AT255298 
AY005110 
.\F305837 
AF252623 
AF252622 
AY044436 
AY029068 
AY033516 
AF325133 
AF325134 
AJ416344 
AJ416346 
AY080894 
AF488377 
AY143430 
AF518567 
AYl 57676 
AY156923 
AJ549244 
AY267213 
AY292654 
AJ567481 
AJ557142 
AY238472 
AY515297 
ABl 76534 
AB177384 
AY649755 
AY822595 
AY954516 
AY750914 
DQ023162 
DQ061159 
DQ102702 
Source organism 
Escherichia coli 
Scdmonellatyphim urium 
Citrobacter freundii 
Salmonella typhimurium 
Salmonella typhimurium 
Salmonella typhimurium 
Salmonella typhimurium 
Citrobacter amalonaticus 
Escherichia coli 
Escherichia coli 
Klebsiella pneumoniae 
' Klebsiella pneumoniae 
Klebsiella pneumoniae 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Klebsiella pneumoniae 
Klebsiella pneumoniae 
Klebsiella pneumoniae 
Proteus mirabilis 
Escherichia coli 
Klebsiella pneumoniae 
Escherichia coli 
Klebsiella pneumoniae 
Escherichia coli 
Klebsiella pneumoniae 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Citrobacter freundii 
Providencia sp. 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Klebsiella oxytoca 
Escherichia coli 
Enterobacter cloacae 
Klebsiella pneumoniae 
Escherichia coli 
Escherichia coli 
Proteus mirabilis 
Escherichia coli 
Acinetobacter baumannii 
Country 
Muenchen FRG 
Muenchen FRG 
Poland 
Greece 
Latvia,USA 
Greece 
Greece 
Brazil 
Spain 
Spain 
China 
Kenya 
China 
China 
India 
France 
France 
France 
France 
France 
France 
China 
Germany 
China 
Canada 
UK 
France 
France 
China 
Canada 
Argentina 
Spain 
Greece 
China 
Canada 
Argentina 
Mongolia 
China 
Israel 
UK 
Israel 
Russia 
Bolivia 
Date 
18 April 2005 
18 April 2005 
18 April 2005 
18 April 2005 
26Augl998 
15April2005 
15April2005 
7July2000 
lAug2002 
lMarch2001 
lAug2000 
19jime2001 
2May2003 
22Dec2006 
llJan2007 
3Oct2001 
30Sep2003 
21Nov2001 
21Nov2001 
15April2005 
15April2005 
4Jan2007 
9Aug2004 
4Jan2007 
29Nov2004 
7March2003 
l-Jul-2003 
15-April-2005 
4-Jan-2007 
27-Oct-2004 
15-Apr-2005 
15-Apr-2005 
14-May-2007 
I2-Dec-2005 
6-Jan-2005 
17-April-2004 
26-Jul-2004 
29-NOV-2004 
27-Oct-2005 
13-Jim-2006 
22-May-2005 
25-Jim-2005 
16-May-2006 
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CTX-M-44 
CTX-M-45 
CTX-M-46 
CTX-M-47 
CTX-M-48 
CTX-M-49 
CTX-M-50 
CTX-M-51 
CTX-M-52 
CTX-M-53 
CTX-M-54 
CTX-M-55 
CTX-M-56 
CTX-M-57 
CTX-M-58 
CTX-M-59 
CTX-M-60 
CTX-M-61 
CTX-M-62 
CTX-M-63 
CTX-M-64 
CTX.M-65 
CTX-M-66 
CTX-M-67 
CTX-M-68 
CTX-M-69 
CTX-M-70 
CTX-M-71 
CTX-M-72 
CTX-M-73 
CTX-M-74 
CTX-M-75 
CTX-M-76 
CTX-M-77 
CTX-M-78 
CTX-M-79 
CTX-M-80 
CTX-M-81 
CTX-M-82 
CTX-M-83 
CTX.M-84 
CTX-M-85 
CTX-M-86 
CTX-M-87 
CTX-M-88 
CTX-M-89 
CTX-M-90 
CTX-M-91 
CTX-M-92 
D37830 
D89862 
AY847147 
AY847143 
AY847144 
AY847145 
AY847146 
DQ211987 
DQ223685 
DQ268764 
DQ303459 
DQ885477 
EF374097 
DQ810789 
EF210159 
DQ408762 
AM411407 
EF219142 
EF219134 
AB205197 
AB284167 
EU213262 
EF576988 
EF581888 
EU177100 
EU402393 
Assigned 
FJ815436 
AY847148 
Assigned 
GQ149243 
GQ149244 
AM982520 
AM982521 
AM982522 
EF426798 
EU202673 
EU136061 
DQ256091 
FJ214366 
FJ214367 
FJ214368 
FJ214369 
EU545409 
FJ873739 
FJ971899 
FJ907381 
GQ870432 
GU127598 
Escherichia coli 
Escherichia coli 
Klebsiella pneumoniae 
Escherichia coli 
Klebsiella pneumoniae 
Klebsiella pneumoniae 
Klebsiella pneumoniae 
Escherichia coli 
Klebsiella pneumoniae 
Salmonella enterica 
Klebsiella pneumoniae 
Escherichia coli 
Escherichia coli 
Salmonella enterica 
Escherichia coli 
Klebsiella pneumoniae 
Klebsiella pneumoniae 
Salmonella typhimurium 
Klebsiella pneumoniae 
Klebsiella pneumoniae 
Shigella sonnei 
Escherichia coli 
Proteus mirabilis 
Escherichia coli 
Klebsiella spARS06-441 
Escherichia coli 
Klebsiella pneumoniae 
Klebsiella pneumoniae 
Enterobacter cloaceae 
Providencia stuartii 
Kluyvera ascorbata 
Kluyvera ascorbata 
Kluyvera ascorbata 
Escherichia coli 
Klebsiella pneumoniae 
Klebsiella pneumoniae 
Escherichia coli 
Salmonella enterica 
Salmonella enterica 
Salmonella enterica 
Salmonella enterica 
Escherichia coli 
Salmonella enteric 
Proteus mirabilis 
Salmonella Sp. 
Proteus mirabilis 
Escherichia coli 
Japan 
Japan 
China 
China 
China 
China 
China 
Spain 
Beijing PRC 
France 
Korea 
Thailand 
Latin America 
UK 
Germany 
Brazil 
Colombia 
France 
Australia 
Japan 
Japan 
U.S. 
Taiwan 
Spain 
New Zealand 
China 
Bulgaria 
China 
Brazil 
Brazil 
Argentina 
Argentina 
Argentina 
China 
China 
Southern China 
China 
China 
China 
China 
China 
China 
Iran 
Pennsylvania,USA 
China 
USA 
Lithuania 
18-Jun-1999 
20-May-1998 
18-Dec-2004 
18-Dec-2004 
18-Dec-2004 
18-Dec-2004 
18-Dec-2004 
ll-Oct-2005 
29-Oct-2005 
19-NOV-2005 
26-July-2006 
30-Oct-2007 
7-Aug-2007 
4-Jan-2008 
3-Feb-2007 
30-April-2008 
8Jan-2007 
6-Feb-2007 
24-Jan-2008 
2-NOV-2006 
20-Jan-2009 
3-Mar-2008 
lO-Apr-2008 
2-Dec-2008 
7-Oct-2007 
9-Feb-2008 
24-Sep-2009 
lO-Jul-2009 
29-Oct-2009 
29-Oct-2009 
29-Jun-2008 
29-Jun-2008 
7-Oct-2008 
7-Oct-2008 
ll-Aug-2008 
3-NOV-2008 
17-April-2009 
15-Dec-2008 \ 
15-Dec-2008 
15-Dec-2008 
15-Dec-2008 
ll-May-2009 
25-Apr-2009 
l-Sep-2009 
22-Jul-2009 
6-Oct-2009 
15-NOV-2009 
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CTX-M-93 
CTX-M-94 
CTX-M-95 
CTX-M-96 
CTX-M-97 
CTX-M-98 
CTX-M-99 
CTX-M-100 
CTX-M-101 
CTX-M-102 
CTX-M-103 
CTX-M-104 
CTX-M-105 
CTX-M-106 
CTX-M-107 
CTX-M-108 
CTX-M-109 
CTX-M-110 
CTX-M-IU 
CTX-M-112 
CTX.M-113 
Assigned 
HMl 67760 
FN813245 
AJ704396 
HM776707 
HM755448 
HM803271 
Assigned 
HQ398214 
HQ398215 
Assigned 
HQ833652 
HQ833651 
HQ913565 
JF274244* 
JF274245* 
JF274248* 
JF274242* 
JF274243* 
JF274246* 
JF274247* 
Escherichia coli 
Kluyvera ascorbata 
Klebsiella pneumoniae 
Escherichia coli 
Escherichia coli 
K. pneumoniae 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Not detected 
Not detected 
Not detected 
Not detected 
Not detected 
Not detected 
Not detected 
Belgium 
Argentina 
Argentina 
Israel 
China 
France 
China 
China 
South China 
South China 
China 
14-Jul-2010 
23-Oct-2010 
15-Apr-2005 
21-Aug-2010 
ll-Oct-2010 
n-Aug-2010 
27-Feb-2011 
27-Feb-2011 
27-Feb-2011 
27-Feb-2011 
14-Mar-2011 
Last accessed on 28 April 2011 as Lahey clinic website 
(http://\VAv\v.lahev.org/studies) 
* Accession number allocated but details not available imtil our last search 
2.9.3.2 Chronolog}' of CTX-M emergence 
As previously reviewed by our group (Shahid et al. 2011), CTX-M was 
first discovered in Japan in 1986, designated as FEC-1, in a cefotaxime resistant E. 
coli strain isolated from the faecal flora of a laborator\" dog which was used for 
pharmacokinetic studies of p-lactam antibiotics. In Germany in 1989, a non-TEM, 
non-SHV ESBL. designated as CTX-M-1 was for the first time isolated from an E. 
coli strain (Bauemfeind et al. 1990). In 1992, an ESBL was reported in a clinical E. 
coli sfrain MEN, as being of same type as previously isolated in 1989 from an Italian 
patient (Bernard et al. 1992). This enzyme was then sequenced by Barthelemy et al. 
(1992), designated as MEN-1; this was the first plasmid mediated non-TEM, non-
SHV type, ESBL of class A. In 1996 the sequencing of two non-TEM, non-SHV 
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ESBL encoding genes revealed that CTX-M-1 is identical to MEN-1 and a variant of 
Toho-1, designated CTX-M-2 in Argentina (Bauemfeind et al. 1996). In Poland, one 
study ha;5 reported an identical variant of CTX-M-1, designated as CTX-M-3 
(Gniadkowski et al. 1998). Initially in 1990s, CTX-M-9 was dominant but 2001 
onwards, the emergence of CTX-M-14 and CTX-M-1 group enzymes including CTX-
M-1, CTX-M-3, CTX-M-15 and CTX-M-32 was observed. CTX-M-1 has been 
described in various countries, including Germany and France (Dutour et al. 2002), 
Italy (Pagani et al. 2003), in several speceis like E. coli. Proteus mirabilis, 
Morganella morganii, and in Citrobacter amalonaticus (Mugnaioli et al. 2005). 
Recently CTX-M-1 has been reported in a large outbreak of Enterobacteriaceae 
infections and first time characterized for dexelopment of in \\\o resistance to 
carbapenems from CTX-M-1 producing Enterobacteriaceae in a Spanish intensive 
care unit (ICU) (Mena et al 2006). 
A CTX-M-3 producing strain. Salmonella enterica Serovar Wien, was first 
recovered from Tunisia (Armand-Lefevre et al. 2003). A CTX-M-27 producing strain 
(Salmonella enterica Serovar Livingstone) has been found to cause a nosocomial 
outbreak in a neonatal ward (Bouallegue-Godet et al. 2005). A new CTX-M gene was 
reported in Israel, designated as blacn-.v-j? (Chmehiitsk>" et al. 2005) A novel plasmid 
mediated CTX-M-8 subgroup CTX-M-40 was isolated from U.K. (Hopkins et al. 
2006). Tlie emergence of a novel ceftazidime-resistant CTX-M tNpe CTX-M-55, a 
member of the CTX-M-1 subgroup has been recently reported in Thailand (Kiratisin 
et al 2007). The emergence of ft/acrx-M-s, */acrx-M-i5 and blasHv-s genes in Salmonella 
typhimurium and blasHV-s in Salmonella enteritidis has been first time reported from 
Hungary (Toth et al 2007). A survey from Bolivia and Peru revealed that the 
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prevalence of ESBL harbouring E. coli strains in healthy children has dramatically 
increased over a three year period from 2002-2005. Comparison of reports from 2005 
with 2002 revealed an increased diversity of CTX-M type ESBLs, in 2005 members 
of the CTX-M-1 group (CTX-M-15) emerged in Bolivia whereas only CTX-M-2 was 
observed in 2002. Members of the CTX-M-9 group (CTX-M-14 and CTX-M-24) 
were found to be emerging in Peru, and a new CTX-M-2 variant named CTX-M-56 
was identified in Bolivia in 2007 (Pallecchi et al. 2007). One recent study from North 
America has reported an E. coli isolate carrying CTX-M-65 type ESBL, a variant of 
CTX-M-14, wiiich was isolated from an ambulator)' female with a history of sickle 
cell anaemia (Doi et al. 2008). A novel variant of CTX-M type ESBL, CTX-M-66 has 
been isolated from P. mirabilis isolate in Taiwan (Wu et al. 2008). hi Japan a novel 
chimeric B-lactamase, CTX-M-64 was identified for the first time in a Shigella somei 
isolated from a tourist who had returned from China (Nagano et al. 2009). 
2.9.3.3 Epidemiology of Geographic dissemination of CTX-M 
producing isolates 
hiitially in the 1990s, TEM and SHV type ESBLs were dominant among 
ESBLs in all over the world, but CTX-M producing organisms may have been present 
e%en without bemg recognized property (Radice et al. 2002). CTX-M-1 was first time 
reported vn Germany (Baumfemd et al 1990). Few studies from Spain showed the 
emergence of CTX-M enz)'mes in 1991 in £ coli isolates with shifting epidemiology 
of different ESBLs. Reports from the early 2000s revealed that CTX-M enzymes were 
the predominant ESBLs in most of East Asia, (Munday et al. 2004) and a similar 
replacement also seemed to have occurred in Europe. 
52 
REVIEW OF LITERATURE 
Tlie first report of CTX-M-9 producing Klebsiella oxytoca occurred in the 
United Kingdom (Alobwede et al. 2003), and the first outbreak on CTX-M-26 
producing K. pneumoniae was reported at City Hospital, Birmingham (Brenwald et al 
2003). A new epidemiological scenario includes an increase in the number of CTX-M 
enzymes due to multiple clones and genetic elements that carry blacix-u genes. 
Spread of CTX-M enzymes follow an allodemic rather than an epidemic pattern, 
which reflects that the increase of CTX-M enzymes has not been due to the 
dissemination of particular clones, but because of the spread of both multiple specific 
clones and mobile genetic elements (Canton et al. 2003). In a study by Pitout et al. 
2005, 55% oiE. coli strams were found positive for blacw-u genes from the CTX-M-
3 group (CTX-M-14 like) in which clonally related strains oi E. coli producing CTX-
M-14 like p-lactamases (CTXM14A and CTXM14AR) were responsible for an 
outbreak of communit}' onset urinary tract infection during 2000 and 2001, in 
Calgary, Canada. 
TEM and SHV type ESBLs are mainly associated with epidemic clones, and 
K. pneumoniae is the main carrier of the ESBL genes and a pattern of the spread of 
the ESBLs in hospitals (Paterson & Bonomo 2005) but the present situation has 
changed m South America in comparison to Europe. E. coli is the beginning to be 
recognized as the major source of ESBLs with higher increase in the community than 
in nosocomial settings (Pitout et al. 2005). The increase of CTX-Ms in the hospital 
setting might be a consequence of the entrance of these enz>Tnes from the community, 
the emergence and expansion in the nosocomial setting has been suggested in the 
studies by Romero et al. (2005) and by Ben-Ami et al. (2006). 
According to Canton et al. (2006), the CTX-M ESBLs are a heterogenous 
53 
REVIEW OF LITERATURE 
family, and the rapid spread of CTX-M enzymes is comparable with the spread of 
TEM-1 fi-lactamases in the 1970s. The study described the then prevalent situation of 
CTX-M typie ESBLs in different geographic areas. Often studies have shown that an 
endemic situation of CTX-M producing isolates is dominant in most European 
countries and in Asia and South America. The USA has sporadic reports of CTX-M-
producing isolates (Paterson & Bonomo 2005). From Argentina two genes identical 
with blacTx.M-3 and blacTx-u-u were detected in the chromosome from a K. ascorbata 
strain and in six strains of K. georgiana isolated from Guyana, respectively 
(Rodriguez et al. 2004; Olson et al 2005). Some of the CTX-M enzymes were found 
to be reported in some specific countries, such as CTX-M-9 and CTX-M-14 in Spain, 
CTX-M-1 in Italy, and CTX-M-2 in most South American countries, Japan and Israel 
(Bonnet 2004; Ben-Ami et al. 2006) whereas CTX-M-15 have been found worldwide 
(Canton & Coque 2006). CTX-M-14 was found to be the most widespread CTX-M 
type enzyme in a very wide geographic area including Europe, North America, South 
Asia and in East Asia (Eckert et al. 2006). In Amesterdam CTX-M ESBLs were 
found dominant (al Naiemi, et al. 2006). Some CTX-M-32 producing strains have 
recently been recovered from both humans and farm animals in Spain, Italy, Greece 
and Portugal suggesting the existence of community reservoir of CTX-M enzymes 
and ongoing widespread dissemination in the Mediterranean area (Cartelle et al. 2004; 
Brinas et al. 2005; Mugnaioli et al. 2006; Oteo et al. 2006). 
Due to the dissemination of CTX-M ESBLs, Lillie et al. (2006) showed a 
rise in the proportion of resistant- £. coli to 9% in 2005 as compared to 2% in 1999. 
In Asian countries, information pertaining to the CTX-M enzymes is readily available 
for isolates obtained from inpatients, but little is kno\vn about the epidemiology 
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among outpatients. The community emergence of CTX-M was found as a major 
ESBL type among urinary tract isolates from women in Hong Kong (Ho et al. 2007). 
ESBLs have been known since 1982 but their types, prevalence and distribution in 
Europe have changed since 2003 (Livermore et al 2007), following similar but earlier 
shifts in South America and Asia. 
A study of healthy population of children in Bolivia and Peru revealed that 
faecal carriage of E. coli strains resistant to expanded spectrum cephalosporins had 
increased in 2005 when compared \\ith the observations of 2002 in the same settings. 
This sugge:5ted thai this phenomenon was mainly related to the dissemination of CTX-
M t>'pe ESBL determinants among commensal E. coli strains (Pallecchi et al. 2007). 
Since the first description of CTX-M-15 in 2001 from India (Karim et al. 2001), 
which differed from CTX-M-3 by a point mutation which increased its hydrolytic 
actix'ity agiiinst ceftazidune, it has rapidly spread worldwide in Asia, Europe, South 
America, Africa and the Middle East (Edelstein et al. 2003; Neuwirth et al. 2003; 
Pagani et al. 2003; Gangoue-pieboji et al. 2005; Moubareck et al. 2005; Valenzula de 
Silva et al. 2006). Italy (from where only CTX-M-1 type |3-lactamases have been 
reported) fVlugnaioli et al. 2006), France and Spain from where clonal dissemination 
of CTX-M-15 in hospitals had never previously been reported, recently all these 
countries have reported outbreaks for CTX-M-15 producing E. coli strains (Lavollay 
et al. 2006; Oteo et al. 2006). Rapid dissemination of CTX-M t>pe enzymes involve 
plasmids or strain epidemics but it also involves mobile elements such as ISEcpl like 
insertion sequences and \SCR1 element (previously called ORF513) (Eckert et al. 
2006). One study in Israel has reported the high occurrence of the CTX-M-25 type 
family and examined integron-based mode of disseminationb^»eeiRiB;^ewA«o«we, 
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E. coli, E. cloacea and P. mirabilis. They also have reported a new type CTX-M-41, 
in P. mirabilis (Navon-Venezia et al. 2008), phylogenetically similar to CTX-M-25, 
initially reported from E. coli in Canada. CTX-M-39 is found in K. pneumoniae, E. 
coli and E. cloacea was reported as similar to CTX-M-26, which was initially 
reported in K. pneumoniae from the UK (Navon-Venezia et al. 2008). In 2008 
6/acTX-M-28 has also been reported from India (Kingsley & Verghese 2008). Recent 
studies, inicluding that of our group, has revealed that K. pneumoniae producing 
CTX\I-15 is also present m various geographic areas in southern India (Muzaheed et 
al. 2009). ;and in nonhem bdia (Ensor et al. 2006; Shahid et al. 2011). 
2.93.4 Enzjmatic properties and structural relationship of CTX-M 
The CTX-M-t>pe p-lactamases represent a rapidly emerging group with a 
t>pical ex'tended spectrum ^-lactamase resistance phenotype but non TEM or non 
SH\'' derivatives. In CTX-M the highest hydrolytic activity is seen against narrow-
spectrum cephalosporins. The activity against cefotaxime is generally at least 35-fold 
greater tham that against ceftazidmie, as observed with the plasmid-mediated SFO-1 
enzyme (P'eduzzi et al. 1997; Matsumoto et al 1999). Weak enz>'matic efficiencies 
against ceftazidune distmguish most CTX-M enzjTnes from TEM and SHV (i.e., 
TEM-3, TEM-4, SH\^-2, and SHV-3). CTX-M enzymes do not exhibit significant 
hydrohiic activities against 7-a-substituted ^-lactams (cefoxitine) and imipenem, as is 
the case for most class A ESBLs. According to Bonnet (2004), the P-lactamases 
responsible for resistance to cefotaxime had alkaline pi values. One study has 
reported that CTX-M-15 differs from CTX-M-3 by 1 amino acid substitution at 
position 240(Asp-240->Gly), which confers an increased catalytic activity to 
ceftazidime (Poirel et al 2002). CTX-M-32 differs from CTX-M-1 by a single 
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Asp240-G]y substitution responsible for its increased level of resistance to 
ceftazidime (Cartelle et al. 2004). Analysis by sequencing of a newer CTX-M type 
gene revealed 99% homology with ft/acTX-M-26, with a substitution of arginine for 
glutamine at position 225 with a higher MIC to cefotaxime; this new enzyme was 
designated as CTX-M-39 (Chmelnitsky et al. 2005). Sequencing of FEC-1 encoding 
gene showed that the FEC-1 enzyme differs from the CTX-M-3 enzyme by only two 
substitutions in the signal peptide. The natural P-lactamase KLUC-1 of K. 
cryocrescens strain shared only 85-86% identity with the most closely related CTX-
M, which belongs to the CTX-M-1 group (Decousser et al. 2001). 
The study by Pallecchi et al. (2007) has described CTX-M-2 group 
determinants, a new variant of this group named blacTx.M-56 (accession no. EF3 74097) 
that differed from blacTx-u-i (Bauemfeind et al. 1996) by a single nucleotide mutation 
(G824A), resulting in a replacement of serine by asparagine at position 275. CTX-M-
9 group determinants, blacix-u-H, a new allele of 6/acTX-M-24(EF374096) showed two 
synonymous transversions (C823A and C825A), when compared with 6/acTX-M-24 as 
described by Eckert et al. in 2006. This new i/acTx-M-24 allele differed from blacjx-M-
i4(Pai et al. 2001) by a single transversion (C825A) due to replacement of a serine by 
an arginine at position 275. A study by Navon-Venezia et al. (2008), has revealed 
CTX-M-^H, a novel member of CTX-M-25 family (accession no DQ03162) which 
differed from CTX-M-25 by three point mutations C239T, G316A and T377G, 
resulting in the amino acid substimtions AlaSOVal, Vall06Ile and Ilel26Ser. 
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2.10 ESBL Detection Methods 
2.10.1 Phenotypic detection methods 
The increased prevalence of Enterobacteriaceae producing ESBLs generates 
a great need for laboratory testing methods which provides clinicians accurate 
information to identify the presence of these enzymes in clinical isolates. Treatment 
of infections caused by ESBL-producing organisms with extended-spectrum 
cephalosporins or aztreonam may result in treatment failure even when these 
causati\e organisms appear to be susceptible to these antimicrobial agents by routine 
susceptibilit}' testing (Paterson et al. 2001; Paterson & Bonomo 2005). Revision of 
cephalosporin breakpoints has been managed by the European Committee on 
Antimicrobial Suceptibilit\- testing (EUCAST) and by Clinical and Laboratory 
Standards Mstimte (CLSI) for better prediction of clinical outcome by MIC values but 
it is still controversial weather this revision might allow clinical laboratories to 
dispense with ESBL detection (Paterson & Bonomo 2005; Kahlmeter 2008). Since the 
1980s, several phenotypic tests for detection of ESBL producers have been developed 
on the bases of characteristics of ESBLs: conferring a reduced susceptibility to 
extended-spectrum cephalosporins and inhibition by clavulanate. If the organisms are 
inducible by chromosomal AmpC p-lactamases then it is difficult to detect ESBL 
production using these methods because AmpC p-lactamase resists inhibition by 
clavulanate. The CLSI method for ESBL detection consists of the initial screen test 
and the phenotypic confirmatory test (CLSI 2008). In the initial screen test 
susceptibilities to more than one of the antibiotics such as cefpodoxime, ceftazidime, 
ceftriaxone, cefotaxime, and aztreonam are evaluated using disk diffusion or broth 
dilution method. Decrease in susceptibilities to one or more antibiotics tested indicate 
58 
REVIEW OF LITERATURE 
the organisms as ESBL producers and subsequently indicates to perform Piienotypic 
Confirmatory test. In Phenotypic confirmatory test, susceptibilities to cefotaxime and 
ceftazidime alone and those with clavulanate are compared using disk diffusion or 
broth dilution method. If the susceptibility of either antibiotic tested increases 
significantly (>5 nrai increase in a zone diameter or a >3 two-fold decrease in an 
MIC) in llie presence of clavulanate confirms ESBL production. Several ESBL 
detection tests that have been proposed are based on the Kirby-Bauer disk-diffusion 
test methodology. Double-disk synergy test was the first proposed ESBL detection 
method described by Jarlier et al. (1988). In this method, the organism is swabbed 
onto a Mueller-Hinton agar plate and on this plate a disk containing ox\"imino-P-
lactam antibiotics and a disk containing amoxicillm.'cla\Tilanate placed 30 mm apart 
(center to center). Enhancement of the zone of inhibition of the ox}'imino-p-lactam 
caused by the synergy of the clavulanate in the amoxicillin'cla\"ulanate disk is a 
positive re:sult. It has been suggested that the sensiti\'it)" of this test can be increased 
by reducing distance between the disks to 20 mm (Thomson & Sanders 1992; Tzelepi 
et al. 2000). Recently it has been described by Shahid et al. (2007) that the sensitivity 
of DDST can be increased by using piperacillin/tazobactam combination in place of 
amoxicillin/clavulanate. The use of ceipodoxime as expanded-spectrum cephalosporin 
has been suggested for use in DDST for ESBL detection (Coudron et al. 1997). A 
similar test was designed by Jacoby and Han, in this test 20 ug of sulbactam was 
added to susceptibility disks containing one of the ox}imino-p-lactam antibiotics 
(Jacoby & Han 1996). An increase of >5 mm in the zone of inhibition in a disk 
containing sulbactam compared to the antibiotic alone is considered a positive test. A 
number of AmpC producing strains also showed an enhancement of the zone diameter 
with the addition of sulbactam (Jacoby & Han 1996). Recently, Shahid et al. (2007) 
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suggested that the ESBL producers can be determined by using ceftriaxone versus 
ceftriaxone/sulbactam in combination disk test, susceptibility criterion used for this 
combination was >8 mm increase in zone diameter of ceftriaxone/sulbactam in 
comparison with that of ceftriaxone alone. Another method for the detection of 
ESBLs is the three-dimensional test described by Thomson & Sanders (1992). In this 
test, following inoculation of a susceptible strain, E. coli 25922, as lawn onto the 
surface of a Mueller-Hinton agar plate, a slit is cut into the agar, into which broth 
suspension of the test organism is introduced antibiotic disks are placed on the surface 
of the plate 3 mm fi^om the slit. Distortion or discontinuity of the circular zone of 
inhibition is considered a positive test (Thomson & Sanders 1992). Recently this 
method has been described as modified three dimensional extract test (MTDET) by 
Shahid et al. (2004). In this test, 10-15 mg of bacterial wet weight was scraped from 
culture pla,te and suspended in 0.5 ml of peptone water in a sterile micro-centrifuge 
tube and incubated at 37°C for one hour. Crude enzyme extract is prepared by 
repeated freezing-thawing. To ensure complete membrane lysis, the freezing-thawing 
may be carried out five times. Lawn culture oiE. coli ATCC 25922 was prepared on 
Mueller-Hinton agar plate and was incubated at 37°C so that plate can dry properly. 
Cefotaximie disks (30 fig) were placed on dried plate then with a sterile scalpel a 
linear trench (3cm x 1mm) was prepared in agar at a distance of 5mm from edge of 
disk in an outward radial direction. 50 \il of enzyme preparation was loaded in trench 
and overfill was avoided. The inoculated media was incubated overnight at 37°C. 
Enhanced grov^h of the surface organism at the point where trench intersected the 
zone of inhibition towards the cefotaxime disk was interpreted as evidence for the 
presence of CTX-M type ESBLs. Several commercial manufacturers have developed 
ESBL detection tests that can be used along with MIC test methods like ESBL 
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detection by using Etest strips (Vercauteren et al. 1997) and automated VITEK ESBL 
test (Sanders et al. 2000; Tenover et al. 1999). 
2.10.1.1 Phenotypic detection of CTX-M ESBLs 
Ceftazidime resistance is used in practice as an indicator of the presence of 
ESBLs, and ceftazidime is usually the best substrate for TEM and SHV type ESBLs. 
When used alone this practice could fail to recognize CTX-M-producing strains 
susceptible to ceftazidime as ESBL producers and therefore greatly hamper the 
control of the spread of the CTX-M enzyme. Many strains producing ESBLs 
demonstrate an inoculum effect, in that the MICs of expanded-spectrum 
cephalosporins rise as the inoculum increases (Bradford 2001). CTX-M-producing 
isolates, wliich are not resistant to ceftazidime in vitro, according to European and 
CLSI guidelines, could therefore be resistant to ceftazidime in vivo. The use of 
ceftazidime to treat infections caused by CTX-M-producing strains can therefore lead 
to therapeutic failure and promote the emergence of CTX-M enzymes with significant 
hydrolytic activities against ceftazidime. Interpretive antibiograms of CTX-M-
producing strains should therefore result in resistance to all expanded-spectrum 
cephalospcdns and aztreonam. In addition to susceptibility to ceftazidime, 
susceptibilit)- to cefotaxune should also be tested to reduce the risk of overlooking 
CTX-M production (Brenwald et al. 2003; Alobwede et al. 2003). 
2.10.2 Molecular detection methods 
Ttie tests described above only presumptively identify the presence of an 
ESBL. The determination of whether a specific ESBL present in a clinical isolate is 
related to TEM and SHV enzymes is a complicated process because point mutations 
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around the active sites of the IBM and SHV sequences have led to amino acid 
changes that increase the spectrum of activity of the parent enzymes (Bradford 2001). 
The molecular methods that are commonly used is the PCR amplification of ESBL 
genes with oligonucleotide primers, followed by sequencing. Sequencing is essential 
to discriminate between the non-ESBL parent enzymes (e.g, TEMl, TEM2, or SHVl) 
and different variants of TEM or SHV ESBLs (Bradford 2001). Several other 
molecular methods without use of sequencing have been developed to characterize 
ESBLs and include PCR with RFLPs (Arlet et al. 1995), PCR with single strand 
conformation polymorphism (M'Zali et al. 1996), ligase chain reaction (Kim & Lee 
2000), combination of PCR-SSCP with PCR-RFLP to identify SHV variants 
(Chanawong et al. 2000), and real-time PCR (Randegger & Hachler 2001). However, 
the increasing number of additional subtypes within each ESBL family has placed 
strict limita.tions on these techniques with regard to their ability to cover the whole 
range of variants with different point mutations. PCR amplification followed by 
nucleotide sequencing remains the gold standard for the identification of specific 
point mutation ofblaiEU or bla^wM ESBL genes (Fluit et al 2001). However, this is 
not always straightforward and cost effective because clinical isolates often have 
multiple copies of ESBL genes. Genetic methods for detection of TEM and SHV 
types of ESBLs are thus complex and challenging because of the diversity of different 
point mutations. The use of genetic methods to identify the different types of TEM 
and SHV ESBLs is mainly restricted to reference laboratories and to molecular 
surveillance studies. Hopefully, recent molecular developments, such as microarrays 
and rapid-cycle sequencing, will make genotypic detection more readily available and 
cost effective for diagnostic laboratories to identif}' these types of ESBLs in a real-
time fashion (Sundsfjord et al 2004). 
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2.10.2.1 Molecular detection of CTX-M enzymes 
The PCR amplification of CTX-M-specific products without sequencing, in 
an isolate that produces an ESBL, usually provides sufficient evidence that a blacix-u 
gene is responsible for this phenotype. This is unlike TEM and SHV types of ESBLs. 
Several recent studies have described various molecular approaches for the rapid 
screening of ESBL-positive organisms for the presence of different blacix-u genes. 
Different v/orkers have designed various PCR protocols for detection of blacTx-u 
detecting tlie CTX-M-genogroups. This involved a PCR assay that used four sets of 
primers to amplify group-specific CTX-M ^lactamase genes (Pitout et al. 2004), 
amplification of a uni\ersal DNA fragment specific for most of the different groups of 
CTX-M p-lactamases (Batchelor et al. 2005). duplex PCR (Pitout et al. 2007) and 
real-time PCR (Birken et al. 2007). A multiplex PCR is also being used with 
modifications by indi\'idual laboratories (Ensor et al. 2006a). Precise CTX-M 
genotypes could be identified either by using monoplex PCR for specific types, by 
reverse line hybridization (Ensor et al. 2006b), or by sequencing. Molecular analysis 
of CTX-M genes can also be done by using different multiplex PCR methods 
(Woodford et al. 2006: Xu et al. 2005). Denaturing high performance liquid 
chromatogjraphy (dHPLC) is a powerful technique which has been used extensively to 
detect genetic variation. The technique was specifically developed to genotype 
members of all blacrx-si DN.A. homolog>- groups. dHPLC is highly accurate, rapid and 
cost effective for the genotjping oiblacTx-st producing ESBLs and has great potential 
for determining the clinical relevance of different and new Z?/«crA--A/genotypes, as well 
as for epidemiological studies and surveillance programmes (Xu et al. 2007). 
Nowdays the combination of real time PCR with pyrosequencing represents a 
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powerful tool for epidemiological studies of CTX-M producers. The pyrosequencing 
technique may also provide a rapid tool for determination of the molecular 
mechanisms of muhidrug resistant strains; this method is based on the detection of 
pyrophosphate released during the synthesis of DNA, allowing real time sequence 
determinsition (Ronaghi 2001; Nass et al 2007). These molecular techniques 
undoubtedly have the potential to play an essential part in the laboratory setting for 
the screening, tracking, and monitoring of the spread of large numbers of organisms 
producing CTX-M enzymes from the community and hospital settings. 
2.11 Genetic environment oiblacrx-M genes 
Although a number of genetic mechanisms have been involved in the 
spreading of blacTx.-M genes, insertion sequences (ISEcpI, IS26, and ISCRJ) with 
association of class 1 mtegrons have played a dominant role in dissemination of these 
genes. Previous analysis of DNA sequence of blacrx-M genes suggested the presence 
of ISEcpl. ISEcpl was first identified upstream of the plasmid-mediated 
cephalosporinase gene blacm-4 in an E. coli isolate from the U.K. (AJ242809) 
(Stapleton 1999). This insertion sequence (IS) was also found associated v i^th several 
blacTX-M CKarim et al. 2001; Cao et al. 2002; Saladin et al. 2002; Poirel et al. 2003: 
Eckert et al. 2004; Lartigue et al. 2006; Poirel et al. 2005; Shahid 2010). Analysis of 
promoter regions of CTX-M enzymes in bacteria producing plasmid mediated ^-
lactamases revealed mobile IS such as IS2(5, ISPOi and ISEcpl elements \\iiich play 
an importcmt role in the spread of ESBLs (Cao et al. 2002; Poirel et al. 2003). It has 
been reported that in some strains insertion sequence ISEcpl was located upstream of 
the 5' end of the blacTX-M gene and this ISEcpl sequence was found disrupted by 
insertion sequences like IS26 or IS/ or ISIO. A similar organization was reported for 
64 
REVIEW OF LITERATURE 
blacTX-M.25 with an IS50 disrupting ISEcpl (Munday et al. 2004b). \S26 and part of 
ISEcpl type organization was also found upstream of the bla genes encoding the 
ACC-1 P-lactamase and upstream of some bhcTx-M (accession number AY462238) 
(Nadjar et al 2000; Saladin et al. 2002; Eckert et al. 2004; Olson et al. 2005). ISW 
was found upstream of the /)/acrA--A/-s(AF 189721) (Eckert et al. 2006). 
However, sequence analysis of DNA downstream of the blacTX-M genes 
revealed a different organization. In the CTX-M-1 cluster, the sequence of Orf477 
was found to be associated uith an additional fragment of mucA as described for the 
plasmid pCTX-M-S (NC00464). Insertion sequence 1^903 was found downstream of 
the blacTX-M-24. blacn.M-r. b!acu-M-i9. blacrx-ss-u and blacTX-M-54 in some strains (Cao 
et al. 2002; Poirel et al. 2005; Bae et al. 2006; Eckert et al. 2006). Insertion sequences 
like IS26 and \S903 have been found flanking the open reading frame region of the 
blacTx-Mgenes (Cao et al. 2002; Saladin et al. 2002). 
In some strains, analysis of surrounding regions of CTX-M genes revealed 
blacTX-M-2 and blacTX-si-9 gene with a different construction (Brigante et al. 2005), these 
genes were found to be located in unusual class 1 integrons having dhfrhI-aadA2 or 
dhfrII-orfF-aadA8 entire gene cassettes, respectively, wthin the variable region. This 
genetic organization was also described for blacTx-M-i and blacTx-si-9 inserted in novel 
complex class 1 integrons InS21, ln35, Inl 16 and In60 (Sabate et al. 2002; Di Conza 
et al. 2002; Arduino et al. 2002; Munday et al. 2004b; Power et al. 2005). This 
unusual integron contains a partial duplication of the 3'conserved segment, and a 
region that includes 6/acrA-wand the Orf513 between both 3' conserved segments. 
Integrons bearing 6/ac7X-.u-2 have resistance cassettes including aac(6')-Ib-oxa-2-orflD 
(In35, InS21 and In 116) (Di Conza et al. 2002; Arduino et al. 2002; Power et al. 
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2005). Dissemination of antibiotic resistance integrons (ARI), which have been found 
unable to promote their own mobiUzation, is mainly linked to transposons and 
plasmids (Novais e( al. 2007). Integrons are recombination and expression genetic 
elements able to capture genes as part of genetic structures known as gene cassettes, 
between their 5' and 3' conserved segment (Fluit et al. 2004; Mazel 2006). CTX-M-9 
encoding genes have been recently characterized as a part of a novel complex Sull-
type integron designated In60 (Garcia et al. 2005). An ISEcpl insertion sequence was 
found to be located 48bp upstream of blacn:\t-i5 (Mahillon et al. 1998). The 5'-
flanking regions of CTX-M genes have shown that all group 2 alleles were associated 
with an ISCRl element, while all group 1 and group 9 alleles were associated with an 
ISEcpl element. Two insertion sequences IS5 and IS7 have been found to be located 
immediately upstream of the 6/acr.v-A/-i2 gene. IS7 was located between the blacTx-M-32 
gene and IS5, and within the -10 and -35 promoter boxes of the blacTx-M-32 gene 
(Fernandez et al. 2007). CTX-M encoding genes ha\e been found on a number of 
plasmids, some of them are part of transposons or constitute cassettes in integrons 
(Bonnet 2004), insertion sequences especially ISEcpl, have been found adjacent to 
genes encoding some of CTX-M tjpe enz\Tnes (Karim et al. 2001; Cao et al. 2002; 
Saladin et al. 2002; Poirel et al 2003; Eckert et al. 2004; Lartigue et al. 2004; Poirel 
et al. 2005). The different genetic elements including ISEcpl like insersion sequences 
(IS) were found to be associated with most of genes within CTX-M-1, CTX-M-2 and 
CTX-M-9 clusters, the CRl element, a putati\ e iransposase was foimd to be linked to 
blacTX-M-2 <ind blacTX-M-9 genes (Garcia et al. 2005; Novais et al. 2006; Toleman et al. 
2006) and phage-related sequences were only identified in the surroundings of the 
blacTX-M-io gene (Oliver et al. 2005). CTX-M-14 was reported to be associated with 
ISEcpl, while an \SCR1 related CTX-M-14 gene was also reported from an E. coli 
66 
REVIEW OF LITERATURE 
isolate (Bae et al. 2007). The association of dfrA12-orfF-aadA2 was first reported 
with blacTx-M-14 gene; this type of genetic organization of resistant gene sequences 
ensures the transfer of the resistant genes from the bacterial chromosome to the 
plasmids (Bae et al. 2007). 
2.12 Mobilization and expression of blacw.^-genes 
Mobilization and expression of MOCTX-M genes to other bacterial genera 
seemed to have occurred b\- recombinatorial events mediated by CRl (a common 
region that includes a putative recombinase named orf513), ISEcpl or phage related 
elements (Bonnet 2004; Lartigue et al. 2004; Oliver et al. 2005; Lartigue et al. 2006). 
ISEcpl and integrons are found as efficient tools for mobilization and expression of 
P-lactamase genes. 
Recent studies of the association of blacrx-M and ISEcpl like insertion 
sequences have revealed that IS is responsible for mobilization and expression of the 
P-lactamase genes (Poirel et al. 2003; Poirel et al. 2005). The ISEcpl element 
contained -35 and -10 promoter regions and could mobihze the genes (Cao et al. 
2002; Poirel et al. 2003; Poirel et al. 2005). IS 10 has been found to take part in 
mobilization of blacrx-M-i gene; the insertion site of the IS is variable from strain to 
strain. 
It has been shown that ISEcplE carried the promoter sequence for high level 
expression of the blacrx-si-u-is, blacrx-M-i? and blacTX-M-i9 p-lactamase genes that 
belong to the same blacu-M-9 subgroup (Cao et al. 2002; Poirel et al. 2003; Bonnet 
2004) and also might be responsible for their mobilization. ISEcplB is able to 
mobilize iJie adjacent blacTx-.u-i9 gene by a transpositional mechanism involving 
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inverted repeats (Poirel et al 2005). Other plasmid mediated p-lactamases blacm type 
genes or genes encoding 16SrRNA methyiase (rtmC) might also be associated with 
ISEcpl in tlieir expression and mobilization (Partridge et al. 2003; D'Andrea et al. 
2006). The evolution of particular CTX-M-1 like genes, blacrx-M-s and blacrx-M-is 
(Baraniak et al. 2002; Jeong et al. 2005) or blacrx-M-i and blacrx-M-32 (Novais et al. 
2007), might contribute to the dissemination and diversity of these enzymes, the 
heterogeneous ISEcpl-blacrx-M regions and the locations of these genes on different 
plasmid platforms would suggest independent mobilization and dissemination cxcnls 
from a common ancestor (Novais et al. 2007). The presence of blacrx-.Kis in difterent 
geographical regions (Gniadkowski et al. 1998; Yan et al. 2000; Paterson & Bonomo 
2005) is the resuh of horizontal transmission assisted by the nearby ISEcpl element. 
Microbiological and biochemical studies revealed lower blacTx-si-32 gene expression in 
bacterial isolates with IS7 between the promoter boxes and a complex structure ISi-
IS7, was detected upstream of the blacTX-M-32 gene and negatively mediated expression 
of the blacTx-M-32 gene by IS 7 because its location modified the promoter region 
(Fernandez et al. 2007). 
2.13 Z>/ac7x-Mgenes and Piasmids 
A 269Kb conjugative plasmid, pk29(ANEF382672) in a Al pneumoniae from 
Taiwan has been identified which harbours multiple antimicrobial resistance genes, 
including those genes which encode CMY-8 type AmpC p-lactamase and CTX-M-3 
ESBL in tlie common backbone of Inc H12 piasmids (Chen et al. 2007). Eckert et al. 
(2006) reported that organization of the DNA sequence of 6/acrA'-.w genes have 100% 
identity w:ith the corresponding region of the plasmid pC-15-Ia. blacTX-M-is^^ found 
to be closely related to the IncFII plasmid of various sizes (85-200kb), transferability 
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properties, aind replicon content (RepFII or RepFII-RepFIA). All FII replicons were 
found identical to the epidemic CTX-M-15 plasmid pel5-la (Boyd et al. 2004) 
(Accession no. AY458016), while all FIA replicons displayed 100% homology with 
the IncFII plasmid pRSB107 (accession no. AJ851089). CTX-M-15 producing 
isolates from different European and Asian countries and from Canada have shown to 
be linked to epidemic IncFII plasmids carrying aac(6')-Ib-cr and blaoxA-i and various 
replicon contents, suggesting pandemic dissemination of CTX-M-15 by IncFII 
plasmid deri\atives of a common element (Hopkins et al 2006; Coque et al. 2008). 
The diversi'^ of rephcons ma> be explained by the different recombinational events 
between IncFII plasmids with different variations in copA, which may alter their 
compatibility properties (Osbom et al 2000; Hopkins et al 2006; Lavollay et al. 
2006). blacTx-sf-} genes of both pk29 and pCTX-M-3 plasmids from Poland (accession 
no. AF550-415), were found to reside in a 3-kb homologous region with >99% 
identit>", including a 1656-bp ISEcp] element upstream of the P-lactamase gene. This 
pCTX-M-3 plasmid also contains blarEM-i, aacC2 and armA genes, as well as 
integronic ,aadA2, dfrA12 and Sull, which confer resistance to the majorit)' of P-
lactams and aminoglycosides and to trimethoprim-sulfamethoxazole (Golebiewski et 
al 2007) 
2.14 Class C (AmpC) type p-Iactamases 
.AjnpC t>-pe P-lactamases are first bacterial enz>-me was reported to destroy 
Penicillin from an Escherichia coli isolate in 1940, but that time it has been not named 
as AmpC (Abraham & Chain 1940). Mutations with stepwise-enhanced resistance 
were termed ampA and ampB (Eriksson-Grennberg 1968; Eriksson-Grennberg et al 
1965), mutation in ampA strain resulted in reduced resistance was designated as 
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ampC. AmpC type P-lactamases are chromosomal encoded cephalosporinases 
detected in E. coll These enzymes are not strongly inhibited by clavulanic acid. 
AmpC type P-lactamases were classified in group 1 according to Bush-Jacoby-
medeiros chissification scheme and in class C according to molecular structure (Bush 
et al 1995; Jaurin & Grundsrom 1981). In this family of p-lactamases ~113 different 
enzymes have been reported, which includes CMY, ACC, CFE, DHA, FOX, LAT, 
MIR and MOX as updated in Lahey Clinic (http://lahey.org/studies) on 28 April 2011. 
These enz^ ,-mes do not confer resistance to ampicillin and first generation 
cephalosporins, and rarely invohed in clinical failure of P-lactams. This happens 
because of gene ampC which encodes AmpC P-lactamases, regulating by a weak 
promoter (Olson et al. 1983) and a transcription attenuator (Jaurin et al. 1981). When 
ampC is leaded by a strong promoter the hyperproduction of AmpC P-lactamases 
occurs (Nelson & Elisha 1999). Two separate mutations in E. coli were also found to 
induce the hyperproduction of this enzyme (Bennett & Chopra 1993). 
Detection of plasmid-mediated ampC genes in Enterobacteriaceae which 
encode ArnpC-type P-lactamases has now become relatively common with the 
identification of MIR-1 (discovered at Miriam Hospital) and CMY-1 (active on 
cephamycins) in Al pneumoniae. BIL-1 (named after the patient Bilal), LAT-3 and 
LAT-4 (nsimed after patient) in E. coli, among others (Bauemfeind et al. 1989; 
Fosberry et al. 1994; Gazouli et al. 1998; Papanicolaou et al. 1990). The occurrence 
of plasmid mediated AmpC P-lactamases has been reported worldwide (Coudron et 
al. 2000; Muratani et al. 2006; Song et al 2006; Woodford et al. 2007; Li et al. 2008; 
Shahid et al 2009). The most common plasmid-mediated AmpC type p-lactamase; 
CMY enz:ymes have been derived from the chromosomal cephalosporinases of 
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Citrobacter freundiii (Miriagou et al. 2004). CMY encoding genes spread worldwide 
may be due to the association of these enzymes with the mobile elements like orf513 
or IS26 (Chen era/. 2007). 
Overall strains which produce AmpC enzymes are generally found resistant to 
penicillin, extended-spectrum cephalosporins, monobactam and cephamycins but are 
susceptible to cefepime, ce^irome and carbapenems (Philippon & Jacoby 2002). So it 
is found very difFicuh to distinguish AmpC-producing organisms and ESBL-
producing organisms using susceptibility testing methods only. 
2.15 Co-existence of CTX-M type p-lactamases with otiier p-
lactamase enzymes 
Plasmid mediated P-lactamases play a key role in the increasing multidrug 
resistance amongst Enterohacteriaceae world-wide. CTX-M-type extended spectrum 
P-lactamases (ESBLs) and AmpC-type p-lactamases have been found as two major 
contributors in recent years (Philippon et al. 2002; Bonnet 2004; Paterson & Bonomo 
2005; Liveirmore et al. 2006). In Taiwan, CTX-M and SHV-type ESBLs and CMY-
and DHA- type AmpC enzymes are reported as the most common p-lactamases 
conferring resistance to extended-spectrum cephalosporins in clinical K. pneumoniae 
isolates (Y<m et al. 2006). CMY-2 type was found to be associated with CTX-M-14 in 
an E. coli isolate (Saladin et al. 2002). The emergence of a multidrug resistant K. 
pneumoniae isolate which produces the MBL type VIM-4, ESBL type CTX-M-15, 
AmpC t>pe CMY-4 and class A type TEM-1, has been reported from France (Ktari et 
al. 2006). Co-existence of CTX-M-2 with IMP-1 has been also reported (Livermore et 
al. 2000). Co-existence of CMY-8 t>pe AmpC and CTX-M-3 type ESBL was 
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reported in a 269 kb conjugative plasmid from K. pneumoniae (Chen et al. 2007). Co-
existence oi" CMY-6 and CTX-M-15 type has recently been reported on the same 
plasmid from India (Shahid et al. 2009). 
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MATERIAL AND METHODS 
3.1 Materials 
3.1.1 Reagents for PCR: 
• PCR Master Mix (2X) and nuclease free water (Fermentas life sciences); PCR 
master mix consisted of 0.05 units/^il Tag DNA Polymerase in reaction 
buffer. 4 mM MgCi2, 0.4 mM dNTP, 0.4 mM dCTP, 0.4mM dGTP and 0.4 
mM dlTP. 
• Molecular markers: High range DNA rular (Bangalore Genei, India) and DNA 
ladder (Fermentas life sciences) 
• Primers (Table 4) and template DNA. 
3.1.2 Reagents for Agarose gel Electrophoresis: 
• Agarose (Bangalore Genei, India) 
• lOX TAE buffer: weighed 48.5g Iris base, 3.5g EDTA, and 11.4ml Acetic 
acid and added in distilled water to make volume to 1 liter, adjusted pH to 8.0 
and autoclaved. 
• Ethidium Bromide: lOmg of Ethidium bromide in 1ml distilled water and 
stored in dark bottles (Bangalore Genei, India). 
• 6X gel loading dye (Bangalore Genei, India). 
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3.1.3 Reagents for isolation of Plasmid DNA 
The following solutions were prepared, sterilized and used: 
• Solution I (Lysis buffer I): 50mM glucose, 25mM Tris-Cl (pH 8.0), lOmM 
EDTA (pH 8.0). Solution I can be prepared in batches of approximately 
100ml, autoclaved for 15 minutes at 10 Ib/sq. in. on liquid cycle, and stored at 
4°C. 
• Solution II (Lysis buffer II); 0.2 N NaOH (freshly diluted from a ION stock) 
and 1^0.SDS. 
• Solution III (Lysis buffer III): 5M potassium acetate (60 ml), 11.5ml glacial 
acetic acid and 28.5ml distilled water. 
• Tris Saturated Phenol: Phenol, 0.1% 8-Hydroxy Quinoline, 0.5 M Tris HCl 
{pH 8.0). 
• Chloroform:Isoamylalcohol (24:1): 24ml of chloroform was added to Iml 
Isoamylalcohol. 
• TE buffer (10 ml): lOm-M Tris HCl (pH 7.5), ImM EDTA (pH 8.0). 
• Ethanol (absolute alcohol) (all chemicals of SRL). 
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Table 4: List of primers used in the study 
Target gene 
6/acTx-M 
*/acTx.M group-1 
blacTx-M group-2 
b!acTx-M group-9 
blacix-u group-8 
blacTX-M group-25 
blam.1 
blasm 
bla^pc 
ISEcpl 
\S26 
ORF513(ISCW) 
Sul-1 
CS region 
Gene to sequence 
CTX-M-
genogroup-1 
CTX-M-
genogroup-1 
CTX-M-
genogroup-9 
CS integron region 
Primer used 
CTX-MUl 
CTX-MU2 
CTX-M gplF 
CTX-MgplR 
CTX-M gp2F 
CTX-M gp2R 
CTX-M gp9F 
CTX-M gp9R 
CTX-M gp8F 
CTX-M gp25F 
CTX-M gp8/25R 
TEM-F 
TEM-R 
SHV-F 
SHV-R 
AmpC-F 
AmpC-R 
ISEcplUl 
P2D 
IS26 
SHA 
ORF513D3 
ORF513D5 
SullA 
SullB 
5'CSFl 
3'CSR 
Sequencing Primers 
ISEcpl-Ul 
CTX-M gp IF 
CTX-M gp9F 
5'CSFl 
Primer sequence 
5'-ATG TGC AGY ACC ACT AAR GT-3' 
5'-TGG GTR AAR TAR GTS ACC AGA-3' 
5'-AAA AAT CAC TGC GCC AGT TC-3' 
5'-AGC TTA TTC ATC GCC ACG TT-3' 
5'-CGA CGC TAC CCC TGC TAT T-3' 
5'-CCA GCG TCA GAT TTT TCA GG-3' 
5'-CAA AGA GAG TGC AAC GGA TG-3" 
Amplicon size 
593 bp 
415 bp 
552 bp 
205 bp 
References 
Pagani et al. 
' 2003 
Woodford et 
al. 2006 
Woodford et 
al. 2006 
Woodford el 
al. 2006 
5'-ATTGGAAAGCGTTCATCACC-3" ' 
5'-TCGCGTTAAGCGGATGATGC-3- ' 666 bp Uoodford er j 
5'-GCACGATGACATTCGGG-.V ] 327 bp ' Woodford et 
j , ai 2006 
5'-AAC CCA CGA TGT GGG TAG C-3- j \ 
5'-KAC AAT AAC CCT GRT .\.AA JGC-T 1 936 bp ' Shahid 2010 
5'-AGTATATATGAGTA.\ACTTGG-3- ; 
5'-TTT ATC GGC CYT CAC TCA AGG-3" 930 bp i Shahid 2010 
5'-GCT GCG GGC CGG ATA ACG-3" ( i 
5-'CCCCGCTTATAGAGCAAC.\.A-3' | 634bp i Feria et ai 
1 ' 2002 
5'-TCA ATG GTC GAC TTC ACA CC -3 ' 
5'-AAA AAT GAT TGA AAG GTG GT-3' 
5'-CAG CGC TTT TGC CGT CTA AG-3' 
5'-GCG GTA AAT CGT GGA GTG AT-3 • 
5'-ATT CGG CAA GTT TFT GCT GT-3-
5'-CTC ACG CCC TGG CA.\ GOT TT-3' 
-llOObp 
Variable 
600 bp 
5 '-CTT TTG CCC TAG CTG CGG T-3' ! 
5'-CTTCGATGAGAGCCGGCGGC-3- j -420 bp 
5'-GCAAGGCGGAAACCCGCGCC-3' ' 
5'-ATGTTACGCAGCAGGGC-3' | Variable 
5'-GGA ATT CGA CCT GAT AGT TTG ' 
GCTGTG-3' 
Primer sequence 
5'-AAA AAT GAT TGA AAG GTG GT-3' 
5'-AAA AAT CAC TGC GCC AGT TC-3-
5'-CAA AGA GAG TGC AAC GGA TG-3' 
5'-ATG TTA CGC AGC AGG GC-3' 
Amplicon size 
llOObp 
415bp 
205bp 
1600bp 
Ensor et al. 
2006 
Woodford et 
a/, 2004 
Shahid 2010 
Shahid 2010 
Y, Wobble (C+T); R, Wobble (A+G); S, Wobble C+G; K, Wobble (G+T) 
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3.2 Methodology 
3.2.1 Specimen collection 
This present study was conducted in the department of Microbiology, J. N. Medical 
College £ind Hospital, Aligarh Muslim University, Aligarh, during the period from 
January 2009 to July 2010. Total of 14,129 patient samples received in the 
bacteriology laboratory from in- and out- patients for routine culture and 
susceptivilit}' testing were studied. These patient samples comprised of various 
clinical specimens such as pus, urine, cervical swab, sputum, drain and abdominal 
fluid. 
3.2.2 Clinical isolates for study 
During the study period (January 2009- June 2010), of the 14,129 clinical specimens 
subjected for routine microbiological examination, yielded growth of Gram-negative 
bacteria; 1610 were E. coli and 455 were Klebsiella spp. Of these, 108 E. coli and 22 
Klebsiella spp. (a total of 130 isolates) that were found resistant to any of the third 
generation chephalosporins were randomly selected for the study. These 130 isolates 
(108 E. coli and 22 Klebsiella spp.) were further processed for phenotypic and 
moleculaj- studies. E. coli ATCC 25922 was used as a control strain for susceptibility 
testing and phenotypic ESBL detection. Previously characterized Citrobacter spp. 
(Dl) and E. coli isolates (D2, and D3) provided by Prof Daniel Jonas, Germany, were 
used as positive controls for SHV, TEM and CTX-M-15, respectively and A2 was 
used as positive control for CTX-M-group-2 provided by Dr. Asad U. Khan, 
department of Biotechnology, AMU, Aligarh. A Citrobacter spp. isolate (13x) was 
used as a control for sull-type integron. 
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3.2.3 Antibiotic susceptibility testing 
Disk susceptibility tests were performed on Mueller-Hinton agar (HiMedia Lab. Ltd., 
India) against the first and second line antibiotics prescribed in our institution and 
interpreted according to CLSI (formerly NCCLS) criteria (NCCLS 2004). The 
antibiotics used and their concentrations (|ig) were: cefoperazone (75|ig), cefixime 
(5|ig), cefpirome (30^g), cefotaxime (SO i^g), ceftriaxone (30), ceftazidime (30|ig), 
cefpodoxime (10|ag), cefepime (30|ig), ofloxacin (5|ig), gentamicin (lO^g), amikacin 
{30ugj. gatifloxacin (5|ag). aztreonam (30|ig), Imipenem (10 ^g), 
piperacillin, tazobactam (lOO'lOug), ceftriaxone/sulbactam (30/15^g), 
cefotaxime/claNTilanate (30/10|ig). The antibiotics disks used were from Himedia Lab. 
Ltd.. India. 
3.2.4 Phenot>T)ic studies for detection of ESBLs 
3.2.4.1 Double Disk synergj' test using piperacillin/tazobactam disks (Shahid et al 
2007) 
For ESBL detection the test inoculams (0.5 McFarland turbidity) were streaked on 
Mueller-Hinton agar. Disks of piperacillin-tazobatam (100/10) were placed 20 mm, 
centre to centre, from discs containing cefotaxime (30 ^g) and ceftazidime (30 |ig) 
and plates were incubated at 37°C overnight to analyze the sensitivity of the 
respective cephalosporins in ESBL detection. Enhancement of zones of inhibition of 
cephalospK)rins towards piperacillin-tazobatam was considered as positive ESBL 
results ^ 
.^^^.^l. -A> , 
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3.2.4.2 ESBL detection by combination disk method 
The combination disk test (CDT) method using cefotaxime versus 
cefotaxime/clavulanate, and ceftriaxone versus ceftriaxone/sulbactam was used for 
the detection of ESBL in E.coli and K. pneumoniae. An increase in zone diameters in 
combination discs (containing inhibitors) of >5 mm for clavulanate and >8 for 
sulbactarci as compared to their respective antibiotics was taken as indication for 
isolates to be presumptive ESBL producers (Shahid et al. 2007). 
3.2.4.3 ESBL detection by modified three dimensional extract test (MTDET) 
(Shahid e/a/. 2004) 
All isolates were confirmed for ESBL production by using modified three 
dimensional extract test (MTDET) as previously given by Shahid et al. (2004). In this 
study cefotaxime disks were placed to determine the presence of CTX-M type p-
lactamases. 
3.2.4.3.1 Method for MTDET by using enzymic extract 
In this test, 10-15 mg of bacterial wet weight was scraped from culture plate and 
suspended in 0.5 ml of peptone water in a sterile micro-centrifuge mbe and incubated 
at 37°C for one hour. Crude en2yme extract is prepared by repeated freezing-thawing. 
To ensure complete membrane lysis, the freezing-thawing may be carried out five 
times. Lawn culture of E. coli ATCC 25922 uas prepared on Mueller-Hinton agar 
plate and was incubated at 37°C so that plate can dr\' properiy. Cefotaxime disks (30 
|ig) were placed on dried plate then with a sterile scalpel a linear trench (3cm x 1mm) 
was prepjired in agar at a distance of 5mm from edge of disk in an outward radial 
direction. 50 \i\ of enzyme preparation was loaded in trench and overfill was avoided. 
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The inoculated media was incubated overnight at 37°C. Enhanced growth of the 
surface organism at the point where trench intersected the zone of inhibition towards 
the cefotaxime disk was interpreted as evidence for the presence of CTX-M type 
ESBLs. 
3.2.5 Molecular studies for detection of ESBLs 
3.2.5.1 Preparation of DNA template 
Template DNA was prepared from freshly cultured bacterial strains by suspending 
two or tliree discrete bacterial colonies in 50^1 of molecular grade water, and then 
heating at 95°C for 5 min and immediately chilling at 4°C. 
3.2.5.2 Polymerase Chain Reaction for detection of WACTX-M genes 
PCR amplification of conserved regions of blacjx-M genes in all 129 isolates were 
determined with the primers (Table 4) as described by Pagani et al. (2003) with some 
modifications. Briefly, the blacrx-u gene was amplified in a total volume of 25 ^1 
reaction mixture (Table 5). The PCR was performed in MJ-mini Bio-Rad thermal 
cycler with cycling conditions consisted of an initial denaturation step at 94 °C for 7 
min. followed by 35 cycles of final denaturation at 94°C for 50 sec, annealing at 50°C 
for 40 sec, extension for 72°C for 60 sec. and the process was completed with final 
extension step at 72°C for 5 min. Amplified PCR products were analyzed by gel 
electrophoresis with 2% agarose (Bangalore Genei, India) gel containing ethidium 
bromide. 
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3.2.5.3 Detection of CTX-M groups by multiplex PCR 
All 129 isolates were characterized for the presence of specific group of CTX-M by 
using multiplex PCR according to the method of Woodford et al. (2006) with some 
modifications. The PCR was performed in MJ-mini Bio-Rad thermal cycler in a 
reaction mixture of 25 i^l (Table 5). The cycling conditions consisted of an initial 
denaturation at 94°C for 5 min, followed by 40 cycles of final denaturation 94°C for 1 
min. annealing at 52°C for 60 sec, extension at 72°C for 1 min and with a final 
extension at ITQ for 10 min. AmpHfied products were screened by gel 
electrophoresis with 2°/o agarose (Bangalore Genei, India) gel containing ethidium 
bromide. 
3.2.5.4 Molecular characterization of other ESBLs like TEM and 
SHV 
3.2.5.4.1 Detection of WOTEM and WOSHV genes 
All isolates were confirmed for the presence of /^ajEM and ZJ/QSHV genes with the 
universal primers (Table 4) as adopted previously by Shahid 2010. PCR was carried 
in a reaction mixture of 15\A (Table 5): the PCR cycling conditions consisted of an 
initial denaturation step at 94°C for 3 min, followed by 30 cycles of final denaturation 
at 94'C for 30 sec, annealing at 64° C for 30 sec, extension at 72 °C for 1 min. PCR 
was completed with final extension at 72°C for 10 min. 
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3.2.6 Characterization of Class C type p-Iactamase 
3.2.6.1 Detection of Waampc genes 
bhampc genes were detected in all the isolates harboring bloESBLs by monoplex PCR 
(the primers cover universal region of ampC gene) as described by Feria et al. (2002) 
with some modifications. The blawi^c was amplified in total volume of 25|il of 
reaction mixture (Table 5). The PCR was performed in MJ-mini Bio-Rad thermal 
cycler with cycling conditions consisted of an initial denaturation step at 95'C for 15 
min. followed by 35 cycles of 94°C for 60 sec, annealing at 58°C for 2 min.. initial 
extension ll'C for 3 min. and the process was completed with final extension step at 
72°Cforl0min. 
Table 5: PCR Reaction mixture for -^lactamase genes 
Target gene 
6/acTX-M 
*/acTx-M groups 
1,2,9,8 and 25 
^/^ampC 
bloj^u 
bla^m 
2X PCR 
Master Mix 
12.5nl 
12.5 \i\ 
12.5 \i.\ 
12.5 nl 
12.5 Hi 
Forward Primer 
0.05 nl 
0.05(11 of each 
group forward 
primer 
0.05 nl 
0.05 \i\ 
0.05 yi\ 
Reverse Primer 
0.05^1 
0.05 H1 of each 
group reverse 
primer 
0.05 H1 
0.05 \i\ 
0.05 nl 
Mili Q 
9.%\ 
9.55 \i\ 
9.9 nl 
9.9 nl 
9.9(11 
Total volume 
25ni 
25 H1 
25 ul 
25 ul 
25 Ml 
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3.2.7 Characterization of mobile genetic elements 
3.2.7.1 Identification of Insertion sequences 
3.2.7.1.1 Detection oflSEcpl like insertion sequence 
All isolates harboring blacix-u genes were processed for ISEcp] detection by using 
primers: ISEcpIUl and P2D (details given in Table 4); generating a fragment of 
-1100 bp which contained the complete CTX-M coding region. The PCR protocol 
used was that of Munday et al. (2004) as adopted previously in our laboratory (Ensor 
et al. 2006). Tlie ISEcpl was amplified in total volume of 25|il of reaction mixture 
(Table 6). PCR amplification was carried out under the following conditions: initial 
denamration at 95X for 3 min, followed by 30 cycles of final denaturation at 95°C for 
1 min, annealing at 55°C for 1 min, and extension at 72°C for 1 min, with a final 
extension at 72°C for 10 min. Representative isolates harbouring ISEcpl were 
sequenced. 
3.2.7.1.2 Association of IS26 with A/OESBLS 
All ESBLs carrying isolates were also screened for the presence of IS26 insertion 
sequence. The isolates were screened using the PCR protocol described by Woodford 
et al. 2004. The primers used for PCR are showTi in Table 4. The \S26 was amplified 
in total volume of 25)JI of reaction mixture (Table 6). The PCR amplification 
conditions were: initial denaturation at 94°C for 5 min; followed by 35 cycles of 94°C 
for 25 sec, 52°C for 40 sec. and 72°C for 50 sec; and a final elongation at 72°C for 6 
min. 
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3.2.7.1.3 Detection of ORF575 (also known as ISCRl) 
All isolates harboring 6/acTx-M and other 6/OESBLS; like blaxEU and blasm were 
characterized for the presence of ORF57i. This ORF57i was detected in all the 
isolates using primers (Table 4) as described previously by Shahid (2010). The 
presence of this insertion sequence with class 1 integron was also determined to 
confirm the presence of complex class 1 integron in the genetic environment of 
isolates. The ORF513 was amplified in total \'olume of 25^1 of reaction mixture 
(Table 6). PCR cycling conditions were as follows: initial denaturation at 95 °C for 3 
min., followed by 35 cycles of final denaturation at 95 T for 1 min. annealing at 58 
°C for 1 min, extension at 72 "C for 2 min, and final extension at 72 °C for 10 min. 
3.2.8 Characterization of Class 1 integrons 
3.2.8.1 Detection of ^ wZ-i-type class-1 integrons 
All isolates harboring bla genes were characterized for Sul-1-iype class 1 integrons 
using primers Sul lA and Sul IB (shown in Table 4) as described previously by 
Shahid (2010). The sul-1 was amplified in total volume of 25)il of reaction mixture 
(Table 6). Cycling conditions comprised of an initial denaturation step at 95 °C for 3 
min, followed by 30 cycles of 95 °C for 1 min, annealing at 63 °C for 1 min, extension 
at 72 °C for 2 min, and a final extension step at 72 °C for 10 min. 
3.2.8.2 Detection of CS region (conserved segment of integrons) 
All isolates were characterized to determine the CS region (specific region for 
integrons) using primers 5'CS Fl and 3'CS R (shown in Table 4); generating variable 
size amplicons in different isolates. The CS region was amplified in total volume of 
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25^1 of reaction mixture (Table 6). Cycling conditions comprised of an initial 
denaturation step at 95 °C for 3 min, followed by 30 cycles of 95 °C for 1 min, 
annealing at 58 °C for 1 min, extension at 72 °C for 2 min., and a final extension step 
at 72 °C for 10 min. 
Table 6: PCR Reaction mixture for amplification of mobile genetic elements 
Target gene 
i \SEcpl 
IS26 
ORf513 
Sul-1 
CS region 
2XPCR 
Master Mix 
12.5ul 
12.5 ul 
12.5 ul 
12.5 ul 
12.5 ul 
Forward Primer 
0.05 l^ 
0.05 l^ 
0.05 i^ 
0.05 l^ 
0.05 ul 
Reverse Primer 
0.05nl 
0.05 ul 
0.05 ul 
0.05 ul 
0.05 ul 
MiliQ 
9.9nl 
9.9 ul 
9.9 ul 
9.9 ^l 
9.9^1 
Total volume 
25nl 
25 ul 
25 ^l 
25 ^l 
25 ^l 
3.2.9 Screening of PCR results and gene sequencing of representative 
isolates 
After amplification PCR products were analyzed in 2% agarose gel (Bangalore Genei, 
India) in IX TAE buffer, for staining EtBr at O.l^l/ml was used as nucleic acid 
intercalating agent for the visualization of amplified products under an UV light. High 
range DNA ruler (Bangalore Genei) was used to determine the size of DNA products. 
Representxiti\'e isolates were also analysed by sequencing for various genes such as 
blacTx-M-mtnosroups and bhampc and for CS region of mtegrons by Chromous Biotech, 
India. 
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3.2.10 Attempt for Plasmid analysis and detection of blacjx-M on 
plasmids in representative isolates 
Plasmid analysis of the isolates simultaneously harbouring bla genes was done by 
using the large-scale alkaline lysis method of Davis et al. (1986) as adopted in our 
previous studies (Shahid et al. 2008). In representative isolates, plasmids were 
characterized for the presence of blacix-u by PCR by using purified plasmids directly 
as template. 
3.2.10.1 Plasmid DNA isolation method 
• Fev/ bacterial colonies were inoculated into 10 ml of Nutrient broth medium 
containing the appropriate antibiotic in a loosely capped 15-ml centrifuge 
tube. The culture was incubated overnight at 37°C with vigorous shaking. 
• The culture was centrifliged at 10,000 rpm for 5 minutes at 4°C. 
• The medium was removed by aspiration, leaving the bacterial pellet as dry as 
possible. 
• For lysis 200|il of ice cold Solution I was added to the pellet. The pellet was 
re-dissolved by vortexing. 
• 400|il of freshly prepared Solution II was added. The tubes were closed 
tightly, and the contents were mixed by inverting the tube rapidly five times. 
Subsequently, the tubes were stored on ice. 
• 300^1 of ice-cold Solution III was added. The tube was closed tightly and the 
contents were mixed by vortexing it gently in an inverted position for 10 
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seconds to disperse Solution III through the viscous bacterial lysate. The 
tubes were stored at -20°C for 10 minutes. 
• The tubes were centrifuged at 10,000 rpm for 10 minutes at 4°C. The 
supernatant was transferred to the fresh tubes and pellet was discarded. 
• Equal volume of phenol .'chloroform was added. Mixed by vortexing and 
centrifuged at 10,000 rpm for 5 minutes at 4°C. The supernatant was 
transfered to the fresh tubes and pellet was discarded. 
• The double-stranded DN.A \sas precipitated with 2 %olumes of ethanol at room 
temperature, mixed b\ \ortexing. The mixture was allowed to stand for 2 
minutes at room temperature. Centrifuged at 10.000 rpm for 5 minutes at 4°C. 
• The supernatant was remo\'ed by gentle aspiration. The tubes were kept in an 
inverted position on a tissue paper to allow all of the fluid to drain away. Any 
residual drops of fluid adhering to the walls of the tube were removed and 
50|il TE buffer was added in all tubes and the mbes were stored at -20°C. 
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Figure 10: Diagrammatic representation of plasmid isolation 
Few bacterial colonies were inoculated into 10 ml Nutrient broth medium containing 
appropriate antibiotic and incubated overnight at 37°C with vigorous shaking 
<] 1 Centrifiiged at 10,000 rpm for 5 min at 4'C 
V 
The supernatant was removed to dry bacterial pellet 
\ / 
For lysis of bacterial cells 200 \il of ice cold Solution I was added and re-dissolved by vortexing 
c 
sz 
The tubes were stored on ice 
400 \i\ of freshly prepared solution II was added, to mix the 
content the tubes were inverted rapidly five times 
I Z 
300 ^ l of ice cold solution III was added, contents were mixed by vortexing for 
10 seconds to disperse solution III through the viscous bacterial lysate 
Supernatant was 
transferred to fresh tubes 
c=> 
C The tubes were stored at -20°C for 10 min 
V 
c Centrifuged at 10,000 rpm for 10 min at 4'C 
Equal volume of phenolxhloroform was added to the supernatant and mixed by vortexing 
Supernatant was 
transferred to fresh tubes 
^J> Centrifuged at 10,000 rpm for 5 rain at 4°C 
V 
Double-stranded DNA was precipitated by adding 2 volumes of ethanol at 
room temperature, mixed by vortexing and allowed to stand for 2 minutes 
\7 
<^  1 Centriftiged at 10,000 rpm for 5 min at 4*C 
Supernatant was removed by gentle aspiration then tubes were kept in inverted 
position on a tissue paper to allow all fluid to drain away 
i z 
50 |A1 of TE buffer was added to the dried precipitate 
of plasmid DNA and stored at -20'C 
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3.2.11 Geniotyping method 
3.2.11.1 RAPD-PCR typing 
All isolates found to carry blacix-u and other bla genes such as TEM and SHV, were 
typed using the RAPD-PCR (Vogel et al. 1999) to determine whether any 
predominant clone existed in this isolate collection. Other superior typing methods 
like Amplified Fragment Length Polymorphism (AFLP) or Pulse Field Gel 
Electrophoresis (PFGE) could not be performed because of their unavailability in our 
laboratof}'. Bacteria were cultured on nutrient agar at 37°C overnight. Template DNA 
was prepared from crude DNA extracts by suspending a colony in 50 1^ of distilled 
water and heating at 95°C for 5 minutes. Each RAPD-PCR reaction consisted of, 10 
pmol of primer ERIC-2b (5'-AAG TAA GTG ACT GGG GTG AGC G-3') and 2 ^1 
of DNA template in a final reaction volume 25 |il. The cycling conditions were as 
follows: one cycle at 94°C for 2 min; 35 cycles of 94°C for 1 min, 25°C for 1 min, and 
72°C for 8 min. RAPD products were separated on a 1.5% agarose gel containing 
ethidium bromide (0.5 mg/L) with TAE running buffer. Molecular size markers 
(Fermentas) were included on all gels. Isolates of the same species were typed in the 
same batch and products run on the same gel. Banding patterns were analysed using 
the software provided with the BioRad gel documentation system (Bio Rad, USA). 
Strains having RAPD banding profiles with at least 85% similarity were regarded as 
being highly related and were grouped into indix'idual clusters. 
88 
CHAPTER 4 
RESULTS 
RESULTS 
CHAPTER 4 
RESULTS 
4.1 Bacterial isolates 
During January 2009 to June 2010, a total of 14,129 samples were subjected 2065 
yielded grcAth of Gram-negative bacteria. Total of 130 Enterobacteriaceae (108 £. 
coli and 22 Klebsiella spp.) were randomly selected from clinical samples of various 
wards including Surger>' (57), Gynaecology (29), Orthopaedic (25), Medicine (12) 
and Paediatric (7). Of these 130 isolates, most of the isolates were isolated from pus 
samples 53.8% (70), followed by urine 31.5% (41), drain 5.3% (7), semen 3% (4), 
Abdominal fluid 1.5% (2), Cervical swab 1.5% (2), NPA 1.5% (2), CSF 0.7% (1), and 
induced sputum 0.7% (1) (Table 7). 
Table 7: Total number of isolates collected from various wards 
Total no. of 
Isolates (n) 
130 
f^o. of samples collected from various wards 
Surgery (56) Pus (36) 
Urine (12) 
Drain (7) 
Abdominal fluid (2) 
Medicine (12) Pus (3) 
Urine (6) 
CSF(l) 
Semen (2) 
Orthopaedic (25) Pus (25) 
Gynaecology (29) Pus (5) 
Urine (20) 
Cervical swab (2) 
Semen (2) 
Paediatric (7) Pus(l) 
Urine (3) 
NPA (2) 
Induced Sputum (1) 
Organisms identified from various samples 
(130) 
£. co//(108) 
28 
11 
6 
1 
:> 
6 
1 
2 
21 
3 
18 
2 
1 
3 
1 
1 
K. pneumoniae (22) 
8 
1 
1 
1 
-
4 
2 
2 
2 
1 
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4.2 Antibiotics Resistance Rates and Patterns 
All the 130 isolates were resistant to cefotaxime, however, the resistance to 
ceftazidime was noticed in 95.3% (124/130) isolates. The resistance rates for other 
antibiotics tested were as follows: 93% (121) to ceftriaxone, 91.5% (119) to 
aztreonam, 90% (117) to cefixime, 88.4% (115) to ofloxacin, 83.8% (109) to 
gatifloxacin, 82.3% (107) to cefoperazone, 78.4% (102) to cefpirome, 63% (82) to 
cefepime, 56.1% (73) to gentamycin. 41.5% (54) to amikacin. None of the isolate was 
found resistant to imipenem. We observ ed % ariation in resistance rates and patterns of 
isolates obtained from different wards, while all isolates obtained fi'om different 
wards were found resistant to cefotaxime. However, the isolates obtained firom 
Orthopaedic and Paediatric showed 100°/b resistance to ceftazidime followed by 
isolates from Surgery (96.4%), Gynaecology (93.1°i), and Medicine (83.3%). The all 
isolates obtained from Medicine and Paediatric were showed 100%) resistance to 
cefixime followed by isolates from surger}' (91.2%)), orthopaedic (88%) and 
Gynaecology (82.7%)). Detailed results are shown in Table 8. 
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RESULTS 
4.3 Phenotypic Studies for the detection of ESBLis 
4.3.1 Phenotypic ESBL detection 
ESBLs were detected phenotypically by double disk synergy tests (DDST) using 
piperacillin/tazobactam disks as a source of ESBL-inhibitor; by combination disk test 
(CDT); and by modified three-dimensional extract test (MTDET). Comparative results 
for these three methods are given in Figure 11. 
Total isolates Identifleci as 
ESBL-producers by various 
phenotypic methods 
B 
I/I 
o C „ 
i s 
• Total isolates as 
ESBL-producers by 
various phenotypic 
methods 
DDST CDT MTDET 
Virioui methodt for detection of 
ESBL-producen 
Figure 11: Occurrence of ESBL-producers by various phenotypic methods 
4.3.1.1 Detection by double disk synerg)' test using piperacillin/tazobactam disks 
(Shahid et al. 2007) 
This is the modified method of double disk s>Tiergy test developed and routinely adopted 
in our laboraton.- Shahid et al. 2007. In this method, piperacillin/tazobactam was used in 
place of co-amoxyclav disk because of its better s>"nergistic acti^ •ity for ESBL-producers 
than co-amoxyclav (Figure 12 a-b). A total of 78.4% (102/130) isolates (Figure 11) were 
detected as ESBL producers, that included 64.6% (84/130) E. coli and 81.8% (18/22) 
Klebsiella spp. 
92 
Figure 12a: Double Disk Synergy Test (DDST) is showing clearing of 
zones towards combination disk 
Figure 12b: Double Disk Synei^y Test (DDST) is showing flanking of the 
zones of cefotaxime and ceftazWime towards combination disk for ESBL-
producers 
RESULTS 
4.3.1.2 Detection by Combination disk method using cefotaxime vs. 
cefotaxime/clvulanate and ceftriaxone vs. ceftriaxone/sulbactam 
By combination disk test (CDT), a total of 89.2% (116/130) isolates (Figure 11) were 
found as ESBL producers, which included 72.3% (94/136) E. coli and 100% (22/22) 
Klebsiella spp. Of these 130 isolates, 80.7% (105/130) were found positive for ESBLs 
with cefotaxime vs. cefotaxime/clavulanate (Figure 13a) while 86.9%) (113/130) were 
found as ESBL producers with ceftriaxone vs. ceftriaxone/sulbactam (Figure 13b). 
4.3.1.3 Detection of ESBLs by modified ttiree dimensional extract test (MTDET) 
j 
By modified three dimensional extract test (MTDET) using cefotaxime (Figure 14). as 
described by Shahid et al. (2004), 80% (104130) of the isolates (Figure 11) were found 
as ESBL-producers. Of which, 79.6% (86/108) £ coli and Sl.S'^ o (18 ZZ) Klebsiella spp. 
were identified as ESBL-producers. 
4.4 Molecular studies for detection of ESBLs with special reference to 
CTX-M 
4.4.1 Detection of WOCTX-M- genes by monoplex-PCR 
By monoplex PCR using universal primers for detection of blacj\.\\. we found 86.15%) 
(112/130) of isolates positive for WOCTX-M genes bearing an amplicon of 593 bp (Figure 
15). Of these blacix-u positive isolates, 89.8% (97.108) and 68.1% (15.'22) isolates were 
E. coli and Klebsiella spp., respectively (Table 9). 
93 
Figure I3a: Combiantion disk test using cefotaxime versus 
cefotaxime/clavulanate is showing positive result for ESBL-preducers 
Figure 13b: Combiantion disk test using ceftriaxone versus 
ceftriaxone/sulbactam is showing positive result for ESBL-producers 
Figure 14: Modified three dimensional extract test (MTDET) using 
cefotaxime is showing positive result for ESBL-producers 
Figure 15: 2% Agarose gel is showing positi\e isolates of CTX-M type 
gene (Lane 3-10) of 593bp with positive control strain D3 {E. coli) in lane 
1 and negative control in lane 2, while lane 11-13 shows negative 
isolates, lanes M are showing Genei High range DNA ruler. 
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RESULTS 
4.4.2 Detection of A/flcrx-M-genogroups by Multiplex-PCR 
The isolates that were found positive for blacix-u by monoplex PCR were fUrther 
characterized for the presence of various genogroups of CTX-M by muUiplex PCR. All 
the 112 isolates were found positive for the presence of CTX-M genogroup-1 (415 bp) 
(Figure 16a), however five isolates of E. coli also showed presence of additional 
amplicon along with the amplification of CTX-M genogroup-l. On performing monoplex 
PCR using specific primers for the specific genogroups, one isolate was found poshive 
for CTX-M-group-8 (666 bp) and the other for genogroup-9 (205 bp) (Figure 16b). 
However 3 isolates gave positive results with genogroup-9-primers but the amplicon size 
did not correspond with genogroup-9 protocol (figure 9b). The representative isolates 
were sequenced to determine the exact CTX-M t>pes; the genogroup-1 amplicons turned 
at to be CTX-M-15 t}pe. The single isolate with amplicon size 205 bp was determined as 
CTX-M-9-like. However, the three isolates with amplicon size not corresponding to 
genogroup-9 (205 bp) and one isolate for genogroup-8 could not provide proper 
sequencing results and hence were specified as non-specific amplifications. 
4.5 Detection of Other biaESBu (^^«TEM and blasuv) by PCR and 
cumulative analysis with blacjx-M 
All 130 isolates were also detected for the presence of blajEU (936 bp) and blasHV (930 
bp) (Figure 17,18). A total of 93% (121/130) isolates were harbouring bla^sBU including 
6/acTX-M. blojzsi and bla^m (Tigure 19). These 121 ESBL positive isolates included 
94.4% (102/108) E. coli and 86.3% (19/22) Klebsiella spp (Table 9). Of which, 92.5% 
(112/121), 45.4% (55/121) and 54.5% (66/121) isolates were found to harbour blacjx-M, 
i/flTEM and blasm, respectively. 
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Figure 16a: 2% Agarose gel is showing positive isolates of CTX-M 
genogroup-1 (Lane 3-10) of 415bp amplified by multiplex PCR with 
positive control strain D3 {E. coli) in lane 1 and negative control in lane 
2, while lane 11-13 shows negative isolates, lanes M are showing Genei 
High range DNA ruler. 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 M 
10000 bp-
3000 bp-
1000 b p — • 
600 bp ^ 
500 b p — • 
400 b p — • 
300 b p — • 
200 b p — • 
100 b p — • 
M—415 bp 
Figure 16a 
Figure 16b: 2% Agarose gel is showing positive isolates of CTX-M type 
genogroups (Lane 1-12); Lane 1-6 are showing positive isolate for CTX-
M genogroup-1 by monoplex PCR; Lane 7 is shoeing positive isolate for 
genogroup-1 and -8 by multiplex PCR and the amplified products for 
these genes by monoplex PCR are shown in lane 8 and 9, respectively; 
Lane 10 is showing positive isolate for genogroup-1 and -9 by multiplex 
PCR and amplified product for these genes by monoplex PCR are shoxsn 
in lane 11 and 12, respectively. Lanes M are showing Genei High range 
DNA ruler. 
M 1 2 3 4 5 6 7 8 9 10 11 12 M 
10000 bp 
'3000 bp 
1000 bp 
600 bp 
500 bp 
400 bp 
300 bp 
200 bp 
100 bp 
<—205 bp 
Figure 16b 
Figure 17: 2% Agarose gel is showing positive isolates of TEM type 
gene (Lane 3-10) of 936bp with positive control strain D2 {E. coli) in lane 
1 and negative control in lane 2, while lane 11-13 shows negative 
isolates, lanes M are showing Genei High range DNA ruler. 
M 1 2 3 4 5 6 7 8 9 10 II 12 13 M 
^—936 bp 
Figure 17 
Figure 18: 2% Agarose gel is showing positive isolates of SHV 
type gene (Lane 3-10) of 930bp with positive control strain Dl 
{Citrobacter spp.) in lane 1 and negative control in lane 2, while 
lane 11-13 shows negative isolates, lanes M are showing Genei 
High range DNA ruler. 
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Figure 19: Occurrence of various types of ESBLs in Enterobacteriaceae 
4.5.1 Analysis of co-occurrence of various combinations of A/acix-M with 
blajiM and blagnv 
Of the 121 isolates harbouring blacjx-M, blojEU and blamv, 29.75% (36/121), 2.4% 
(3/121) and 3.3% (4/121) were found harbouring single bla genes v.i.z. blacrx-M, blasnv 
and blajiiM, respectively. While co-occurrence of blacw-u with each of bla^wM, blajEu 
and with both blasm + blajEM was noticed in 28% (34/121), 13.2% (16/121), 21.4% 
(26/121), respectively. 1.6% (2/121) isolates were also found to harbour combination of 
bla%m + blajEu (Table 9). 
These isolates were also analysed for the presence of various combinations of hla genes 
according to the wards from where they were collected. Most of the isolates harbouring 
blacTx-M and other bla genes were from Medicine. Gynaecology, Orthopaedic, and 
Surgery wards while least number of isolates were from Paediatric ward (complete details 
are shown in Table 9). All isolates from medicine were of £•. coli type and found positive 
i 
for blacjx-M and other blaESBis-
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4.6 Characterization of Co-existence of Class A and Class C type beta-
lactamases 
4.6.1 Detection of A/tfampc (Class C) type ^-lactamases 
All 121 isolates harbouring Class A type ^-lactamases (ft/acix-M- blaw-M and hlasm) were 
analysed for the presence of Class C type p-lactamases (blaampc) by monoplex PCR that 
produces amplicon of 634 bp (Figure 20). Of the 121 isolates studied, 71.9% (87/121) 
were found positive for co-existence of Z)/flESBis and /^flampc- We also found that in those 
isolates that harboured blacjx-M, 75% (84/112) isolates were showed co-existence of 
bla-impc. The rates of co-existence of bloampc genes were found in 69.4% (25/36), 76.4% 
(26/34), 76.9% (20/26), and 81.2% (13/16) with various combinations of blacjx-M, 
blacix-M^bla-xEU+blasm, hlacjx.u+bla^wy, and hlacjx-M+blajEM. respectively. Co-
existence of fe/aampc was found in 25% (1/4) and 100% (2/2) isolates that harboured 
blasHv and /j/aTEM+^ /^ sHV^  respectively, while none of the isolates harbouring only blajEu 
were found positive for co-existence of W«ampc (complete details of co-existence of these 
genes are shown in Figure 21). 
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120 00% 
100 00% 
u 
c 
• t tz 
3 
u u 
O 
76.4%(2»3<1) 
60 00% 69.4%(2»36) _ ^ _ . 
76 9%(2Cl'2h. 
-:l J-%(r3/\e,) 
25%(1/4) 
20 00% T ? W 26.'%(3*130) 
27 S%'(36'130) M 20%(2ffl30) 12 3%(16'130) 
CTX-
CTX4M •mt*Hlf*TK\ 
I M \ 
WtjtM 7V^40K 7tMa% 
|} j |{ | j 2 3%(*13p) 3%(4/130) 1S%(2^13P) 
TEM aHir I SHV+TCM 
^ onaMmtcm of Q a n « and a a a C 
lypa or H a e b i m i w 
<: Tatar in«l)«af*BistK or a a o i i t ^ r p * ^ Z7J0« { m « M 
li 
0% 
Figure 21: Co-existence of Class A and Class C type p-lactamases 
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Figure 20: 2% Agarose gel is showing positive isolates of AmpC 
type gene (Lane 3-10) of 634bp with positive control strain Dl 
{Citrobacter spp.) in lane 1 and negative control in lane 2, while 
lane 11-13 shows negative isolates, lanes M are showing Genei 
i 
High range DNA ruler. 
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4.7 Comparative evaluation of occurrence of Class A and Class C type 
P-lactamases in Enterobacteriaceae during year 2009 and 2010 
We analyzed our bacterial cohort on the year-wise basis of our collection: 76 isolates 
were obtained during 2009 and 54 during the year 2010. On comparison of genotypic 
results of two year's collections (2009 and 2010), we found nearly similar occurrence for 
WoESBLs; 92.1% (70/76) and 94.4% (51/54) in the respective years, 2009 and 2010. In 
2009, 88.1% (67/76), 43.4% (33/76), 43.4% (33/76) isolates were found positive for 
blacTx-M, blasHw, and 6/OTEM, respectively, while in 2010 these bla genes were present in 
83.3% (45/54), 61.1% (33/54), and 40.7% (22 54)i5;olates. respectively. On 
characterization of various combinations like blacTx.\i. blacrx-srblasm'. blacjx-
M+bla-xEM, and blacTx-u+blasm+blaTEu in 2009 we found 31.4% (2270). 18.5% (13 70). 
20% (14/70), and 25.7% (18/70) positive isolates, respectively, while in 2010 these 
combinations were present in, 27.4% (14/51), 25.4% (13/51), 3.9% (2/51). and 31.3% 
(16/51), respectively. In 2010, 3.9% (2/51) isolates were also found positive for 
combination of blasuv+blajEu while this combination was absent in 2009 collection. By 
PCR, in the isolates harboring bloESBis, bla^pc was detected in 81.4%. (57/70) and 58.8% 
(30/51) isolates from collections of year 2009 and 2010, respectively. In 2009, co-
existence of Waampc as 86.3%(19/22), 92.3%(12/13). 85.7%(12 14). 72.2%(13 18i \%-ith 
different combinations of blacjx-M, blacTx-\f>-blasH\, blacjxsrblaTEM^ blacix-
M+blasHY+blajEM, respectively, while in 2010 the co-e.xistence of 6/aampc '^^ ith the 
combinations of blacix-M, blacjx-M+blasm, blacjx-w^blajEw. blacrx-M'^blasHy^blajEM 
and WasHv+WaiEM was found in 42.8% (6/14), 61.5% (8/13). 50% (1/2), 81.2% (13/16), 
and 100% (2/2) of isolates, respectively. In 2009 out of two isolates horboring only 
blasHv, one was positive for co-existence with bla^mpc, while in 2010 none of the isolate 
98 
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was found positive for bla^mpi: which harboured only single gene of hluswv and hlawiu 
each (Figure 22). 
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Figure 22: Comparison for the presence of Class A and Class C type P-
laetamases during years 2009 and 2010 
4.8 Molecular studies for the characterization of Mobile genetic 
elements 
All 130 isolates were analysed for the presence of mobile genetic elements such as 
integrons (Sul-1 and CS region) and insertion sequences (ISEcpl, \S26, ISC/?); of which 
89.2% (116/130) isolates were found positive for an\ oi' these elements (Figure 23). 
These mobile elements harbouring isolates included 82.4% (89/108) E. coli and 86.3% 
(19/22) Klebsiella spp. The mobile genetic elements were associated with various 
combinations of hla genes: 25.8% (30/116) with hlanx-M- 13.7% (16/116) with blacrx-
M+blajEM, 21.5% (25/116) with blacjx-M+blamw. and 28.4% (33/116) with blanx-
M+blajEM +blasm- While only 3.4% (4/116). 1.7% (2/116'), and 0.8% (1/116) isolates 
99 
RESULTS 
harbouring hla^uv, /'/^IEM and A/arEM+ /^^ SHv, respectively, were found to be associated 
with mobile genetic elements (Table 10 demonstrates the detailed results of £ coli and 
Klebsiella spp. harbouring these mobile genetic elements and hia genes). 
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Figure 23: Occurrence of various types of mobile genetic elements associated with 
^/«ESBI.s 
Table 10: Detection of various mobile genetic elements in isolates harbouring blacw-
M and other ESBLs 
Various combinations of 
hlarsau genes 
CTX-M only 
CTXM +TEIV1+SHV 
CTX-M+TEM 
CTX-M+SHV 
TEM only 
SHV only 
TEM+SHV 
Without any hla gene 
% occurrence of various mobile genetic elements (n) 
Total mobile 
genetic elements 
89.2%(n6/130) 
25.8(30) 
28.4(33) 
13.7(16) 
21.5(25) 
1.7(2) 
3.4(4) 
0.8(1) 
4.3(5) 
E. coli 
89.8%(97/l08) 
29.8(29) 
25.7(25) 
14.4(14) 
22.6(22) 
2(2) 
2(2) 
1(1) 
2(2) 
Klebsiella spp. 
86.3%( 19/22) 
5.2(1) 
42.1(8) 
10.5(2) 
15.7(3) 
-
10.5(2) 
-
15.7(3) 
100 
^ RESULTS 
4.8.1 Association of cIass-1 type Integrons with CTX-M and other 
ESBLs by analysing sul-1 and CS variable region 
Of the 130 isolates. 76.1% (99) isolates were found positi\'e for the presence of integrons 
(Figure 24). of which 75.9% (82/108) were £ coli and 77.2% (17/22) were Klebsiella 
spp. These integrons were found associated with various combinations of hlacjx-M and 
other hkiisnis such as, in 31.3%o (31/99) isolates harbouring hlac\x-M+bla\],M +Wasiiv, 
23.2%) (23/99) each with W^CTX-M. and blacvx-M+hlasnv, 11.1% (11/99) with bhcjx-
M+/)/aii;M. 3.03% (3/99) with hlasux. 2.02% (2/99) of each with blan-M- and 
blajEM+blasvw- While 5.05%) (5/99) isolates were detected to harbour integrons but 
without any bla gene. Details of E. coli and Klebsiella spp. harbouring integrons are 
given in Table 11. 
c 
Total posjtjvjty 
for integrons 
76.1%|»/138) t .)0 
« 3 0 . ^ ^ ^ ^ - fS2%mm 55.3%(72/130| 
10 
0 
G l i a l Sul-1 CS region 
Jntigreni 
Various types of class 1 type integrons 
Figure 24: Occurrence of various types of Class-1 integrons associated with 
blaysms 
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RESULTS 
4.8.1.1 Analysis of sul-1 type cIass-1 integrons association with A/ACTX-M 
and other bla genes 
I 
All 130 isolates were analysed for the presence of sul-1 type class-1 integrons based on 
the presence of an amplicon of molecular size ~420bp (Figure 25). A total of 59.2% 
(77/130) isolates were found positive for this type of integrons (Figure 24). Among these 
77 isolates carrying sul-1 type integrons, 23.3% (18/77), 11.6% (9/77), 20.7% (16/77), 
33.7% (26/77), 2.5% (2/77). 2.5% (2/77) and 1.2% (1/77) isolates were found associated 
with various combinaiions blacT\.s\. blacTX-M'^blajE\u blacrx-M+blasuw, blacjx-
M+blaTEs&bhsHw blasnx. b!a-~\i. and bla-E\rbIasyy. respectively. 3.8%) (3/77), isolates 
were found positive for sul-1 type class 1 integrons while these isolates were not 
harbouring any bla gene. Details of the presence of sul-1 tjpe class 1 integrons in E. coli 
and Klebsiella spp. are sho\Mi inTable 11. 
4.8.1.2 Analysis of CS variable regions of integrons association with 
blacT\-M and other bla genes 
All 130 isolates were analysed for the presence of CS variable regions (Figure 26a-b), 
which is kno\Mi as specific region of integrons. Total of 55.3%) (72/130) isolates were 
found harbouring this region ^Figure 24). Among these 77 isolates carrying CS type 
integrons, 25% (18/72). 12.5% (9/72), 23.6% (17/72), 33.3% (24/72), and 1.3% (1/72) 
isolates w^ ere found associated with various combinations v.i.z. blacix-M, blac-xx. 
M+blajEU, blacrx.},rblasH\. blacrx-s&blorEsrblasm, and blasm, respectively. Those 
isolate which harbour blajEsu and blaTE^&blasm genes were found negative for CS type 
integrons. 4.1% (3/72) isolates were found to carry CS region, which were found negative 
for the presence of any of the bla genes. Details for the presence of CS type class 1 
integrons in E. coli and Klebsiella spp. are given in Table 11. These CS type integrons 
i 103 
Figure 25: 2% Agarose gel is showing positive isolates of Sul-1 
type gene (Lane 3-10) of 420bp with positive control strain 13X 
{Citrobacter spp.) in lane 1 and negative control in lane 2, while 
lane 11-13 shows negative isolates, lanes M 
High range DNA ruler. 
are showing Genei 
M l 2 3 4 5 6 7 8 9 10 11 12 13 M 
10000 bp 
3000 bp 
1000 bp 
4—420 bp 
Figure 25 
Figure 26a: 2% Agarose gel is showing positive isolates of CS 
regions of integron (Lane 1-13) represented by single bands 
variable sizes. Lanes M are showing Genei High range DNA ruler. 
10 11 12 13 M 
1600 bp 
800 bp 
4S0bp 
Figure 26a 
Figure 26b: 2% Agarose gel is showing positive isolates of CS 
region of integrons (Lane 1-13) represented by single and multiple 
bands of variable sizes. Lanes M are showing Genei High range 
DNA ruler. 
M 1 2 3 6 7 8 9 10 11 12 13 M 
Figure 26 
RESULTS 
were showing different banding patterns of variable amplicon sizes, some of the isolates 
were also having multiple copies (Figure 26b). Total of 72 isolates were having 
amplicons at ~1.6kb, ~900bp, ~800bp, ~500bp, ~450bp, ~350bp, and ~180bp in 33.3% 
(24), 4.1% (3), 12.5% (9), 5.5% (4), 5.5% (4), 1.3% (1) and 1.3% (1) isolates, 
respectively. Some of the isolates were also having duplicate amplicons of variable sizes 
(^ laDie u). 
1 
Table 12: CS regions of various sizes associated with different groups of bla genes 
and other mobile genetic elements 
No. of 
amplicons 
amplified by 
5'CS and 
3'CS Primers 
1 amplicon 
1 amplicon 
I amplicon 
1 amplicon 
1 amplicon 
1 amplicon 
Amplicon size 
(bp) 
180 
350 
450 
450 
450 
500 
500 
500 
500 
800 
800 
800 
800 
800 
800 
900 
900 
900 
No. of isolates associated with various groups ofbla Total no. of 
genes and mobile genetic elements (n) isolates 
: 55 J % ; 
1 ! (72/130) j 
CTX-M+0RF(1) I \3Vo(\n2) \ 
SHV(i) 1 i.3%(i;7:) 
CTX-M+TEM+SHV (2) | 5.5%(4/72) 
CTX-M+ TEM+SHV+IS£cp7 (1) 
CTX-M+AmpC+TEM+SHV (1) 
CTX-M+AmpC+TEM+SHV+Sul-l+ORF513+IS£c/7/ 
(1) 
CTX-M+AmpC+TEM+SHV+Sul-1+0RF513(1) 
CTX-M+AmpC+TEM+SHV+Sul-1+0RF513(1) 
Sul-1+0RF513+1825(1) 
5.5%(4/72) 
• 
CTX-M+AmpC+TEM+Sul-l+ORF513+IS£c/7;(l) ; \2.5'M.9''2) . 
CTX-M+AmpC+TEM+SHV+Sul-l+lS£cp7(l) , j 
CTX-M+AmpC+TEM+SHV+Sul-l+ORF513+IS££;?/ ! \ 
(3) 
CTX-M+AmpC+Sul-l+ORF513 (1) 
CTX-M+AmpC+SHV+IS£c/77 (1) 
CTX-M+AmpC+TEM+SHV+Sul-l+ORF513+IS£cp; 
+1S2<5(2) 
CTX-M+TEM+Sul-l+ORF5]3+IS£c/7; (1) 
CTX-M+AmpC+Sul-l+ORF513+IS£cp/(l) 
ORF513+lS£cp;+lS2<5(l) 
4.1%(3/72) 
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RESULTS 
1 amplicon 
' 
1 
i 
1 
! 
1 1 amplicon 
2 amplicons 
2 amplicons 
2 amplicons 
j 2 amplicons 
i 
! 2 amplicons 
2 amplicons 
2 amplicons 
1600 
1600 
1600 
1600 
1600 
1600 
1600 
1600 
1600 
1600 
1600 
1600 
1600 
1600 
1600 
2000 
2000 
180 and 700 
180 and 950 
180 and 950 
180 and 950 
180 and 1600 
350 and 600 
350 and 900 
350 and 1600 
350 and 2000 
450 and 500 
450 and 600 
450 and 600 
500 and 900 
500 and 1600 
500 and 1600 
800 and 900 
CTX-M+AmpC+TEM+SuH+0RF5 B+IS^c/?; (2) 
CTX-M+AmpC+TEM+SHV+Sul-l+ORF513+ISJ?cp7 
+IS2<5(1) 
CTX-M+AmpC+TEM+SHV+Sul-l+ORF513(l) 
CTX-M+AmpC+TEM+SHV+Sul-l+IS£cp/+IS2d(l) 
CTX-M+AmpC+TEM+Sul-1 +lSEcpI( 1) 
CTX-M+AmpC+SHV+Sul-l+IS£cp7(4) 
CTX-M+AmpC+SHV+Sul-l+IS£cp7 +IS26 (1) 
CTX-M+AmpC+SHV+0RF513+IS25 (1) 
CTX-M+SHV+Sul-l+ISjFcp/+IS26 (1) 
CTX-M+AmpC+Sul-l+ORF513 (1) 
CTX-M+AmpC+Sul-1+0RF5 U+\SEcpl{3) 
CTX-M+AmpC+Sul-l+0RF513+IS£cp7+IS2d (3) 
CTX-M+AmpC+Sul-l+IS£c/7/(2) 
CTX-M+AmpC+IS25(l) 
CTX-M+AmpC(l) 
CTX-M+AmpC+TEM+SHV+Sul-1 +lSEcpl{ 1) 
CTX-M+AmpC+SHV (1) 
CTX-M+AmpC+TEM+S 
(1) 
TV+Sul-l+ORF513+IS2(5 
CTX-M+TEM+SHV+Sul-l+ORF513+IS£cp7+IS2<5 
(1) 
CTX-M+AmpC+TEM+SHV+Sul-1+0RF5 U+lSEcpl 
+IS26(1) 
CTX-M+AmpC+TEM+Sul-l+IS2(5 (1) 
CTX-M+AmpC+SHV+Sul-1+0RF513 +lSEcpJ( 1) 
CTX-M+AmpC+TEM+IS£cp7( 1) 
CTX-M+TEM+IS£cp7 (1) 
Sul-1 
CTX-M+AmpC+SHV+Sul-1+0RF513 +IS£'cp7( 1) 
CTX-M+AmpC+Sul-1 -IS£cp7( 1) 
CTX-M+TEM+SHV+ORF513(1) 
CTX-M+AmpC+ORF513+IS£cp7 (1) 
CTX-M+AmpC+TEM+S] 
(1) 
-TV+Sul-1+0RF5 l3+\SEcpl 
CTX-M+AmpC+TEM+SHV+Sul-1 +IS£'C/J7+IS2<J (1) 
CTX-M+AmpC+SHV+Sul-1+0RF513+IS£cp7 (1) 
CTX-M+AmpC+TEM+Sul-1+0RF513+IS£cp7( 1) 
33.3%(24/72) 
2.7%(2/72) 
1.3%(l/72) 
4.1%(3/72) 
1.3%(l/72) 
1.3%(l/72) 
1.3%(l/72) 
1.3%(l/72) 
1.3%(l/72) 
1.3%(l/72) 
2.7%(2/72) 
1.3%(l/72) 
2.7%(2/72) 
5.5%(4/72) 
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2 amplicons 
2 amplicons 
multiple 
amplicons 
800 and 900 
800 and 900 
800 and 1600 
800 and 1600 
800 and 1600 
1500 and 1815 
300, 450, 500, 
600, 1000, 
1150 and 2000 
CTX-M+AmpC+SHV+Sul-l+0RF513+IS2(5 (1) 
CTX-M+AmpC+Sul-1+0RF513 HSEcpI{2) 
CTX-M+AmpC+TEM+SHV+Sul-1+0RF513+IS£cp7 
(1) 
CTX-M+AmpC+SHV+Sul-1+0RF5 l3+lSEcpJ+lS26 
(1) 
CTX-M+AmpC+SHV+Sul-1+0RF513+IS£'cp7( 1) 
CTX-M+AmpC+TEM+SHV+Sul-1+0RF513(1) 
CTX-M+AmpC+TEM+SHV+Sul-l+ORF513+IS£cj9/ 
+IS2(5(1) 
4.1%(3/72) 
1.3%(l/72) 
1.3%(l/72) 
4.8.2 Detection of Insertion sequences associated with CTX-M and otiier 
ESBLs by performing PCR for IS£cp/, ISO? (ORF513), IS26 
Total of 83.8% (109/130) Enterobacteriaceae isolates (Figure 27), that included 87% 
(94/108) E. coli and 68.1% (15/22) Klebsiella spp., were found positive for the presence 
of insertion sequences like ISEcpl, ISCR (ORF513) and IS26. Among these 108 isolates, 
association of these mobile elements with following combinations of blacix-u and other 
bloESBLs'- blacrx-M, blacTx-M+blajEM, blacTx-u^blasuv, blacix-u+blajEM+blasm, blajEM, 
blasHV, and WaiEsi+WasHv were detected in 25.6% (28/109), 14.6% (16/109), 22% 
(24/109), 27.5% (30/109), 1.8% (2/109), 3.6% (4/109), and 0.9% (1/109) isolates, 
respectively. 3.6% (4/109) isolates were found positive for insertion sequences while not 
harbouring any bla gene. Description of the association of these insertion sequences with 
various combinations of bla genes in £. coli and Klebsiella spp. is given in Table 13. On 
analysing the presence of \arious combinations of bla genes with different combinations 
of mobile genetic elements it was found that most of the isolates harboured sul-
l+CS+ORF513+IS£cp/ t)pe combination of mobile genetic elements and the second 
most conmion combination was of sul-l+CS+ lS£'c/?7+ORF513+lS26 type, while none of 
106 
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the isolate was found harbouring the combination of IS£'(:"p/+ORF513+IS2(5. The 
detection of various combinations of mobile genetic elements is shown in Table 14. 
u 
a 
u 
o 
90 
60 
70 
60 
50 
40 
30 
20 
10 
0 
83K(10W13Q 
-1=1= 
Total positivity 
for Insertion 
sequences 
68.4'X(?6n30) S3ix<69naiq 
dym^/andBii 
1 
Insertion ISEcpl 0RFS13(ISCR1} IS26 
Kquences 
Various types of insertion sequences 
Figure 27: Various types of insertion sequences associated with the isolates 
harbouring WAESBLS 
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RESULTS 
4.8.2.1 Analysis for the association of ISEcpl with various combinations 
of blucTx-M and other A/AESBLS 
A total of 56.9% (74/130) Enterobacteriaceae isolates were found positive for the 
presence of ISEcpl (Figure 27) as characterized based on amplicon of molecular size 
-UOObp (Figure 28), included 61.1% (66/108) as E. coli and 36.3% (8/22) Klebsiella 
spp. isolates. Of these 74 isolates, 25.6% (19/74), 13.5% (10/74), 25.6% (19/74), 29.7% 
(22/74), and 1.3% (1/74) were found positive for ISEcpl with association of bhcix-u, 
blacTx-srblaTEM, blacrx-h&blasm, blacTx-M^blajEu^blasHw, and blasm, respectively. 
Those isolate which harbour blajEM, and blarEh&blaswj genes were found negative for 
this t>pe of insertion sequences. \VTiile 4% (3/74) isolates negative for any bla genes were 
found positive for ISEcpl. Details for the occurrence of ISEcpl in isolates of £ coli and 
Klebsiella spp. are given in Table 13. 
4.8.2.2 Analysis for the association of ORF513 (LSCRl) with various 
combinations of A/acxx-M and other A/AESBLS 
A total of 53% (69/130) Enterobacteriaceae isolates (Figure 27) were found positive for 
the presence of ORF513 (ISCRl) as demonstrated by the presence of amplicon of 
molecular size ~600bp (Figure 29). These included 51.8% (56/108) of E coli and 59% 
(13/22) of Klebsiella spp. isolates. Of these 69 isolates, 27.5% (19/69), 15.9% (11/69), 
15.9% (11/69), 28.9% (20/69), 2.8% (2/69), 1.4% (1/69), 1.4% (1/69), were found 
positive for ISCR with association ofblacjx-M, ^/^CTX-M+^/^TEM, blacix-M^blasHw, blacjx-
i.'&blajEM^blasHv, blasm, blajEu, and blaiEU+blasuw, respectively. While 5.7% (4/69) 
isolates negative for any bla genes were found positive for ISCR. Details of occurrence of 
ISCR in isolates ofE. coli and Klebsiella spp. are given in Table 13. 
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Figure 28: 2% Agarose gel is showing positive isolates of ISEcpl 
type insertion sequence (Lane 3-10) of llOObp with positive 
control strain in lane 1 and negative control in lane 2, while lane 
11-13 shows negative isolates, lanes M are showing Genei EQgh 
range DNA ruler. 
M l 2 3 4 5 6 7 8 9 10 11 12 13 M 
10000 bp-
3000 bp-
1000 bp-
600 bp-
500 bp-
400 bp-
300 bp-
200 bp-
100 bp-
1100 bp 
Figure 28 
Figure 29: 2% Agarose gel is showing positive isolates of ORF513 
(Lane 3-10) of 600bp with positive control in lane 1 and negative 
control in lane 2, while lane 11-13 shows negative isolates, lanes M 
are showing Genei High range DNA ruler. 
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Figure 29 
RESULTS 
4.8.2.3 Analysis of IS26 association with various combinations of blacrx-
I 
I 
M and other A/aESBLs 
Total of 33% (43/130) Enterobacteriaceae isolates (Figure 27) were found positive for 
the presence of IS2(J (Figure 30a-c), which included 32.4% (35/108) of £ coli and 36.3% 
(8/22) oi Klebsiella spp. isolates. Of these 43 isolates, 20.9% (9/43), 9.3% (4/43), 25.5% 
(11/43), 27.9% (12/43), 6.9% (3/43), 2.3% (1/43) isolates were found positive for IS26 
with association oiblacxx-u, blacxx-\&blaj^s{, blacw.^&hla^Yw, blacw-^&bla^^^blasm, 
blasm, and /^OTEM, respectively. Those isolate which were found positive for 
I 
bla-mA+blasHW, were not associated vsith IS26 elements. 'V^ Tiile 6.9% (3'43) isolates, 
negative for any bla genes were found positi\e for IS26 elements. Details of occurrence 
of IS2(5 in isolates ofE. coli and Klebsiella spp. are given in Table 13. 
Most of the isolates showed amplicons of variable sizes for the IS26 tjpe insertion 
sequences: 6.9% (3/43), 39.5% (17/43), 4.6% (243), 11.6% (5/43), 2.3% (1/43), 9.3% 
(4/43), 2.3% (1/43), 2.3% (1/43), 2.3% (1/43), and 11.6% (5/43) isolates with amplicons 
of ~1.8kb, ~850bp, ~800bp, ~700bp, ~650bp, ~600bp, ~590bp, ~550bp, ~350bp, and 
~180bp, respectively. However, 6.9% (3/43) isolates were also found to have duplicate 
copies of IS26 of variable sizes (Figure 30b-c). Duplicate amplicons of molecular sizes 
~250bp and ~350bp were also present in 4.6% (2'43) isolates. 
4.9 Comparative analysis for the presence of mobile genetic elements in 
Enterobacteriaceae collected during years 2009 and 2010 
All the isolates collected during years 2009 (76 isolates) and 2010 (54 isolates), 
harbouring /^^ ESBLS, were comparatively analysed for the presence of various mobile 
genetic elements v.i.z. Sul-1, CS region, ISEcpI, ISCR (ORF513), and IS26. In 2009, of 
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Figure 30a: 2% Agarose gel is showing positive isolates of IS26 
elements (Lane 2-13) represented by single bands of variable sizes. 
Lanes M are showing Genei High range DNA ruler. 
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Figure 30a 
Figure 30b: 2% Agarose gel is showing positive isolates of IS26 
elements (Lane 2-13) represented by single and double bands of 
variable sizes. Lanes M are showing Genei High range DNA ruler. 
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Figure 30c: 2% Agarose gel is showing positive isolates of IS25 
elements (Lane 2-12) represented by single and duplicate bands of 
variable sizes, and negative isolate in lane 13. Lanes M are showing 
Genei High range DNA ruler. 
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RESULTS 
the 70 isolates harbouring blofSBis, 71.4% (50/70), 61.4% (43/70), 75.7% (53/70), 64.2% 
(45/70), and 25.7% (18/70) isolates were found associated with the Sul-1, CS regions, 
ISEcpl, ORF513, and IS26, respectively, while in 2010, of the 51 isolates harbouring 
bla^sBLs these mobile genetic elements were associated in 47% (24/51), 50.9% (26/51), 
39.2% (20/51), 41.1% (21/51), and 43.1% (22/51) isolates, respectively (Figure 31). 
K Total positiv« 
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Various types of mobile genetic 
elements associated with E S B L 4 
Figure 31: Comparative analysis of various types of mobile genetic elements 
associated with ESBLs in the isolates collected during 2009 and 2010 
4.10 Plasmid analysis and detection of multiple genogroups on plasmids 
All 130 isolates were screened in 0.8% agarose gel after plasmid isolation and showed the 
presence of a single plasmid of c.a. -23 kb (Figure 32). Randomly selected isolates 
including those five isolates which harboured multiple genogroups of CTX-M were 
confirmed for the presence of these genogroups on plasmids. Further, multiplex PCR 
detection of these isolates by using plasmid as a template revealed the presence of 
genogroup-1 in all isolates, while of the five isolates which harboured multiple 
geogroups, four were found positive for genogroup-1 only, however one isolate was 
I 111 
Figure 32: 2% Agarose gel is showing positive isolates for 
I 
I 
plasmids (Lane 2-6) of c.a. ~23kb. Lane 1 and 8 are showing hind 
III lambda digest DNA ruler (Bangalore Genei). 
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2.3 kb 
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23 kb 
Figure 32 
Figure 33: 2% Agarose gel is showing positi\'e isolates of CTX-M 
genogroup-1 (Lane 3-9) of 415bp and in lane 10 isolate positive for 
genogroup-1 and -9 amplified by multiplex PCR and lane 11 for 
genogroup-9 amplified by monoplex PCR, while lane 12-13 shows 
negative isolates, lanes M are showing Genei High range DNA 
ruler. 
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RESULTS 
found positive for multiple genes that included, CTX-M genogroup-9 and genogroup-1 
(Figure 33). 
4.11 Genotyping of Enterobacteriaceae isolates by using RAPD analysis 
RAPD profile of all 130 Enterobacteriaceae isolates was obtained to determine the 
various genotypes, by using ERJC-PCR which amplified various Enterobacterial 
repetitive consensus sequences. Of these 130 isolates, 101 could be typed, while 
I 
remaining 29 isolates could not be typed as they did not produce any RAPD profile. By 
analysing these consensus sequences we found a total of 18 clusters of 
Enterobacteriaceae, which included 15 clusters (EC-1 to EC-15) of 45 E. coli isolates 
and 3 clusters (K-1 to K-3) of 6 Klebsiella isolates (Table 15). RAPD pattern of various 
Enterobacterial isolates were also observed for the presence of different clusters as they 
harboured various combinations of bla genes such as CTX-M only (Figure 34a-b). 
CTX-M+TEM (Figure 35a-b), CTX-M+SHV (Figure ida-b) and CTX-M+TEM-SH\^ 
(Figure 37a-b). While all Klebsiella isolates harbouring all combination of these genes 
were found in 3 clusters (Figure 38a-b). We were not found any cluster in those isolates 
that harboured bla genes such as TEM or SHV or TEM+SHV (Figure 39). Most of the 
isolates were clustered in different clusters harbouring similar type of bla genes, but these 
clusters were of isolates fi^om different clinical wards (Table 15). The E. coli isolates 
collected from different wards were clustered as follows: 5 isolates in EC-1 (3 from 
Orthopaedic + 2 fi-om Surger>'); 4 isolates in EC-2 (2 from Orthopaedic + 2 fixjm 
Surgery); 2 isolates in EC-3 (1 from Orthopaedic + 1 from Medicine); 4 isolates in EC-4 
from Orthopaedic; 2 isolates in EC-5 (1 from Orthopaedic +1 from Surgery); 4 isolates in 
EC-6 (1 from Surgery + 3 from Gynaecology); 2 isolates in EC-7 (1 from Orthopaedic 
and 1 from Medicine); 5 isolates in EC-8 (4 from Surgery and 1 from Medicine); 2 
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isolates in EC-9 (1 from Surgery + 1 from Medicine); 4 isolates in EC-10 (1 from surgery 
+ 1 from Paediatric + 2 from Gynaecology); 2 isolates in EC-11 (1 from Orthopaedic + 1 
from Surgery); 2 isolates in EC-12 from Orthopaedic; 3 isolates in EC-13 (2 from Surgery 
+ 1 from Gynaecology); 2 isolates in each of EC-14 and EC-15 were from Gynaecology. 
Like this Klebsiella isolates collected from different wards were also clustered as: 2 
isolates in K-1 (I from Surgery + 1 from Gynaecology); 2 isolates in K-2 from Surgery; 
and 2 isolates in K-3 (1 from Gynaecology + 1 from Orthopaedic). It was noticed that all 
the Klebsiella isolates clustered in these 3 clusters harboured similar /^AESBLS, such as 
bhcTx-si- bli^>TE.\{- and 6/asH\'-
I 
Table 15: RAPD profile of various Enterobacteriaceae isolates harbouring different 
bla genes i 
Cluster 
name 
EC-1(5) 
EC-2 (4) 
Isolate 
No. 
CI 
CI 
C13 
C18 
C21 
C3 
: 1 CIO 
1 C19 
1 C23 
EC-3 (4) C4 
C6 
i C l l 
EC-4 (2) 
EC-5 (2) 
EC-6 (4) 
C12 
C9 
C25 
CT2 
CT5 
CT3 
CT8 
Wards 
Orthopaedic 
Orthopaedic 
Orthopaedic 
Surgery 
Surger}' 
Orthopaedic 
Orthopaedic 
Surgery 
Surgery 
Orthopaedic 
Orthopaedic 
Orthopaedic 
Orthopaedic 
Orthopaedic 
Medicine 
Surgery 
Orthopaedic 
Surgery 
Gynaecology 
Associated bla genes and mobile genetic elements 
ClX-M+\SEcpl 
CTX-M+AmpC+Sul-HCSHSEcpJ+lS26 
CTX-M+AmpC+CS+0RF513 
CTX-M+AmpC+5«/-/+CS+ORF5 l3+lSEcpJ+lS26 
CTX-M+AmpC+Sul-J+CSHSEcpJ 
CTX-M+AmpC+Sul-] 
CTX-M+AmpC+5w/-;+ORF5 U+lSEcp} 
CTX-M+AmpC+5«/-7+ORF5 l3+lSEcp] 
CTX-M+AmpC+CS+IS26 
CTX-M+AmpC-fCS+0RF513+IS£cp; 
CTX-M+AmpC+5M/-;+CS+ORF5 U+lSEcpl 
CTX-M+AmpC+Su/-7+ORF513 
CTX-M+AmpC+Sw/-;+CS+0RF513+IS£cp7+IS2<5 
CTX-M+AmpC+5«/-7+CS+ORF513 
CTX-M+AmpC+IS2<5 
CTX-M+TEM+AmpC+5w/-;+CS+ORF513+IS£cp7 
CTX-M+TEM+CS+lS£cp7 
CTX-M+TEM+AmpC+SM/-7+CS+ORF513+IS£cp7 
CTX-M+TEM+AmpC+0RF513+\SEcp} 
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EC-7 (2) 
EC-8 (5) 
EC-9 (2) 
EC-10 (4) 
EC-11(2) 
EC-12 (2) 
EC-13 (3) 
EC-14 (2) 
EC-15(2) 
K-1 (2) 
K-2 (2) 
K-3 (2) 
CT9 
CTIO 
CT7 
CTll 
CSl 
CS4 
CS9 
CSIO 
CS16 
CS6 
CS13 
CSS 
CS17 
CS18 
CS20 
CTS3 
CTSIO 
CTS5 
CTS13 
CTS8 
CTS9 
CTS20 
CTS15 
CTS18 
CTS16 
CTS17 
KC7 
KC9 
KC8 
KCll 
KCIO 
KC12 
Gynaecology 
Gynaecology 
Orthopaedic 
Medicine 
Surgery 
Surgery 
Surgery 
Surgery 
Medicine 
Surgery 
Medicine 
Surgery 
Paediatric 
Gynaecologj' 
Gynaecolog)' j 
Surgery 
Orthopaedic 
Orthopaedic 
Orthopaedic 
Surgery 
Surgery 
Gynaecology 
Gynaecolog>' 
Gynaecolog)' 
Gynaecolog}' 
Gynaecolog>' 
Surgery 
Gynaecology 
Surgery 
Surgery 
Gynaecology 
Orthopaedic 
CTX-M+TEM+AmpC+0RF513+IS£cp7 
CTX-M+TEM+AmpC+5M/-/+CS+ORF513+lSEcpl 
CTX-M+TEM+AmpC+CS+IS£cp7 
CTX-M+TEM+AmpC+5M/-7+CS+ORF513+IS^cpy 
+1S26 
CTX-M+SHV+0RF513+\S26 
CTX-M+SHV+AmpC+5«/-7+CS+ORF513+lSEcpl 
+IS26 
CTX-M+SHV+AmpC+CS+IS2<5 
CTX-M+SHV+AmpC+^M/-7+CS+ORF513+IS£'c/77 
CTX-M+SHV+AmpC+0RF513+lSEcp] 
CTX-M+SHV+AmpC+5M7-7+CS+0RF513+IS£'cp7 
CTX-M+SHV+AmpC+52y/-7+CS+ORF513+1S26 
CTX-M^SH\VAmpC-Su7-7-CS-0RF513+IS£cp7 
+IS26 
CTX-M-SH\'-\mpC-0RF513 
CTX-NKSH\-AmpC-5u/-7^S^IS£cp7^IS26 
CTX-M+SH\'+AmpC^5w/-7+CSTORF513+IS£c/77 
CTX-M+TEM+SH\'+AmpC+Su/-7^S+ORF513+ 
IS£cp7 
CTX-M+TEM+SHV+S«/-7+CS+ IS£cp7 
CTX-M+TEM+SHV 
CTX-M+TEM+SHV+AmpC+5'u/-7+CS+0RF513 +IS26 
CTX-M+TEM+SH\'+AmpC+5«/-7+ORF513+ IS£c;77 
CTX-M+TEM+SHV+AmpC+5«/-7+CS+ORF513+ 
IS£c/77+IS26 
CTX-M+TEM+SHV+AmpC+S«/-7+CS+ORF513+ 
IS£<:/?7+IS2<J 
CTX-M+TEM+SHV+5w/-7+ORF513+ IS£C/J7+IS26 
CTX-M+TEM+SH\^ +AmpC+IS£c/77 
CTX-M+TEM-SH\'-.\mpC^5u/-7-ORF513 
CTX-M+TEM^SH\'-,\nipC+IS£cp7 
CTX-M+TEM-SH\'^ .AmpC+CS 
CTX-M+TEM+SH\'+AmpC+CS 
CTX-M+TEM-Sm'•^.\mpC+5u/-7-K:S+ORF513 
CTX-M+TEM-SH\'-.AjnpC-5u7-7-CS+ORF513+ 
IS£cp7 
CTX-M+TEM+SHV+CS+ORF513 
CTX-M+TEM+SHV 
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Figure 34a: 2% Agarose gel is showing RAPD pattern of the E. 
coli isolates harbouring blacjx.\i genes (Lane 1-25) of different 
wards, lanes M are showing Fermentas DNA ladder. 
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6000bp 
2000bp 
ISOObp 
lOOObp 
500bp 
400bp 
300bp 
200bp 
lOObp 
Figure 34a 
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Figure 34b: Clusters of the isolates harbouring blacm-w genes 
(EC1-EC4) 
CI C7 C13 CIS C21 C3 CIO C19 C23 C4 C6C11C12 C9 C25 
E C l EC 2 EC 3 EC 4 
Figure 34b 
Figure 35a: 2% Agarose gel is showing RAPD pattern of the E. 
coli isolates harbouring combination of blacjx-s&blaj^^i genes 
(Lane 1-12) of different wards, lanes M are showing Fermentas 
DNA ladder. i 
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1500bp 
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Figure 35a 
Figure 35b: Clusters of the isolates harbouring blacrx-s&blarEM 
genes of different wards (EC5-EC7) 
CT2 CT5 CT3 CT8 CT9 CTIO CT7 CTll 
ECS EC 6 EC 7 
Figure 35b 
Figure 36a: 2% Agarose gel is showing RAPD pattern of the E. 
coli isolates harbouring blacTx-M^blasuw genes (Lane 1-20) of 
different wards, lanes M are showing Fermentas DNA ladder. 
M 1 2 3 4 5 6 7 8 9 10 11 12 1314 15 16 17 1819 20 M 
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ISOObp 
1000bp-> 
500bp 
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Figure 36a 
Figure 36b: Clusters of the isolates harboi^ ring blacT\.\&blasHv 
genes of different wards (EC8-EC10) 
CSl CS4 CS9 CSIO CS16 CS6 CS13 CSS CS17CS18 CS20 
ECS EC 9 EC 10 
Figure 36b 
Figure 37a: 2% Agarose gel is showing RAPD pattern of the E. 
coli isolates harbouring /^flcTx-M+^ ^^ TEM+^ ^^ SHv genes (Lane 1-23) 
of different wards, lanes M are showing Fermentas DNA ladder. 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 M 
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Figure 37a 
Figure 37b: Clusters of the isolates harbouring blacw. 
M'^blajEM'^blasm genes (ECl 1-EC15) 
CTS3 CTSIO CTS5 CTS13 CTS8 CTS9 CTS20 CTS15 CTS18 CTS16 CTS17 
ECU EC 12 EC 13 
F i g u r e 3 7 b 
EC 14 EC 15 
Figure 38a: 2% Agarose gel is showing RAPD pattern of the 
Klebsiella isolates harbouring various combinations of bla^sm.s\ 
blacTx-M (Lane 1), blacrx-srblaTEM (Lane 2-3), bhcTx-M+bhsHv 
t I 
(Lane 4-5), ^/^CTX-M+^^^TEM+^/^SHV (Lane 6-13) of different 
wards, lanes M are showing Fermentas DNA ladder. 
M l 2 3 4 5 6 7 8 9 10 11 12 13 M 
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Figure 38b: Clusters of the Klebsiella isolates harbouring various 
combinations of ESBLs (K1-K3) 
KC7 KC9 KC8 KCll KCIO KC12 f 
Kl K2 
Figure 38b 
K3 
Figure 39: 2% Agarose gel is showing RAPD pattern of the all 
isolates that harbouring blajESi or blasE\' or combination of these 
genes. 
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Figure 39 
RESULTS 
4.12 Sequencing results 
Representative isolates were sequenced to identify the type of CTX-M genogroup-1, 
CTX-M-genogroup-9, AmpC-type P-lactamase, and for CS region of integrons. We found 
CTX-M-genogroup-1 as CTX-M-15 type (gene bank accession no. JF918433) and CS 
region was analysed as sul-1 type class 1 integron (gene bank assession no. JF918432). 
We also found CTX-M-genogroup-9 as CTX-M-9 like (BankIT ID 3A3246). The 
sequence dendograms of CTX-M-15, CTX-M-9, AmpC and CS region are shown in 
Annexure-1,1.1, 111 and IV, respectively. 
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CHAPTER 5 
DISCUSSION 
Extended Spectrum P-lactamases (ESBLs) are widespread all over the world, but the 
prevalence and phenotypic characteristic among clinical isolates may vary between 
geographical areas (Winokur et al. 2001; Navon-Venezia et al. 2003). This 
geographical difference may be due to the differences in the use of antibiotics and 
selection of organisms. TEM and SHV were found as the most prevalent t>pe of 
ESBLs followed by CTX-M enzymes in various countries (Xiong et al. 2002; Muhe}' 
et al. 2004). However, in India, CTX-M is reported as the most prevalent enz>-me than 
any other ESBL (Karim et al. 2001; Ensor et al. 2006; Shahid 2010; Shahid et al. 
2011b). 
Some studies from India have reported 6.6-68% Enterobacteriaceae isolates as ESBL 
producers (Menon et al. 2006). From South hidia Subha et al. (2002) has reported 
6.6% prevalence of ESBL production among Klebsiella pneumoniae isolates from 
Children. 68% of Gram-negative bacterial isolates from a tertiary care hospital from 
Delhi were reported as ESBL producers (Mathur et al. 2002). One study from north 
India, on ESBL production in uropathogens, has shown 26.6% ESBL producers 
comprising of Klebsiella, E. coli, Enterobacter, Proteus, and Citrobacter species 
(Khurana et al. 2002). 86.6% of Klebsiella spp., 73.4% of Enterobacter spp. and 
63.6% of £. coli isolates from cases of neonatal septicaemia were reported as ESBL 
producers (Jain et al. 2003), while another study 48.3% urinary isolates were found as 
ESBL producers (Tankhiwale et al. 2004). In a report from Tamil Nadu, 40% and 
41% isolates were found as ESBL producers among K. Pneumoniae and E. coli, 
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respectively (Babypadmini et al. 2004). Whereas another study reported, 58.06% E. 
coli and 57.14% Enterobacter spp. isolates as ESBL producers (Ananthakrishnan et 
al. 2004). A previous study from our college hospital (JNMCH) reported 42% of 
isolates as ESBL producers among which 34.42% were E. coli isolates (Akram et al. 
2007), but a subsequent study from the same place found 14.3% E. coli and 24.5% K. 
Pneumoniae isolates as ESBL producers (Shahid et al. 2008). 
In the present study, 130 Enterobacteriaceae isolates (108 E coli and 22 Klebsiella 
spp.) Nvere selected based on the resistance to any of the third generation 
cephalos]porin. The susceptibilit) pattern to various antibiotics noticed 100% 
(130) resistance to cefotaxime, while majority of the isolates 95.3% (124/130) 
were ako found resistant to ceftazidime. Other antibiotics such as ceftriaxone, 
cefixime. cefoperazone and aztreonam were also showing significantly high rates of 
resistance, 93% (121/130), 90% (117/130), 82.3% (107/130) and 91.5% (119/130), 
respectively, while none of the isolate was found resistant to imipenem. A 
previous study by Shukla et al. 2004 has revealed 72% of Gram-negative bacteria 
resistant to all third generation cephalosporins. In this study resistance rates to 
fourth generation cephalosporins, cefepime and cefepirome, was noticed in 63% 
(82/130) and 78.4% (102/130) isolates, respectively. Concurrent high resistance 
rates to other antibiotics such as ofloxacin (88.4%)) and gatifloxacin (83.8%)) was 
noticed however a comparatively low resistance to aminoglycosides like gentamycin 
(56.1%)) and amikacin (41.5%) was noticed in our isolates. We found variation in the 
resistance rates and patterns in the isolates obtained from different wards. 100%) 
resistance to ceftazidime was observed in the isolates obtained from Orthopaedic 
ward, while the isolates obtained from Medicine ward showed 100%) resistance to 
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cefixime. The isolates obtained from paediatric ward showed 100% resistance to most 
of the antibiotics such as ceftazidime, cefoperazone, cefixime, ofloxacin, gatifloxacin 
and to aztreonam. 
On analyzing the phenotypic detection of ESBL producers by double disk synergy test 
(DDST), combination disk test (CDT) and modified three dimensional extract test 
(MTDT) we found CDT as the most appropriate confirmatory test because this 
method showed 89.2% positivit>- in comparison to DDST and MTDT that showed 
78.4% and 80% positivit\', respecti\ ely. In this study we used piperacillin^tazobactam 
combination instead of amoxyclav, and ii gave us beuer results for detection of ESBL 
producers in comparison to amox)clav (Amoxyclav was used in few representati\'e 
isolates that showed negati\it}' for ESBL producers). In MTDT, we also used 
cefotaxime in place of ceftazidime, which again gave us much better result then 
ceftazidime and also helped confirming the presence of blacTK-u genes in the 
Enterobacteriaceae isolates of this study. 
In this study, genotypically, of the 130 cefotaxime resistant isolates, only 86.1% (112) 
were found positive for blacrx-si genes that included higher number ofE. coli isolates 
(89.8%) then Klebsiella isolates (68.1%). We obserxed that of the all cefotaxime 
resistant isolates, 18 were not found to harbour blacix-M genes. May be any other 
enzyme mimics the activity of CTX-M t>-pe ^-lactamases so we found these isolates 
resistant to cefotaxime, however blocrx-M gene was absent. A previous study from 
south India in 2006 (Sekar et al. 2006), has reported 35.89% prevalence for blacix-M 
gene wliile in present study we observed a noteworthy increase 86.1%, which is 
inflexible in comparison to some recent reports from China (89%), Ireland (89%), 
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Spain (86%), France (83%) and UK (85.2%) (Yu et al. 2007; Morris et al. 2009; 
Blanco et al. 2009; Arpin et al. 2009; Xu et al 2010). 
Recently more than 113 different variants of CTX-M type p-lactamases 
(http://wAvw.lahey.org/studies/webt.htm) belonging to six different groups has been 
reported (Rossolini et al 2008; Shahid et al 2011). Since the first description of 
6/acTX-M-i5 in India (Karim et al 2001), it is now considered a dominant type with 
some exceptions worldwide (Canton & Coque 2006; Hawkey & Jones 2009). On 
reviewing the literature of Indian studies we found only CTX-M group-1 as the 
dominant genogroup of CTX-M (Shahid 2010; Ensor et al 2006; Kingsley & 
Verghese 2008; Shahid et al 2011). So in this study we also determined the various 
CTX-M genogoups and we found CTX-M genogroup-1 as the most prevalent group, 
while only five isolates were found having multiple groups which included one for 
genogroup-8 and four for genogroup-9 along with genogroup-1. By monoplex PCR 
for these genogoups we found amplicons for genogroup-1 (415bp), genogroup-8 
(666bp) and one isolate for genogroup-9 (205bp), whereas other three isolates gave 
positive results vdth genogroup-9-primers but the amplicon size did not correspond 
with genogroup-9 protocol, these genes amplified at molecular size of ~900bp. The 
sequencing of amplicons of genogoup-8 and genogroup-9, including those which did 
not corr<;spond the exact amplicon size for genogroup-9 was determined. The single 
isolate vdth amplicon size 205bp was determined as CTX-M-9 like (which is for the 
fu-st time isolated from India) but we obtained short sequence (-150 nucleotites) so 
the gene sequence was not accepted by gene bank. The representative isolates were 
also sequenced to determine the exact CTX-M genogroup-1 type (these isolates 
included those isolates harbouring genogroup-8 and genogroup-9) and we found 
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the presence of CTX-M-15 type. The occurrence of two other CTX-M-
genogroups (-8 and -9) along with genogroup-1 in the present study is denoting 
the newly emerging mechanism of resistance in Indian Enterobacteriaceae. 
Some global studies on occurrence of blacvx-M and its co-occurrence with ft/aesBLs 
reported 77.7% positivity for blacTx-u gene among E. coli ESBL-producing isolates 
from Gentnany (Mshana et al. 2009), while from New Zealand 97.6% ESBL-
producing isolates were found to carry blacxx-u ESBLs, of which 75.9% were CTX-
NM5 t>pe, 13.3% were CTX-M-14 type and only 1.2% each were reported to possess 
SH\' and TEM npes (Hefferman et al 2009). In another study from Saudi Arabia all 
of the K. pneumoniae isolates were found to carry CTX-M-15, SHV-1 and TEM-1 
genes (AJ-Agamy et al. 2009). In a recent study from Iran 63.8%, 51% and 23.4% of 
E. coli isolates were found positive for blajEu, blasnw and blacix-u, respectively 
(Kalanter & Mansouri 2010) and from Turkey 73.43%, 21.87% and 17.18% of 
respective isolates of E. coli, Acinetobacter and Klebsiella were found positive for 
blacrx-M, bla^m and blajEu. respectively (Bali et al 2010). 
However, similar studies on concurrent occurrence of multiple bla genes are 
fragment;ir>' from India. In India, the prevalence rate of ESBLs varies in different 
institutions from 28-84% (Das et al 2001). One institute from Chandigarh reported 
12.6% prevalence rate for ESBL production in Enterobacteriaceae (Datta et al. 2004). 
A study by Grover et al 2006, reported 88.8% of the Klebsiella isolates positive for 
i/oTEM and/or blasnw- Recently from south hidia 14% E. coli, 15% Enterobacter spp. 
and 45% Klebsiella spp. isolates were reported to harbour blasuv genes while 50% E. 
coli, 28% Enterobacter spp., 40% Klebsiella spp. and 2% other Gram-negative bacilli 
were reported to possess blacrx-M genes (Kingsley et al 2008). Another study from 
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Eastern part of India reported co-occurrence of 85.4% blacrx-u positive isolates with 
32.9% 6/asHv and 54.9% blaj^M either alone or in combination (Goyal et al. 2009). 
In early 1990s publications on ESBLs reported blajEM or blasuw variants especially in 
Klebsiella but the situation has continuously been changing in the last few years and 
CTX-M P-lactamases are emerging as a predominant mechanism of resistance mainly 
among E. coli (Canton et al. 2008; Rossolini et al. 2008). So, in our study we also 
determined the other two most commonly occurring p-lactamases. blajEu and blasm, 
with blacTx-M to find out the most prevalent ESBL in our collection of North-Indian 
Enterobacteriaceae. In the present study on detennination of ESBLs like TEM and 
SHV, we found 93% (121/130) positivit}- for W^ESBLS, including 92.5% (112/121), 
45.4% (55/121) and 54.5% (66/121) isolates of 6/acrx-M- blox^^i and 6/asH\', 
respectively. While in a recent study by our group conducted on a collection of 
Enterobacteriaceae isolates from year 2007-2008, reported 28.8% /^OCTX-M, followed 
by 13.7% 6/asHv and 10.9% blajEu (Shahid et al. 2011b). The higher percentage of 
blacTX-M is denoting that this gene is currently the most common tyipe of ESBL then 
blaTEM and blasm in our North-Indian Tertiar>- Care hospital. In the present study we 
have noticed 9 isolates as ESBL-producers by phenot>pic detection method but they 
were not found to harbour any of the screened bla genes. Most probably, these 
isolates harbour any other type of 6/flESBL that were not screened in the present study. 
While on analysing the presence of \arious combinations of bla genes (blacrx-M, 
blajEM and blasm), we found blacrx-M+blajEM+blasHv as the most common 
combination in 28% (34/121) isolates followed by blacn-M+blasm in 21.4% 
(26/121), whereas only 13.2% (16/121) were having the combination of blacix-
M+blajEM- Least common combination was found in 1.6% (2/121) isolates having 
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blasHyf^blajEM type. But if we look for the presence of various genes alone then we 
found 29.7% (36/121) isolates harboured only blacrx-u gene while 2.4% (3/121) and 
3.3% (4/121) isolates were harbouring single gene ofblajEM and blasm, respectively, 
which again signifies that blacix-u is the most common gene than any other ESBLs. 
On analysis of these isolates for the presence of various bla genes according to the 
wards from where they were collected, 100% (12/12) isolates from Medicine ward 
were found to harbour 6/aESBLs, while 96.5% (28/29), 96% (24/25), 91.2% (52/57), 
and 71.4%) (5/7) collected from Gynaecology, Orthopaedic, Surgery and Paediatric 
wards, respectively, were found to harbour bloESBis- All the isolates collected from 
medicine were E. coli and found positive for various combinations of blacrx-u and 
other bloESBLs but none of the isolates was found to harbour single gene (ft/ajEM or 
blasHv) or the combination of both these genes. 
CTX-M-t}T)e extended spectrum P-lactamases (ESBLs) and AmpC-type P-lactamases 
have been found as two major contributors for antibiotics resistance in recent years 
(Paterson & Bonomo 2005; Bonnet 2004; Philippon et al. 2002; Livermore & 
Woodford 2006). Reports of multiple p-lactamases in a single pathogen are increasing 
in Enterobacteriaceae (Hanson et al. 1999; Alvarez et al. 2004; Yan et al. 2004; Song 
et al. 2006; Moland et al. lOQl; Shahid 2010). CMY-2 type was found to be 
associated with CTX-M-14 m a Parisian E. coli isolate (Saladin et al. 2002). In 
Taiwan. CTX-M and SHV-type ESBLs with CMY- and DHA- type AmpC enzymes 
were reported as the most common P-lactamases that conferred resistance to 
extended-spectrum cephalosporins in clinical K. pneumoniae isolates (Yan et al. 
2004; Yan et al. 2006). The emergence of a multidrug resistant K. pneumoniae 
isolate, which produces VIM-4, CTX-M-15, TEM-1, CMY-4 has been reported from 
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France (Ktari et al. 2006). Co-existence of CMY-8 and CTX-M-3 was reported in a 
269 kb conjugative plasmid from K. pneumoniae (Chen et al. 2007). A recent report 
for co-existence of CMY-6 and CTX-M-15 has recently been reported on the similar 
type of plasmid from India (Shahid et al. 2009). Recently Enterobacteriaceae isolates 
has been reported harbouring CTX-M-15 and CMY-6 in patients with bronchogenic 
carcinoma (Shahid et al 2010). These studies prompted us to find out the co-
existence of multiple genes responsible for production of p-lactamases especially of 
rvvo major classes, class A and class C in our isolates. In this study 75% (84/112) 
isolates were showed co-existence of blacrx-u and bhampc- Simultaneously only 50% 
(3-6) isolates were showed co-existence of 6/aampC with blasm (1) or combination of 
blctrE}.&blasH\' (2), while none of the isolate has shown this co-existence with i/aiEM-
The higher occurrence of co-existence of blacTx-u with bhampc is denotes that these 
class A and class C type beta-lactamases may concurrently be present on the same 
plasmid. In various combinations of bloESBis, highest rate of co-existence of blaampc 
i.e. 81.2% (13/16) was present with the combination of blacTx-M+blaiEM, which was 
the least common combination of the bloESBL genes in our Enterobacteriaceae 
isolates. "^ Vhile 69.4% (25/36), 76.4% (26/34), and 76.9% (20/26) co-existence of 
bloasTipc was found with various combinations of blacTx-u, blacrx-M+blajEu+blasHw, 
and blacTX-M^blasm, respectively, which shows the least co-existence with the single 
gene blacrx-u- This revealed that if the A/aESBL genes possess blacrx-M then the 
possibility for the presence of Class C tj pe ^-lactamases increases. 
On comparative evaluation of occurrence of class A and class C type p-lactamases in 
Enterobacteriaceae during years 2009 and 2010, we found nearly similar occurrence 
of WflESB)^ : 92.1% and 94.4% in respective years, 2009 and 2010. On characterization 
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of various combinations like blacrx-u, blacjx-M+blasHv, /^OCTX-M+ /^^ TEM, and blacrx-
M+blasuw+blaTEM in 2009 we found 31.4% (22/70), 18.5% (13/70), 20% (14/70), and 
25.7% (18/70) positive isolates, respectively, while in 2010 these combinations were 
present in, 27.4% (14/51), 25.4% (13/51), 3.9% (2/51), and 31.3% (16/51), 
respectively. We clearly observe here that in 2009 collection most of the isolates 
harboured single gene of blacrx-u while in 2010 collection the most common 
combination was WacTx-M+A/flsHV+WaxEM- In 2010,3.9% (2/51) isolates were also 
found positive for combination of blusHs^blajzM while this combination was 
absent in 2009 collection. By PCR, in the isolates harboring WAESBLS, Wa.nipc ^as 
detected in 81.4% (57/70) and 58.8% (30/51) isolates from coUfctions of year 
2009 and 2010, respectively. 
We also observed that in 2009, out of two isolates which harboured bIasH\ gene only 
one isolate was found positive for co-existence of bhan^pc- while in 2010 this co-
existence was absent in all those isolates which harboured only single gene of blasuw 
and blajEM each (data submitted for publication). This reflects that the implementation 
of antibiotic prescription policies in our institution is moving on a right track. 
Insertion sequences IS26, ISEcpI and ISC^l in association \\i\h class 1 integron 
structures, as well as phage related elements seem to have played a prominent role in 
acquisition of CTX-M genes (Arduino et al, 2002; Eckert et al, 2006: Oliver et al., 
2005; Poirel et al, 2008). Studies analysing the presence of mobile genetic elements 
are also fragmentary from India (Shahid 2010; Bhattacharjee et al. 2010), therefore 
we looked our isolates for the presence of mobile genetic elements. Different genetic 
environments might be involved in the mobilization ofblacjx-u and other ESBLs. On 
characterization of various mobile genetic elements (integrons and insertion 
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sequences) we found 89.2% (116/130) were harbouring these mobile elements i.e. sul-
1, CS-region, ISEcpl, IS26 and ORF513 (ISCRl). Higher percentage of mobile 
genetic elements [28.4% (33/116)] was found to be associated with combination of 
bhcTx-M+blaTEtA+blasHv- 4.3% (5/116) isolates harboured mobile genetic elements 
but were not found to harbour any bla gene, which shows that mobile genetic 
elements in these isolates may be associated with any other type of resistance genes 
(i.e. aminoglycoside or fluoroquinolones) which were not studied in this study. 4.6% 
(6/130) isolates which harboured blacrx-u genes only, were not found associated with 
any t>pe of mobile genetic elements, so we hypothesize based on the current finding 
that these bla genes were mobilized through plasmids. 
Few studies have reported that classic class 1 integrons include in their 5'-conserved 
segment (5'-CS) an integrase gene (intll) and in their 3'-conserved segment (3'-CS) 
the qacEAl+sull genes encoding resistance to quaternary ammonium compounds 
(partially deleted) and sulphonamides, respectively (Partridge et al 2009). However, 
non-classic class 1 integrons lacking the 3'-CS region have also been reported (Liu et 
al. 2009; Soufi et al. 2009; Chaunchuen et al. 2008; Sunde et al. 2008; Vinue et al. 
2008; Ajtitunes et al. 1^1; Cocchi et al. 2007; Saenz et al. 2004). 76.1% (99/130) 
isolates were found to harbour mtegrons {sul-1 and CS regions) and included higher 
percentage of Klebsiella 11.1% (17/22) then E. coli 75.9% (82/108). Pitout et al. 
(2005) has reported CTX-M types of genes associated with genetic structures such as 
sul-I type integrons, which might explain the multidrug resistant nature of organism 
producing these enzymes. This structure is genetically linked to class-1 integrons 
known to integrate antibiotic resistant gene cassettes responsible for resistance to P-
lactams, aminoglycosides, chlorampenical, sulphonamides, and to a lesser extent 
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rifampicin. Recently class-1 integrons were detected in 27% of E. coli isolates 
(Shaheen et al. 2010). The sul-J gene, as part of the 3'-conserved segment (3'CS) of 
class 1 integrons were the most frequently detected integrons in Enterobacteriaceae 
(Carattoli 2001). In this study, sul-1 type class-1 integrons were found in 59.2% 
(77/130) Enterobacteriaceae isolates, while in a previous study from our laboratory, 
32.5% Citrobacter spp. isolates harbouring sul-I type class-1 integrons were reported 
(Shahid 2010). 61.6% (69/112) Enterobacteriaceae isolates which harboured blacix-u 
genes were associated \Wth sul-] t\~pc class-1 integrons in our collection. We noticed 
that the imtegrons were present in higher number of isolates [33.7% (26/77)] that 
harboured the combination of CTX-MTTEM+SHV genes. The occurrence of CS 
regions (specific regions for integrons) was noticed in 55.3% (72/130) whereas the 
sul-1 t>pe class-1 integrons was obserxed in 59.2% (77/130). This is showing higher 
occurrence of classic class 1 integrons due to the presence of sul-J gene in 3'CS 
region as pre%iously reponed by Partridge et al. (2009). CS regions and sul-1 genes 
were most commonly associated in those isolates which harboured the combination of 
blacTX.u^blaT£\{+b!asHw. We found that the isolates harbouring blacjx-u genes were 
associated with nearly CS regions and sul-1 genes nearly in similar percentage 60.7% 
(68/112) and 61.6% (69 112). respectively. This is showing that in present study the 
Enterobacteriaceae isolates harbouring blacrx-u genes were frequently mobilized by 
classic class 1 integrons. We also observed 17 isolates that harboured CS regions but 
not associated with sul-1 genes, this is showing the presence of non-classic class 1 
integrons due to the absence of normal 3'CS region which contain the sul-1 gene, as 
recently reported by Vinue et al. (2010) that the qacEAl-sull fragment of normal 
3'CS region replaced by qacH-IS440-sul3. The sul-1 type class-1 integrons were 
found associated in the isolates that harboured either SHV/TEM alone or 
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combination of SHV+TEM ESBLs. But, the isolates that harboured TEM alone 
or SHV+TEM genes were noticed not to be associated with CS regions except 
one isolate that harboured SHV gene and was found positive for CS region. The 
occurrence of single WOCTX-M gene was higher 29.7% (36/121) than the combination 
of blacTX'M+blarEM+blasHv [28% (34/121) of the all ESBL positive isolates], but in 
the present study we noticed that the association of integrons was higher (31.3%) in 
isolates with combination of blacTx-u+blajEU+blasHv than the isolates (23.2%) which 
harboured only blacjx-u- This shows here that the dissemination of more t>pes of 
antibiotic resistance genes might be due to the higher occurrence of integons as 
previously reported by Pitout et al. (2005). From different European hospitals 
commonly three sizes of inserted regions of DNA (800, 1000 and 1500bp) were 
reported among class 1 integrons in unrelated clinical isolates of Enterobacteriaceae 
(Martine2>Freijo et al. 1999). While in present study we found \arious bla genes 
associated with variable size of CS integrons such as ~1600bp, -900bp, -800bp, 
~500bp, ~450bp, ~350bp, and ~180bp in 33.3% (24), 4.1% (3), 12.5% (9), 5.5% (4), 
5.5% (4), 1.3% (1) and 1.3% (1) isolates, respectively. This shows that quite larger 
fraction of isolates harbours CS region of ~1600 bp. Most of our Enterobacterial 
isolates, which harboured CS regions of higher molecular weight, were found 
associated with sul-1 type class-1 integrons, while those which contain lower 
molecular weight amplicons of CS region (ranging from 180 to 450bp) were found 
devoid of sul-1 t^pe class-1 integrons. We also found that one isolate showing rvvo 
bands of CS amplicon, harboured sul-1 type class-1 integron but did not show 
presence of any /^AESBL (noticed in this study) or any other mobile genetic element 
(ISEcpl, ORF513, IS26). This class 1 integron may be responsible for mobilization of 
any other type of resistance genes such as aminoglycosides or fluoroquinolones. As 
127 
DISCUSSION 
previously reported that qnrA-like gene was located in sul-J type class 1 integrons 
(Poirel et al. 2005). Two other isolates harbouring sul-l+ORF513+IS26 and 
ORF513+IS£cp7+IS2(5 combination of mobile genetic elements and showing 
amplicons at 500bp and 900bp respectively, also found devoid of bla gene screened 
here in this study. Probably they may also be responsible for mobilization of 
resistance gene of other class of antibiotics. 
The association of insertion sequences with antibiotic resistance genes has been 
reported previously (Ford & Avison 2004; Miriagou et al. 2005; Smet et al. 2010). 
However, similar to the reports on mobile genetic elements, the reports on insertion 
sequences are also fragmentary from India (Karim et al. 2001; Shahid 2010). On 
analyzing the insertion sequences we noticed that a total of 83.8% (109/130) 
Enterobacteriaceae isolates harboured insertion sequences such as \SEcpl, ORF513 
(ISCRl) Eind IS26; higher frequency of occurrence in E. coli [87% (94/108)] than 
Klebsiella spp [68.1% (15/22)]. Similar to the results to integrons, these insertion 
sequences were also found highly associated in those isolates which harboured the 
combination of ft/acrx-M+^/^TEM+^/^SHV [(27.7%) (30/108) isolates], followed by the 
WflcTX-M (25.9%). hi this study we found 56.9% (74/130), 53.07% (69/130) and 33% 
(43/130) Enterobacteriaceae isolates harbouring ISEcpl, ORF513 (ISCRl) and IS26, 
respectively. This shows the association of ISEcpl is higher than ISCRl and \S26 
with bloESEis- Moreo\^ er, ISEcpl elements and its remnants constitute an ahemative 
promoter region (Karim et al, 2001) which leads to increased, clinically relevant 
expression of the blacrx-M gene that is only weakly expressed in its natural reservoirs 
(Karim et al, 2001; Poirel et al, 2003). ISEcpl is always found upstream of 5' end of 
blacjx.M-\5 and is strongly implicated in the mobilization of this antibiotic resistance 
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gene (Karim et al. 2001; Saladin et al. 2002). In the present study 94.5% (70/74) 
isolates harbouring ISEcpl type insertion sequences were associated with various 
combinations of blacix-u with other ESBLs such as blacjx-w^blajEM, blacix-
M+blasH\, blacTK-M+blajEM^blasm- One isolate was also found to harbour ISEcpl 
associated with blasnv, while those isolates which harboured blajEu and combination 
of blajEM^blasm were not found to harbour ISEcpl. This shows probably WATEM 
and combination of blajEM+blasH\ is not mobilized by these mobile elements, 
while blasm gene is mobilized by this insertion sequence. 
blacTX-si genes belonging to the CTX-M-1, CTX-M-2 and CTX-M-9 clusters are 
associated with lS£cp/-like insertion sequences while \SCR1 elements are found 
upstream of the blacTx-\i-2 and blacTx-s{-9 genes (Eckert et al. 2006; Ryoo et al. 2005; 
Sabate et al. 2002). CTX-M-14 has been reported to be associated with ISEcpl, while 
an ISCRl related CTX-M-14 gene is also reported from an E.coli isolate (Bae et al. 
2007). In the present smdy we found most of the isolates harbouring blacxx-u genes 
associated with ISEcpl and ORFjyj. Of these 69 ORFJ/i positive isolates, 27.5% 
(19/69), 15.9% (11/69), 15.9% (11/69), 28.9% (20/69), 2.8% (2/69), 1.4% (1/69), 
1.4% (1/69), were associated with i/acrx-M, /^ocTX-M+ /^aiEM, blacrx-M+blasm, 
blacTX-hr-blajE},rblasH\\ blasH\', blorEsu and i/aiEM+^^^SHv, respectively. This shows 
the higher association of ORF513 with bloESBis also in those isolates which harbour 
the blajEsi or 6/as:-rv or combination of blorEs&blasHv- So we hvpothesize that this is 
the most important insertion sequence required for mobilization of different types of 
bloESBU at least in our collection of Enterobacteriaceae. We also found one isolate 
harbouring CTX-M genogroup-9 with genogroup-1 that was found associated with 
ISEcpl but not with ORF513, while previous studies also showed presence of 
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ORF513 with blacTx-M-9 (Brigante et al. 2005). On analysing the association oilS26 
elements in these isolates with different combinations we found 27.9% (12/43) 
isolates which harbour blacrx-ij&blaTEu+blasHw as the most common combination 
while 25.5% (11/43) isolates harbouring blacrx-M+bhsHV as the second most common 
combination in which 182(5 elements were found associated. Whereas only 20.9%) 
(9/43) isolates were showing association of IS26 elements with blacrx-u genes. Least 
number of isolates [9.3%) (4/43)], which harbour blacrx.-s&blaTEM, were found 
associated with IS26 elements. In the present study we noticed that IS26 was most 
commonly found in those isolates that harboured blasH\ genes \\iih other ESBLs and 
suggests us the mobilization of SHV type of ESBLs by IS26 elements. This was also 
suggested in a previous report that blasnw originated from the chromosome of K. 
pneumoniae and an IS26 element played a role in mobilization of 6/asHv to plasmid 
(Ford & Avison 2004). Those isolate which harbour blojEsi+blasm, were not 
associated with IS26 elements and also with ISEcpl but their association with 
ORF57i shows that this combination is mobilized by ISCR. In this study, variable 
sizes for the 1826 type insertion sequences were detected in: 6.9%) (3/43), 39.5%) 
(17/43), 4.6% (2/43), 11.6% (5/43), 2.3% (1/43), 9.3% (4/43), 2.3% (1/43), 2.3% 
(1/43), 2.3% (1/43), and 11.6% (5/43) isolates with amplicons of-1.8kb. -850bp. 
~800bp, ~700bp, ~650bp, ~600bp, ~590bp, ~550bp, ~350bp, and -180bp, 
respectively. This shows the presence of various molecular sizes of 182(5 elements 
inserted with blaESBis, but amplicon size of ~850bp was most frequently obser\ed. 
This amplicon size has also been reported as the most common size in a previous 
study from our laboratory (Shahid et al. 2010). Few isolates were also found to 
possess duplicate copies of 182(5 elements in concordance to a previous report that 
insertion sequences connected to bhcTX-M as well as other genes are located between 
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two IS26 elements (Literacka et al. 2009; CuUik et al. 2010). In this study some 
isolates also had multiple amplicons of IS2(J (suggesting the presence of multiple IS2<5 
copies) but these isolates could not be sequenced due to the presence of multiple 
amplicons in these isolates. 
On analysing the presence of various combinations of mobile genetic elements in 
Enterobacteriaceae isolates we found most of the isolates harboured sul-
l+€S+ORF513+IS£cp7 type combination of mobile genetic elements and the second 
most common combination was of sul-I+CS+ IS£'cpi+ORF513+IS26 type, while 
none of the isolate was found harbouring the combination of IS£c/)7+ORF513+182(5 
(Table 9). On analysing the occurrence of various combinations of mobile genetic 
elements with different combinations of MQESBU, ^e found ft/acTx-M+^/oTEM+^/^SHv 
and blacYx-f^'&blasHv combinations of bla genes associated with at least 16 different 
combinations of mobile genetic elements and blacTx-u was the second most common 
combination which was associated with 15 combinations of these genetic elements. 
The most common combination of bla genes {blacrx-M+blaTEM+blasHv) in this study 
was found associated with sul-l+CS+ IS£'c/77+ORF513+IS26 combination in 
majority of the isolates. In this study we found four isolates that harboured only 
blacTXM genes and were associated with only IS26 elements, and thus suggests 
that this gene can even be mobilized only by the help of this insertion sequence. 
IS26 has been reported to be associated with blacrx-si genes including 6/acTX-M-i5 and 
more specifically inserted within ISEcpl, the insertion of 1826 differs from strain to 
strain (Eckert et al. 2006). It was observed in the present study that of the 76 isolates 
harbouring ISEcpl, 31.5% (24) were found flanking by the IS26 elements. This has 
already been reported previously that ISEcpl is found disrupted by the insertion 
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sequences like \S26 (Monday et al 2004). A recent study also reported that the 
occurrence of IS26 together with ISEcpl could play a critical role in the evolution of 
diverse multiresistant plasmids in clinical Enterobacteriaceae (Smet et al. 2010). In 
this study CTX-M genogroup-9 like gene was also found associated with ISEcpl 
and IS26, while this gene was not associated with ORF513 (also known as 
ISCRl). It has been reported that OKF513 associated with class-1 integrons (known 
as a complex class-1 mtegrons) can mediate resistance to chlorampenicol, 
trimethoprim, aminoglycosides and tetracycline and may carry a range of p-lactamase 
genes as well as the qnrA gene (Toleman et al. 2006). The complex class-1 integrons 
contain tlie 5"CS and part of the 3'CS flanking one or more gene cassettes, this 3' CS 
is a region knov^ ii as the common region (CR) consisting of orf513 and a 
recombination crossover site followed by genes that do not resemble a gene cassette 
and flanking by another copy of the qacEAl/sull complex (Partridge & Hall 1995). 
More interestingly, in this study, out of 69 isolates that harboured sul-1 type class-1 
integron, 73.9% (51) were found to harbour ORF5/5 which shows the higher 
occurrence of complex class-1 type integrons with WOESBLS including blacrx-M in 
our North Indian collection of Enterobacteriaceae. 
On comparative analysis for the presence of various mobile genetic elements in the 
collections of 2009 and 2010, ISEcpl w^ as found as the dominant genetic element in 
2009 while in 2010, CS region of integrons was the dominant element for 
mobilization of A/AESBLS-
In this study we found that all isolates showed the presence of a single plasmid of 
~23kb. On analysis of plasmids for the presence of CTX-M-genogroups in 
representative isolates, these plasmids were found to harbour CTX-M-genogroup-1 
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and genogroup-9 (205bp). This revealed that these genogroups are mobilized among 
the bacterial cells through plasmids. 
In infections caused by the same bacterial clone (monoclonal outbreak) or by a few 
bacterial clones (Oligoclonal outbreaks), the pathogen usually migrate horizontally 
(from patient to patient), while infections originated by various clones of the same 
species (polyclonal outbreaks) are usually caused by the intensive selective pressure 
imposed by antibiotic use (Paterson and Bonomo 2005). On genot}ping by ERIC-
PCR of Enterobacteriaceae isolates great diversity was noticed. A total of 51 isolates 
were found clustered in 18 clusters which included 15 clusters of 45 E. coli isolates 
and 3 clusters of 6 Klebsiella spp., while other 50 isolates were showing their own 
distinctive patterns. This RAPD-typing revealed diverse bacterial population and 18 
dominant clones were identified. Analysis of RAPD profile of various isolates 
collected from different wards revealed most of the isolates clustered in different 
clusters were from Surgery (18), Orthopaedic (16), Gynaecology (12), while least 
number of isolates were from Medicine (4) and Paediatric (1). Isolates from Surgery 
were clustered in 11 clusters and found clonally related with Orthopaedic, Medicine, 
Gynaecology, and Paediatric wards. Isolates from Orthopaedic ward clustered in 9 
clusters and clonally related with isolates of Surgery, Medicine and G>"naecoIogy. 
Gynaecology isolates were clustered in 6 clusters and were clonally related with 
Orthopaedic and Surgery. Medicine isolates were clustered in 4 clusters and clonally 
related mth isolates of Surgery and Orthopaedic wards, while the only 1 isolate from 
Paediatric ward was found clonally related with isolates of Surgery and Gynaecology. 
It can be concluded that probably the very same clone circulating in the gynaecology, 
surgery and orthopaedics wards as these wards are sharing the same building block in 
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our hospital and hence the chances of cross contamination are high. As some isolate 
from different wards were found matching, so it can be concluded that proper 
sterilization conditions are not maintained in our hospital wards/operation theatres; 
however, variability among isolates is still maintained. 
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CHAPTER 6 
SUMMARY 
Antibacterial agents have been used for the treatment of infectious diseases since the 
17* century, these antibiotics were not novel biological agents but common natural 
microbial products whose usefiil antibiotic activity had been discovered by the 
laboratory screening in the pharmaceutical industry. Enormous quantities of natural 
products, the antibiotics with demonstrated and tested therapeutic activities \^ ere 
manufactured and tested for human use by a new generation of pharmaceutical 
companies and released into the biosphere, being toxic agents they created a terrible 
condition for terrestrial bacteria with significant knock-on effects on the microbial 
ecology in many different ecosystems. There is no doubt that significant variations in 
the microbial population and extensive modifications have taken place whene%'er 
antibiotics were used. The treatment of infectious disease is compromised by the 
development of antibiotic resistant strains of microbial pathogens. The production of 
p-lactamases in Gram-negative bacteria is a serious global problem and protects 
bacteria against the lethal effect of P-lactam antibiotics, p-lactam antibiotics are a 
broad cL'iss of antibiotics that contain a p-lactam nucleus in their molecular structure 
and include penicillin derivatives, cephalosporins, monobactams and ^-lactamase 
inhibitors. P-lactam antibiotics inhibit the synthesis of the peptidoglycan layer of 
bacterial cell walls, but P-lactamases open the P-lactam ring of penicillin and 
cephalosporins to abolish their antimicrobial activity. The third generation 
cephalosporins have been introduced into clinical practice in the early 1980s and were 
heralded as a major breakthrough in the fight against p-lactamase mediated bacterial 
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resistance to antibiotics. The production of P-lactamase was found as the single most 
prevalent mechanism that is responsible for resistance to P-lactams among clinical 
isolates of the family Enterobacteriaceae and extended-spectrum p-lactamases 
(ESBLs) that mediate resistance to oxyimino-cephalosporins but not to cephamycins 
have nov/ been observed worldwide in all species of Enterobacteriaceae, although 
AmpC-type P-lactamases provide resistance to both oxyimino-cephalosporins and 7-
a-methoxy cephalosporins and monobactams. In recent years, a new family of 
ESBLs. tlie CTX-M-type ESBLs that are derived from point mutation from TEM-type 
and SH\"-i>pe P-lactamases, have emerged as a prominent cause of antibiotic 
resistance. Since the fu-st description of CTX-M type P-lactamases from India it has 
been found worldwide as the dominant type of ESBL. Molecular studies on the 
presence of blacrx-M and its co-occurrrence with blasm and blajEu are fragmentary 
from India and similar is the the scenario for co-existence of this class A type P-
lactamases with class C t>pe P-lactamases. It was reported that the main mechanism 
to mobilize these enzymes mvolved various mobile genetic elements such as insertion 
sequences and also by association of class 1 type integrons. Due to the paucity of 
Indian literature on the mechanisms of mobilization of the various P-lactamases 
(CTX-M, TEM, SHV, and AmpC) among bacterial populations from India, this study 
has been planned to fulfil these requirements and has been completed in three parts. 
In the first pan of this study we have determined the ESBL producers with special 
reference to CTX-M, in our collection of Indian Enterobacteriaceae {E. coli and 
Klebsiella pneumoniae). In the present study maximum numbers of isolates were 
obtained from pus samples (53.8%), followed by urine (31.5%), and then drain 
(5.3%). We obtained the major numbers of isolates from clinical samples of Surgery 
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(57), followed by Gynaecology (29), Orthopaedic (25), Medicine (12) and Paediatric 
(7). Furthermore, to study the ESBL production in of our collection we subdivided 
this part in the phenotypic and genotypic experiments for determination of CTX-M 
type P-lactamase. We found most of the isolates, resistant to any of the third 
generation cephalosporins which included 100% resistance to cefotaxime, followed 
by the forth-generation cephalosporins, 78.4% resistance to cefpirome and 63% to 
cefepime. Resistance to cefotaxime was the main marker of our bacterial isolates 
indicating the presence of i/acrx-M genes. .AJong \s-ith rising resistance to 
cephalosporins, the second highest rates of resistance was noticed for fluoroquinolone 
(88.4% to ofloxacin and 83.8% to gatifloxacin) but the genes responsible for this 
resistance were not studied in this study. Howe\'er, resistance rates to 
aminoglycosides in our collection were not comparatively so high (56.1% to 
gentamycin and 41.5%) to amikacin) as compared to cephalosporins and 
fluoroquinolones. Resistance rates to third- as well as fourth- generation 
cephalosporins in our collection indicate the presence of class A and class C type p-
lactamases. On conflrming ESBL-production by double disk synergy test 
(DDST), combination disk test (CDT) and modified three dimensional extract 
test (MTDET), higher numbers of ESBL producers were obser\'ed by CDT 
(89.2%) as compared to DDST (78.4%) and MTDET (80%). All isolates were 
found as ESBL-producers by any of the three phenot>-pic confirmatory- tests. 
Genotypically by monoplex PCR, 86.1% (112) were found to harbour 6/acTX-M genes. 
Most probably, any other enzyme mimics the property' of CTX-M type P-lactamases 
so we observed resistance to cefotaxime in higher number of isolates while 6/acTX-M 
was noticed in lesser number of isolates. On reviewing the Indian literature for the 
presence of different CTX-M type genogroups we found CTX-M genogroup-1 as the 
137 
SUMMARY 
predominant genogroup (Ensor et al. 2006; Shahid et al. 2009). Similar to previous 
reports we also observed CTX-M-genogroup-1 as dominant genogroup, while in this 
collection we have also found five E. coli isolates harbouring one more genogroup in 
association with genogroup-1. Of which one isolate was found positive for 
genogroup-8 and four were found positive for genogroup-9. Of the four isolates that 
harboured CTX-M-genogroup-9 only one isolate provided the amolicon that 
corresponded with correspond the exact amplicon size (205 bp) of genogroup-9 whUe 
other three isolates did not provided the amplicon that corresponding to the exact 
position for genogroup-9. On sequencing of the representative isolates, the amplicons 
of CTX-M-genogroup-1 were confirmed as CTX-M-15 type. The sequencing results 
of amplicon of genogroup-9 (that corresponded to the exact amplicon size) confirmed 
it to be CTX-M-9 like. Thus, we for the first time have observed the presence of 
CTX-M genogroup-9 in Indian Enterobacterial isolates. Moreover, it shows that 
the different genogroups of CTX-M type of ESBLs are also rapidly emerging in 
Indian Enterobacteriaceae. 
In the second part of this study all isolates were determined for co-occurrence of TEM 
and SPfV type ESBLs by PCR. blacix-u, blasm and blajEu alone were noticed in 
29.7%, 2.4% and 3.3% of cefotaxime resistant isolates. Maximum number of isolates 
showed ttie combination of blacTx-M^blasHv+blaTEu (30.3%), followed by blacrx-
M+^ /flSHV (23.2%)). The resistance pattern of the isolates for fourth generation 
cephalosporins showed the presence of class C type P-lactamases in the present 
collection. So in this part of study we also determined all bloESBi positive isolates for 
co-existence of blasmpc- We noticed that 71.9% isolates showed co-existence of 
bloESBLs and bloampc- We noticed higher co-existence (81.2%) of these class C type p-
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lactamases in those isolates that harbours blacjx-M+blajEu and then in 76.9% and 
76.4% isolates harbouring blacrx-u^blasHW and blacrx-M^blajEM^blasHW genes, 
respectively. Least co-existence for 6/aampc was noticed in isolates harbouring blacix-
M genes only. This is showing that the probability for co-existence of class C type P-
lactamases increases if any other type of ESBL gene also exists with blacjx-u type. 
On comparative evaluation of occurrence of Class A and Class C type P-lactamases in 
Enterobacteriaceae during 2009 and 2010, we noticed nearly similar occurrence of 
i/flESBU in 92.1% and 94.4% isolates in the respective years, 2009 and 2010. Various 
combinaiions ofbla^sBU like blocrx-w, blacix-s&blasw,; blacTX-h&blajEu, and blocrx-
srblasHw^blojEsi were observed in 31.4%, 18.5%, 20%, and 25.7% isolates 
harbouring these genes, respectively, in 2009, while m 2010 these combinations were 
noticed in, 27.4%, 25.4%. 3.9%, and 3r.3% isolates, respectively. We also observed 
that in 2010 the combination of blacrx-h&bhjEM genes were observed in only 3.9%) 
isolates while in 2009, 20% isolates were found to harbour the same combination. In 
2010, we have noticed 3.9% isolates harbouring combination of blasm+blajEu while 
this combination was absent in 2009 collection. By PCR, in isolates which harboured 
bloESBLs- bloampc t>pe P-lactamascs were observed in 81.4% and 58.8%) isolates in the 
collections of year 2009 and 2010, respectively. In 2009, co-existence of Z?/aampc was 
noticed m 86.3%. 92.3%, 85.7%, 72.2% isolates which harboured different 
combinations of blacrx-M, blacrx-u^blasw, blacrx-u^blajEu, blacrx-
u^-blasH\-^blarEsu respectively, while in 2010 the co-existence of i/aampc ^ i^th these 
combinations was observed in 42.8%, 61.5%, 50%, and 81.2% isolates, respectively. 
In 2010 we observed that the isolates harbouring combination of 6/flsHv+6/flTEM were 
found positive for co-existence oibla^^pc- While in 2009, we also noticed that of the 
two isolates that harboured blasm only, one was found positive for co-existence with 
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bloampc, while in 2010 none of the isolate harbouring bla^m or blarEu only showed 
this co-existence. This study reflects that the occurrence of various bla genes has 
reduced from 2009 to 2010. This is showing that the implementation of antibiotic 
prescription policies in our institution is moving on a right track. 
In the third part we have studied all isolates for the presence of mobile genetic 
elements to understand the mobilization pattern of various bla genes among Indian 
Enterobacteriaceae. These mobile genetic elements included integrons {sul-1 t\'pe 
class 1 integrons and CS regions of integrons) and insertion sequences {\SEccpl. 
\S26, ISCRI). We have noticed 89.2% isolates harbouring these mobile generic 
elements. Of the total 112 isolates harbouring i/acrx-M genes. 92.8% isolates were 
found associated with these mobile genetic elements. In all CTX-M positive isolates. 
62.5%, 54.4%, 32.1%, 61.6%, and 60.7% isolates were found associated with ISEcpL 
ISCRI (ORF513), IS26, sul-1 type class 1 integron and CS regions, respectively. This 
showed nearly equal number of CTX-M harbouring isolates was associated with 
ISEcpl, sul-1 and CS regions, followed by ORF513, but least number of the isolates 
were observed associated with 1S26. 76.1%) isolates showed the presence of Integrons 
which included sul-1 type class I integrons and CS variable regions of integrons. 
59.2%) isolates were noticed positive for the presence of sul-1 t\-pe class 1 integrons. 
We also observed that higher number of isolates harbouring blacrx-su bla-^M and 
blasHw, were observed associated with sul-1 gene and suggests their mobilization bv 
sul-1 type class 1 integrons. While least association with sul-\ t>pe integron was 
noticed in isolates harbouring combination of i/acrx-M+^ /flTEM- 3.8% isolates were 
also found to possess sul-1 type class 1 integrons but not associated with any bla gene 
noticed in this study; probably these integrons were mobilizing some other resistance 
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genes such as aminoglycosides and flouroquinoolones resistance genes. 55.3% 
isolates (harbouring all three types of bla genes i.e. CTX-M, TEM and SHV) were 
noticed positive for the presence of variable regions of CS integrons. We have also 
noticed isolates harbouring variable amplicon sizes of CS regions at ~1.6kb, ~900bp, 
~800bp, ~500bp, ~450bp, ~350bp, and ~180bp, while some of the isolates were also 
harbouring muhiple amplicons. The occurrence of CS regions (specific regions for 
integrons) was noticed in 55.3% (72/130) whereas the sul-1 type class-1 integrons 
was obsen'ed in 59.2% (77/130). This showed higher occurrence of classic class 1 
integrons due to the presence of sul-1 gene in 3'CS region as previously reported by 
Partridge ei al. (2009). We observed 17 isolates to harbour CS regions but not found 
positi%e for sul-I genes, this is showing the presence of non-classic class 1 integrons 
as previously reported by Vinue et al. (2010), that the qacEAI-sull fragment of 
normal 3'CS region replaced by qacH-IS440-sul3. 
On detection of insertion sequences like ISEcpJ, ORF513 and IS26 we have noticed 
83% isolates containing any of these insertion sequences to mobilize bla genes. 
Resistance genes of 56.9% isolates were mobilized by ISEcpl type insertion 
sequences, while 53.07% and 33% isolates were mobilized by ORF513 and IS26, 
respectively. On analysing ISEcpl type genetic element in the isolates harbouring 
various combinations of blaEsnis, maxunum number (29.7%) of isolates harboured 
combination of blacrx-u+blarEh&blasm- Those isolates that harbour i/ajEM and 
combination of blajEM^blasHv were not found to be associated with ISEcpl, while 
association of A/asHv was noticed with ISEcpl. 53.07% isolates were detected for the 
presence of ORF513 (also known as ISCRl) associated with WOESBLS. It was found 
associated with all types of 6/aESBLs v.i.z. blacix-u, blajEu, and blasHV, and also in the 
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isolates which harbour blajEu or blasnw alone. This is showing that ORF513 type 
insertion sequence can mobilize any type of bloESBi. In this study we have noticed 
only 33% isolates positive for IS26 type insertion sequences to mobilize associated 
bla genes. These isolates harboured variable size of amplicons i.e. 1.8kb, ~850bp, 
~800bp, ~700bp, ~650bp, ~600bp, ~590bp, ~550bp, ~350bp, and -ISObp, some 
isolates also showed multiple amplicons of IS26 elements. In the present study we 
found that majorit>' of the isolates showed amolicon of ~850bp. In our study, in 
isolates thai: harboured ISEcpI like insertion sequences, 31.5% isolates were found 
flanking by the IS26 elements. In this smdy we found four isolates that harboured 
blacTx-si alone, and were associated with only 1S26 elements. It represents that this 
gene can be mobilized only with the help of this mobile element. 79.3% isolates 
harbouring sul-1 t)pe class 1 integrons were found associated with ORF513. This is 
showing higher occurreDce of complei class 1 integrons in studied collection of 
Indian Enterobacteriaceae. On determination of various combinations of mobile 
genetic elements in present collection, 5w/-7+CS+ORF513+IS£'cp7 is the most 
common combmation of mobile genetic elements followed by ^M/-/+CS+ 
ISfc^y+OlilFSn+ISi^. None of the studied isolates represents the 
IS£cp7-rORF513+IS2(5 combination of mobilizmg elements. In this study, all isolates 
have shown a single plasmid of c.a -23 kb. On analysis of randomly selected 
plasmids far CTX-M genogroups by multiplex PCR, most of the isolates have shown 
occurrence of CTX-M-genogroup-1 on plasmids while the isolate found positive for 
genogroup-l and genogroup-9 also showed the presence of these genogroups on 
plasmids. The isolate that harboured CTX-M genogroup-l and genogroup-9 also 
showed the presence of 5M/-7+CS+ \^Ecpl+\^26 but was not found positive for 
ORF5I3. 
142 
SUMMARY 
On RAPD typing of our collection, we observed that out of 130 isolates, 51 isolates 
could be clustered into 18 clusters which included 15 clusters ofE. coli and 3 clusters 
of Klebsiella spp. Most of the isolates that were clustered in different groups were 
from Surgeiy, and have also been found clonally related with the isolates collected 
from various other wards such as Orthopaedic, Medicine, Gynaecology and 
Paediatric. Only one isolate from Paediatric ward was found clonally related with 
isolates of Surgery and Gynaecology. 
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CHAPTER 7 
CONCLUSIONS 
• In the present study higher resistance rates were observed in our collection of 
Enterobacterial isolates. Among third-generation cephalosporins, 100% 
isolates were resistant to cefotaxime, followed by resistance to fourth-
generation cephalosporins. In our collection flouroquinolones also showed 
higher resistance rates such as 88.4% to ofloxacin but comparatively lower 
resistance rates to aminoglycosides was noticed. Resistance rates and patterns 
to tliird- as well as fourth-generation cephalosporins denotes the presence of 
class A and class C type P-lactamases in this collection of North Indian 
Enterobacteriaceae. 
• All cefotaxime resistant isolates were found as ESBL producers on the basis of 
any of the three detection methods such as double disk synergy test (DDST), 
combination disk test (CDT) and modified three-dimensional extract test 
(MTDET). In the present study we found CDT as the best detection method 
for identification of ESBL producers. 
• In our Enterobacterial collection, on molecular basis we found 93% (121/130) 
occurrence for bloESBu which included WOCTX-M 92.5% (112 121) as the 
predominant type of ESBL gene followed by blajESi 54.5% (66/121) and 
blasuw 45.4% (55/121). 62.8% isolates of this collection of Indian 
Enterobacteria showed co-occurrence of blacrx-u with ZJ/ATEM or blasuw or 
with both of these genes. Out of total /^OESBLS harbouring isolates, 29.7% 
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(36/121) were harbouring single gene of blacTK-u while only 3.3% (4/121) and 
2.4% (3/121) isolates harboured single gene of each blajEu and blasuw, 
respectively. This shows that in our collection higher occurrence of multiple 
genes has occurred due to the selection pressure developed by increasing 
usage of cephalosporins. 
• In tlie present study, by multiplex PCR, we found CTX-M-genogroup-1 as the 
predominant genogroup, but for the first time we also observed CTX-M-
genogroup-9 in one £ coli isolate that was confirmed by sequencing. This is 
showing that other CTX-M types are also emerging in Indian Enterobacteria. 
• Due to the presence of resistance to third- as well as fourth- generation 
cephalosporins in our isolates, of the ESBL positive isolates, 71.9% (87) also 
showed co-existence of bhampc with /^OESBLS- Moreover, in 112 isolates that 
harboured blacix-u genes, 75% showed co-existence of bloampc- This shows 
that in our collection of Indian Enterobacteriaceae class C type beta-
lactamases is concurrently present with class A type beta-lactamases on the 
same plasmid. 
•> On comparative studies of class A and class C t>pe P-lactamases in the 
Enterobacterial collections during 2009 and 2010, we found nearly similar 
occurrence of blaESBU in 92.1% and 94.4% isolates in the respective years, 
2009 and 2010. On characterization of co-existence of class A and class C 
type p-lactamases, we found that co-existence of these classes decreased from 
81.4% to 58.8% in the respective years, 2009 and 2010. This is showing 
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improvement of the prescription policies of antibiotics as well as the 
implementation of straight infection control policies in our Institution. 
• On determination of various mobile genetic elements {sul-1, CS region, 
ISEcpl, IS26 and ORF513), we found 89.2% (116/130) isolates carrying these 
mobile genetic elements with various bla genes and passively help in their 
mobilization. 92.8% isolates that harboured blacTX-M genes were found to be 
associated with these mobile genetic elements. We noticed higher number of 
isolates harbouring combination of CTX-M--TE.\t-SH\' that were associated 
with these mobile genetic elements for mobilization. 
• We also found 4.6% isolates which harboured only gene of blacrx-si but not 
associated with any mobile genetic elements, and passively in these cases bla 
genes were mobilized through plasmids. 
• 76.1% (99/130) isolates were found to harbour integrons (sul-1 and CS 
regions) and showed higher association of bla genes with sul-1 type class-1 
integrons than CS region. This denotes higher occurrence of classic class-1 
integrons in our collection as previously reported by Partridge et al. (2009) 
where it is being reported that presence of sul-1 gene in 3'CS region of class 1 
integron is the characteristic of classic class 1 integron and absence of this 
normal 3'CS region denotes the presence of non-classic class 1 integron. We 
also found that 17 isolates that harboured CS regions but not associated with 
sul-1 gene which is showing the presence of non-classic class 1 integrons for 
mobilization of various fe/oESBLs in this Enterobacterial collection. We also 
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found higher number of isolates harbouring combination of blacjx-
u+bla-TEM+blasHw associated with class 1 integrons. 
• We observed that all isolates that harboured SHV/TEM or combination of 
these genes were associated with sul-1 type integrons while none of the isolate 
was; found associated with the CS region of integrons, only one isolate that 
harboured SHV gene was found associated with CS region and IS26 like 
insertion sequence. So we can hypothesized that in our Enterobacterial 
coilection those isolates that harboured only SHV or TEM genes are mobilized 
more frequently by sul-1 t)T5e class 1 integrons. 
• On determination of various insertion sequences (ISEcpl, ORF513 and IS26) 
we found 83.8% (109/130) Enterobacteriaceae isolates that harboured 
insertion sequences such as ISEcpI, ORF513 (ISCRl) and IS26. Like 
integrons we also found these insertion sequences in most of the isolates that 
harboured combination of bhcTx-u^blaiEM+blasm- High frequency (56.9%) 
of isolates harbouring i/oESBLs was found associated with ISEcpJ, while least 
(33%) were found with IS26. 
<* We also found that in the present collection the isolates that harboured TEM 
or TEM+SHV genes were not associated with ISEcpl, while the isolates 
ha]-bouring only SHV-gene were associated \sith ISEcpl. This shows probably 
A/OTEM and combmation of blajEu^blasm is not mobilized by these mobile 
elements, while Z?/asHvgene is mobilized by this insertion sequence. 
• In the present study we observed that IS26 is most commonly found in those 
isolates that harboured blasm genes (with other ESBLs) and this shows that 
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the mobilization of SHV type of ESBLs is by IS26 elements. We also found 
various molecular sizes of 1826 elements inserted with bloESBLs, but amplicon 
size of ~850bp was the most frequently observed. We found four isolates that 
harboured only blacTx-u genes associated with only 1S26 elements, and thus 
suggests that this gene can even be mobilized only by the help of this insertion 
sequence. 
<• We also found CTX-M genogroup-9 like gene associated with ISEcpl and 
IS26, while this gene was not associated with ORF513 (also known as ISCRI). 
*l* Of the 69 isolates that harboured sul-J t)pe class-1 integrons, 13.9% (51) were 
found to harbour ORF57i which shows the higher occurrence of complex 
class-1 type integrons with bloESBLs including i/acrx-M in our North Indian 
collection of Enterobacteriaceae. 
•> We found all isolates to harbour -23 kb plasmid, and on analysis for the 
presence of various CTX-M genogroups on plasmids, we found presence of 
CTX-M-genogroup-1 and -9 on the plasmid. 
•t* By RAPD typing to determine the clonal relationship of our bacterial isolates, 
it can be concluded that probably the ver> same clone is circulating in the 
gynaecology, surgery and orthopaedics wards as these wards are sharing the 
same building block in our hospital and hence the chances of cross 
contamination are high; As some isolate from different wards were also found 
matching, so it can be concluded that still stringent sterilization conditions are 
not maintained in our hospital wards/operation theatres; however, variability 
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among isolates is still maintained. Therefore, we suggest further work-out 
steps to minimize the spread of bla genes in our hospital environment. 
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